{"status": "ok", "message-type": "work-list", "message-version": "1.0.0", "message": {"facets": {}, "total-results": 83032, "items": [{"indexed": {"date-parts": [[2019, 12, 2]], "date-time": "2019-12-02T12:25:28Z", "timestamp": 1575289528518}, "reference-count": 0, "publisher": "Ovid Technologies (Wolters Kluwer Health)", "issue": "3", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Contemporary Diagnostic Radiology"], "published-print": {"date-parts": [[2011, 1]]}, "DOI": "10.1097/01.cdr.0000393443.42458.29", "type": "journal-article", "created": {"date-parts": [[2013, 10, 11]], "date-time": "2013-10-11T23:32:57Z", "timestamp": 1381534377000}, "page": "6", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Molecular Breast Imaging"], "prefix": "10.1097", "volume": "34", "author": [{"family": "&NA;", "sequence": "first", "affiliation": []}], "member": "276", "container-title": ["Contemporary Diagnostic Radiology"], "language": "en", "deposited": {"date-parts": [[2013, 10, 11]], "date-time": "2013-10-11T23:32:58Z", "timestamp": 1381534378000}, "score": 25.261456, "subtitle": ["A New Modality for Diagnosing Breast Cancer"], "issued": {"date-parts": [[2011, 1]]}, "references-count": 0, "journal-issue": {"issue": "3"}, "URL": "http://dx.doi.org/10.1097/01.cdr.0000393443.42458.29", "ISSN": ["0149-9009"], "issn-type": [{"value": "0149-9009", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 30]], "date-time": "2019-11-30T23:50:24Z", "timestamp": 1575157824636}, "reference-count": 0, "publisher": "Springer Science and Business Media LLC", "issue": "S2", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2005, 6, 1]], "date-time": "2005-06-01T00:00:00Z", "timestamp": 1117584000000}, "delay-in-days": 0, "content-version": "unspecified"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Breast Cancer Res"], "published-print": {"date-parts": [[2005, 6]]}, "DOI": "10.1186/bcr1086", "type": "journal-article", "created": {"date-parts": [[2005, 6, 25]], "date-time": "2005-06-25T18:13:29Z", "timestamp": 1119723209000}, "source": "Crossref", "is-referenced-by-count": 1, "title": ["Dissection of molecular pathways of cancer by high-throughput biochip technologies and RNA interference"], "prefix": "10.1186", "volume": "7", "author": [{"given": "O", "family": "Kallioniemi", "sequence": "first", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2005, 6, 17]]}, "container-title": ["Breast Cancer Research"], "language": "en", "link": [{"URL": "http://link.springer.com/content/pdf/10.1186/bcr1086.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/article/10.1186/bcr1086/fulltext.html", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/content/pdf/10.1186/bcr1086.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 1, 18]], "date-time": "2017-01-18T15:14:49Z", "timestamp": 1484752489000}, "score": 24.964994, "issued": {"date-parts": [[2005, 6]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2005, 6]]}, "issue": "S2"}, "alternative-id": ["1084"], "URL": "http://dx.doi.org/10.1186/bcr1086", "ISSN": ["1465-542X"], "issn-type": [{"value": "1465-542X", "type": "electronic"}], "subject": ["Cancer Research", "Oncology"], "article-number": "S.43"}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T15:50:10Z", "timestamp": 1574178610800}, "reference-count": 20, "publisher": "Springer Science and Business Media LLC", "issue": "7", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Drugs & Therapy Perspectives"], "published-print": {"date-parts": [[2002, 7]]}, "DOI": "10.2165/00042310-200218070-00006", "type": "journal-article", "created": {"date-parts": [[2006, 1, 22]], "date-time": "2006-01-22T00:22:34Z", "timestamp": 1137889354000}, "page": "17-21", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Bisphosphonates reduce tumour-related osteolysis in breast cancer and multiple myeloma"], "prefix": "10.1007", "volume": "18", "author": [{"family": "&NA;", "sequence": "first", "affiliation": []}], "member": "297", "reference": [{"issue": "9", "key": "R1-6", "doi-asserted-by": "crossref", "first-page": "1253", "DOI": "10.2165/00003495-200161090-00003", "volume": "61", "author": "McCloskey", "year": "2001", "journal-title": "Drugs"}, {"issue": "3", "key": "R2-6", "doi-asserted-by": "crossref", "first-page": "391", "DOI": "10.2165/00003495-200059030-00001", "volume": "59", "author": "Diel", "year": "2000", "journal-title": "Drugs"}, {"key": "R3-6", "author": "Purohit", "volume": "72", "first-page": "1289", "year": "1995", "journal-title": "Br J Cancer", "DOI": "10.1038/bjc.1995.502", "doi-asserted-by": "crossref"}, {"key": "R4-6", "author": "Lahtinen", "volume": "340", "first-page": "1049", "year": "1992", "journal-title": "Lancet", "DOI": "10.1016/0140-6736(92)93075-X", "doi-asserted-by": "crossref"}, {"key": "R5-6", "author": "McCloskey", "volume": "100", "first-page": "317", "year": "1998", "journal-title": "Br J Haematol", "DOI": "10.1046/j.1365-2141.1998.00567.x", "doi-asserted-by": "crossref"}, {"key": "R6-6", "author": "Brincker", "volume": "101", "first-page": "280", "year": "1998", "journal-title": "Br J Haematol", "DOI": "10.1046/j.1365-2141.1998.00695.x", "doi-asserted-by": "crossref"}, {"key": "R7-6", "author": "Berenson", "volume": "16", "first-page": "593", "year": "1998", "journal-title": "J Clin oncol", "DOI": "10.1200/JCO.1998.16.2.593", "doi-asserted-by": "crossref"}, {"key": "R8-6", "author": "Paterson", "volume": "11", "first-page": "59", "year": "1993", "journal-title": "J Clin Oncol", "DOI": "10.1200/JCO.1993.11.1.59", "doi-asserted-by": "crossref"}, {"key": "R9-6", "author": "Kanis", "volume": "19", "first-page": "663", "year": "1996", "journal-title": "Bone", "DOI": "10.1016/S8756-3282(96)00285-2", "doi-asserted-by": "crossref"}, {"key": "R10-6", "author": "Hortobagyi", "volume": "16", "first-page": "2038", "year": "1998", "journal-title": "J Clin Oncol", "DOI": "10.1200/JCO.1998.16.6.2038", "doi-asserted-by": "crossref"}, {"key": "R11-6", "author": "Theriault", "volume": "17", "first-page": "846", "year": "1999", "journal-title": "J Clin Oncol", "DOI": "10.1200/JCO.1999.17.3.846", "doi-asserted-by": "crossref"}, {"key": "R12-6", "author": "Hultborn", "volume": "19", "first-page": "3383", "year": "1999", "journal-title": "Anticancer Res"}, {"key": "R13-6", "author": "Diel", "volume": "339", "first-page": "357", "year": "1998", "journal-title": "N Engl J Med", "DOI": "10.1056/NEJM199808063390601", "doi-asserted-by": "crossref"}, {"key": "R14-6", "author": "Riccardi", "volume": "5", "first-page": "833", "year": "1994", "journal-title": "Int J Oncol"}, {"key": "R15-6", "author": "Laitinen", "volume": "27", "first-page": "293", "year": "2000", "journal-title": "Bone", "DOI": "10.1016/S8756-3282(00)00321-5", "doi-asserted-by": "crossref"}, {"issue": "4", "key": "R17-6", "doi-asserted-by": "crossref", "first-page": "241", "DOI": "10.2165/00002512-199914040-00001", "volume": "14", "author": "Lipton", "year": "1999", "journal-title": "Drugs and Aging"}, {"key": "R18-6", "author": "Laakso", "volume": "87", "first-page": "725", "year": "1994", "journal-title": "Br J Haematol", "DOI": "10.1111/j.1365-2141.1994.tb06730.x", "doi-asserted-by": "crossref"}, {"key": "R19-6", "author": "Bruce", "volume": "104", "first-page": "358", "year": "1999", "journal-title": "Br J Haematol", "DOI": "10.1046/j.1365-2141.1999.01194.x", "doi-asserted-by": "crossref"}, {"key": "R21-6", "author": "Hillner", "volume": "18", "first-page": "72", "year": "2000", "journal-title": "J Clin Oncol", "DOI": "10.1200/JCO.2000.18.1.72", "doi-asserted-by": "crossref"}, {"key": "R22-6", "author": "Powles", "volume": "17", "first-page": "123", "year": "1998", "journal-title": "Prog Proc Am Soc Clin Oncol"}], "container-title": ["Drugs & Therapy Perspectives"], "language": "en", "deposited": {"date-parts": [[2019, 3, 21]], "date-time": "2019-03-21T15:37:01Z", "timestamp": 1553182621000}, "score": 24.339165, "subtitle": [""], "issued": {"date-parts": [[2002, 7]]}, "references-count": 20, "journal-issue": {"issue": "7"}, "URL": "http://dx.doi.org/10.2165/00042310-200218070-00006", "relation": {"cites": []}, "ISSN": ["1172-0360"], "issn-type": [{"value": "1172-0360", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 21]], "date-time": "2019-11-21T11:37:42Z", "timestamp": 1574336262001}, "reference-count": 0, "publisher": "Springer Science and Business Media LLC", "issue": "784", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Inpharma Weekly"], "published-print": {"date-parts": [[1991, 4]]}, "DOI": "10.2165/00128413-199107840-00038", "type": "journal-article", "created": {"date-parts": [[2007, 12, 5]], "date-time": "2007-12-05T11:48:03Z", "timestamp": 1196855283000}, "page": "14", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Multiple antineoplastic courses are better than a single course in node-positive breast cancer"], "prefix": "10.1007", "volume": "&NA;", "author": [{"family": "&NA;", "sequence": "first", "affiliation": []}], "member": "297", "container-title": ["Inpharma Weekly"], "language": "en", "deposited": {"date-parts": [[2013, 2, 27]], "date-time": "2013-02-27T13:35:01Z", "timestamp": 1361972101000}, "score": 24.339165, "subtitle": [""], "issued": {"date-parts": [[1991, 4]]}, "references-count": 0, "journal-issue": {"issue": "784"}, "URL": "http://dx.doi.org/10.2165/00128413-199107840-00038", "ISSN": ["1173-8324"], "issn-type": [{"value": "1173-8324", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 12, 4]], "date-time": "2019-12-04T23:52:02Z", "timestamp": 1575503522382}, "reference-count": 54, "publisher": "IGI Global", "isbn-type": [{"value": "9781799802495", "type": "print"}, {"value": "9781799802518", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2020]]}, "abstract": "<jats:p>The educational system is undergoing radical pressure to change. The increased need for individuals to learn and adapt has resulted in a huge demand for higher education. However, higher educational institutes are failing to keep pace with learner and societal needs. Firstly, the skills profile required for individuals to succeed is changing; there is a change in emphasis from discipline-specific to transversal skills due to the dynamic labor market. Secondly, the learner profile has changed with individuals from diverse backgrounds, cultures, abilities, and contexts, and catering for such a diverse range of students is challenging. Technology is a key enabler in providing HEIs with the means to address such issues. This chapter explores a conceptual model which integrates pedagogical approaches such as multiple intelligence theory, learning styles, competency-based education with digital technologies to offer a solution to some of the concerns facing higher education in the 21st century. </jats:p>", "DOI": "10.4018/978-1-7998-0249-5.ch002", "type": "book-chapter", "created": {"date-parts": [[2019, 8, 27]], "date-time": "2019-08-27T15:31:53Z", "timestamp": 1566919913000}, "page": "19-40", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Enhancing 21st Century Learning Using Digital Learning Objects and Multiple Intelligence Theory"], "prefix": "10.4018", "author": [{"given": "Emma", "family": "O Brien", "sequence": "first", "affiliation": [{"name": "Mary Immaculate College, Ireland"}]}], "member": "2432", "reference": [{"key": "978-1-7998-0249-5.ch002.-1", "author": "T.Armstrong", "year": "2009", "journal-title": "Multiple intelligences in the classroom"}, {"key": "978-1-7998-0249-5.ch002.-2", "unstructured": "Attwell, G. (2007). The personal learning environments - the future of eLearning? eLearn. Pap., 2(1)."}, {"key": "978-1-7998-0249-5.ch002.-3", "DOI": "10.12738/estp.2016.6.0015", "doi-asserted-by": "publisher"}, {"issue": "3", "key": "978-1-7998-0249-5.ch002.-4", "first-page": "365", "article-title": "Effects of multiple intelligences supported project-based learning on students\u2019 achievement levels and attitudes towards English lesson.", "volume": "2", "author": "G.Ba\u015f", "year": "2017", "journal-title": "International Electronic Journal of Elementary Education"}, {"key": "978-1-7998-0249-5.ch002.-5", "author": "H.Beetham", "year": "2013", "journal-title": "Rethinking pedagogy for a digital age: Designing for 21st century learning"}, {"key": "978-1-7998-0249-5.ch002.-6", "unstructured": "Bloom, B. S. (1956). Taxonomy of Educational Objectives. New York: Academic Press."}, {"key": "978-1-7998-0249-5.ch002.-7", "DOI": "10.1007/s40692-016-0069-y", "doi-asserted-by": "publisher"}, {"key": "978-1-7998-0249-5.ch002.-8", "unstructured": "Coffield, F., Moseley, D., Hall, E., & Ecclestone, K. (2004). Learning styles and pedagogy in post-16 learning: A systematic and critical review. Academic Press."}, {"key": "978-1-7998-0249-5.ch002.-9", "DOI": "10.1016/j.iheduc.2011.06.002", "doi-asserted-by": "publisher"}, {"key": "978-1-7998-0249-5.ch002.-10", "unstructured": "DCMI. (2014). Dublin Core Metadata Initiative. Retrieved from http://www.dublincore.org/documents/dcmi-terms/"}, {"key": "978-1-7998-0249-5.ch002.-11", "author": "R. A.DeLorenzo", "year": "2009", "journal-title": "Delivering on the promise."}, {"key": "978-1-7998-0249-5.ch002.-12", "DOI": "10.1111/j.1467-9620.2004.00322.x", "doi-asserted-by": "publisher"}, {"key": "978-1-7998-0249-5.ch002.-13", "author": "H.Digitalisierung", "year": "2017", "journal-title": "The digital turn \u00c0 pathways for higher education in the digital age"}, {"key": "978-1-7998-0249-5.ch002.-14", "DOI": "10.1177/1477878517735233", "doi-asserted-by": "publisher"}, {"key": "978-1-7998-0249-5.ch002.-15", "DOI": "10.1080/13562517.2018.1527763", "doi-asserted-by": "publisher"}, {"key": "978-1-7998-0249-5.ch002.-16", "unstructured": "Fallon, C., & Brown, S. (2000). e-Learning Standards: A Guide to Purchasing, Developing and Deploying Standards-Conformant E-Learning. St Lucie Press."}, {"key": "978-1-7998-0249-5.ch002.-17", "author": "R.Gagne", "year": "1992", "journal-title": "Principles of instructional design"}, {"key": "978-1-7998-0249-5.ch002.-18", "author": "H.Gardner", "year": "1993", "journal-title": "Frames of mind: The theory of multiple intelligences"}, {"key": "978-1-7998-0249-5.ch002.-19", "unstructured": "Gardner, H. (1999). Are there additional intelligences? The case for naturalist, spiritual, and existential intelligences. In Education, information and transformation. Englewood Cliffs, NJ: Prentice Hall."}, {"key": "978-1-7998-0249-5.ch002.-20", "author": "S.Hayden", "year": "2011", "journal-title": "Enabling Curricula: The Development of a Teaching Observation Protocol to Address Students\u2019 Diverse Learning Needs."}, {"key": "978-1-7998-0249-5.ch002.-21", "DOI": "10.1002/ase.1777", "doi-asserted-by": "publisher"}, {"key": "978-1-7998-0249-5.ch002.-22", "year": "1990", "journal-title": "IEEE Standard computer dictionary: A compilation of IEEE standard computer glossaries"}, {"key": "978-1-7998-0249-5.ch002.-23", "unstructured": "IEEE. (2002). Learning Object Metadata. Retrieved from https://standards.ieee.org/standard/1484_12_1-2002.html"}, {"key": "978-1-7998-0249-5.ch002.-24", "unstructured": "IMS. (2001). IMS Learning Resource Meta-Data Information Model. Retrieved from https://www.imsglobal.org/metadata/imsmdv1p2p1/imsmd_infov1p2p1.html"}, {"key": "978-1-7998-0249-5.ch002.-25", "author": "C.Jewitt", "year": "2006", "journal-title": "Technology, literacy and learning: A multimodal approach"}, {"key": "978-1-7998-0249-5.ch002.-26", "author": "R.Kelchen", "year": "2015", "journal-title": "The landscape of competency-based education"}, {"key": "978-1-7998-0249-5.ch002.-27", "author": "P. A.Kirschner", "year": "2018", "article-title": "Educating Youth for Nonexistent/Not Yet Existing Professions.", "journal-title": "Educational Policy"}, {"key": "978-1-7998-0249-5.ch002.-28", "DOI": "10.1007/978-3-319-46254-7_38", "doi-asserted-by": "publisher"}, {"key": "978-1-7998-0249-5.ch002.-29", "DOI": "10.4324/9780203160329", "doi-asserted-by": "publisher"}, {"key": "978-1-7998-0249-5.ch002.-30", "author": "E.Lawrence", "year": "1970", "journal-title": "The Origins and Growth of Modern Education"}, {"key": "978-1-7998-0249-5.ch002.-31", "author": "C.Le", "year": "2014", "journal-title": "The past and the promise: Today\u2019s competency education movement. Students at the Center: Competency Education Research Series"}, {"key": "978-1-7998-0249-5.ch002.-32", "unstructured": "Longmire, W. (2000, March). A Primer on Learning Objects. Learning Circuits, 6."}, {"key": "978-1-7998-0249-5.ch002.-33", "DOI": "10.1016/j.iheduc.2017.06.002", "doi-asserted-by": "publisher"}, {"key": "978-1-7998-0249-5.ch002.-34", "unstructured": "McCarthy, M., & Butler, B. (2013). Universal Design for Learning and Multiple Intelligences Theory and Practice as SoTL Levers. Academic Press."}, {"key": "978-1-7998-0249-5.ch002.-35", "author": "D.Merrill", "year": "1983", "article-title": "Component Display Theory", "journal-title": "Instructional-design theories and models: an overview of their current status"}, {"issue": "3", "key": "978-1-7998-0249-5.ch002.-36", "first-page": "39", "article-title": "Universal Design for Individual Differences.", "volume": "58", "author": "A.Meyer", "year": "2000", "journal-title": "Educational Leadership"}, {"key": "978-1-7998-0249-5.ch002.-37", "DOI": "10.1002/cbe2.1004", "doi-asserted-by": "publisher"}, {"key": "978-1-7998-0249-5.ch002.-38", "author": "V.Papageorgiou", "year": "2017", "journal-title": "Multimodal Teaching and Learning with the Use of Technology: Meanings, Practices and Discourses"}, {"key": "978-1-7998-0249-5.ch002.-39", "DOI": "10.1016/j.nedt.2016.09.010", "doi-asserted-by": "publisher"}, {"key": "978-1-7998-0249-5.ch002.-40", "author": "S.Redding", "first-page": "3", "year": "2016", "article-title": "Competencies and personalized learning", "journal-title": "Handbook on personalized learning for states, districts, and schools"}, {"key": "978-1-7998-0249-5.ch002.-41", "unstructured": "Reigeluth, C. (1999). The Elaboration Theory: Guidence for Scope and Sequence Decisions. In C. Reigeluth (Ed.), Instructional Design Theories and Models Volume 2: A new paradigm of Instructional Theory (pp. 428 \u2013 453). Mahwah, NJ: Lawrence Erlbaum."}, {"issue": "2", "key": "978-1-7998-0249-5.ch002.-42", "first-page": "135", "article-title": "Universal design for learning in postsecondary education: Reflections on principles and their application.", "volume": "19", "author": "D. H.Rose", "year": "2006", "journal-title": "Journal of postsecondary education and disability"}, {"key": "978-1-7998-0249-5.ch002.-43", "first-page": "859", "article-title": "Content analysis of Turkish studies about the multiple intelligences theory.", "volume": "9", "author": "A.Saban", "year": "2009", "journal-title": "Educational Sciences: Theory and Practice"}, {"key": "978-1-7998-0249-5.ch002.-44", "unstructured": "SCORM. (2004). SCORM 1.2. Retrieved on 13th May 2019 from https://scorm.com/scorm-explained/technical-scorm/scorm-12-overview-for-developers/"}, {"key": "978-1-7998-0249-5.ch002.-45", "DOI": "10.1111/j.1467-9620.2004.00325.x", "doi-asserted-by": "publisher"}, {"key": "978-1-7998-0249-5.ch002.-46", "unstructured": "Sinclair, G. (2010). Exploring Canada\u2019s digital future. Paper presented at the Congress of the Humanities and Social Science, Concordia University, Montreal, Canada."}, {"key": "978-1-7998-0249-5.ch002.-47", "author": "W.Surr", "year": "2015", "journal-title": "Partners in crafting competency-based pathways to college and career readiness"}, {"key": "978-1-7998-0249-5.ch002.-48", "unstructured": "Surr, W., & Redding, S. (2017). Competency-based education: staying shallow or going deep? Retrieved on June 17, 2019 from https://ccrscenter.org/sites/default/files/CBE_GoingDeep.pdf"}, {"issue": "10", "key": "978-1-7998-0249-5.ch002.-49", "first-page": "61", "article-title": "Enhancing Learning through Multiple Intelligences in Elementary Education", "volume": "2", "author": "E.Ucak", "year": "2006", "journal-title": "Journal of Baltic Science Education"}, {"key": "978-1-7998-0249-5.ch002.-50", "unstructured": "Union, I. (2014). Communication from the Commission to the European Parliament, the Council, the European Economic and Social Committee and the Committee of the Regions. Retrieved from http://www.xploit-eu.com/pdfs/Europe,202020,20"}, {"key": "978-1-7998-0249-5.ch002.-51", "unstructured": "Verbert, K., & Duval, E. (2004). Towards a Global Component Architecture for Learning Objects: A Comparative Analysis of Learning Object Content Models. Edmedia 2004, Lugano, Switzerland.", "DOI": "10.1007/978-3-540-30470-8_82", "doi-asserted-by": "crossref"}, {"key": "978-1-7998-0249-5.ch002.-52", "DOI": "10.1111/j.2044-8279.1998.tb01281.x", "doi-asserted-by": "publisher"}, {"key": "978-1-7998-0249-5.ch002.-53", "author": "D. A.Wiley", "year": "2000", "journal-title": "Learning Object Design and Sequencing Theory"}, {"key": "978-1-7998-0249-5.ch002.-54", "unstructured": "Wilson, S., Liber, O., Johnson, M., Beauvoir, P., Sharples, P., & Milligan, C. (2007). Personal learning environments: challenging the dominant design of educational systems. Journal of e-Learn, 3, 27\u201338."}], "container-title": ["Examining Multiple Intelligences and Digital Technologies for Enhanced Learning Opportunities", "Advances in Educational Technologies and Instructional Design"], "link": [{"URL": "https://www.igi-global.com/viewtitle.aspx?TitleId=236461", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 8, 27]], "date-time": "2019-08-27T15:32:32Z", "timestamp": 1566919952000}, "score": 23.419292, "subtitle": ["A Conceptual Model"], "issued": {"date-parts": [[2020]]}, "ISBN": ["9781799802495", "9781799802518"], "references-count": 54, "URL": "http://dx.doi.org/10.4018/978-1-7998-0249-5.ch002", "relation": {"cites": []}, "ISSN": ["2326-8905", "2326-8913"], "issn-type": [{"value": "2326-8905", "type": "print"}, {"value": "2326-8913", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 21]], "date-time": "2019-11-21T11:39:16Z", "timestamp": 1574336356200}, "reference-count": 0, "publisher": "Springer Science and Business Media LLC", "issue": "1064", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Inpharma Weekly"], "published-print": {"date-parts": [[1996, 11]]}, "DOI": "10.2165/00128413-199610640-00026", "type": "journal-article", "created": {"date-parts": [[2007, 12, 5]], "date-time": "2007-12-05T12:23:53Z", "timestamp": 1196857433000}, "page": "12", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Breast cancer vaccine extends survival in breast cancer"], "prefix": "10.1007", "volume": "&NA;", "author": [{"family": "&NA;", "sequence": "first", "affiliation": []}], "member": "297", "container-title": ["Inpharma Weekly"], "language": "en", "deposited": {"date-parts": [[2013, 2, 27]], "date-time": "2013-02-27T16:04:52Z", "timestamp": 1361981092000}, "score": 23.391521, "subtitle": [""], "issued": {"date-parts": [[1996, 11]]}, "references-count": 0, "journal-issue": {"issue": "1064"}, "URL": "http://dx.doi.org/10.2165/00128413-199610640-00026", "ISSN": ["1173-8324"], "issn-type": [{"value": "1173-8324", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T15:15:54Z", "timestamp": 1574522154575}, "reference-count": 0, "publisher": "Ovid Technologies (Wolters Kluwer Health)", "issue": "8", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Oncology Times UK"], "published-print": {"date-parts": [[2012, 8]]}, "DOI": "10.1097/01.otu.0000418755.79130.97", "type": "journal-article", "created": {"date-parts": [[2012, 12, 13]], "date-time": "2012-12-13T18:37:45Z", "timestamp": 1355423865000}, "page": "4", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Molecular \u2018post-it\u2019 signals metastasis risk in breast cancer"], "prefix": "10.1097", "volume": "9", "author": [{"family": "&NA;", "sequence": "first", "affiliation": []}], "member": "276", "container-title": ["Oncology Times UK"], "language": "en", "deposited": {"date-parts": [[2018, 2, 9]], "date-time": "2018-02-09T03:32:58Z", "timestamp": 1518147178000}, "score": 23.159264, "subtitle": [""], "issued": {"date-parts": [[2012, 8]]}, "references-count": 0, "journal-issue": {"issue": "8"}, "URL": "http://dx.doi.org/10.1097/01.otu.0000418755.79130.97", "ISSN": ["1742-8009"], "issn-type": [{"value": "1742-8009", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T07:00:56Z", "timestamp": 1574406056462}, "reference-count": 39, "publisher": "Genetics and Molecular Research", "issue": "1", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Genet. Mol. Res."], "DOI": "10.4238/vol9-1gmr649", "type": "journal-article", "created": {"date-parts": [[2010, 1, 18]], "date-time": "2010-01-18T11:56:50Z", "timestamp": 1263815810000}, "page": "97-106", "source": "Crossref", "is-referenced-by-count": 4, "title": ["Mammaglobin and maspin transcripts in blood may reflect disease progression and the effect of therapy in breast cancer"], "prefix": "10.4238", "volume": "9", "author": [{"given": "O.", "family": "Bitisik", "sequence": "first", "affiliation": []}, {"given": "P.", "family": "Saip", "sequence": "additional", "affiliation": []}, {"given": "S.", "family": "Saglam", "sequence": "additional", "affiliation": []}, {"given": "D.", "family": "Derin", "sequence": "additional", "affiliation": []}, {"given": "N.", "family": "Dalay", "sequence": "additional", "affiliation": []}], "member": "2758", "published-online": {"date-parts": [[2010]]}, "container-title": ["Genetics and Molecular Research"], "link": [{"URL": "http://www.funpecrp.com.br/gmr/year2010/vol9-1/pdf/gmr649.pdf", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 2, 1]], "date-time": "2019-02-01T13:41:55Z", "timestamp": 1549028515000}, "score": 22.952852, "issued": {"date-parts": [[2010]]}, "references-count": 39, "journal-issue": {"published-online": {"date-parts": [[2010]]}, "issue": "1"}, "URL": "http://dx.doi.org/10.4238/vol9-1gmr649", "ISSN": ["1676-5680"], "issn-type": [{"value": "1676-5680", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T03:43:41Z", "timestamp": 1574135021033}, "reference-count": 1, "publisher": "Springer Science and Business Media LLC", "issue": "S1", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2000, 3, 1]], "date-time": "2000-03-01T00:00:00Z", "timestamp": 951868800000}, "delay-in-days": 0, "content-version": "unspecified"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Breast Cancer Res"], "published-print": {"date-parts": [[2000, 3]]}, "DOI": "10.1186/bcr194", "type": "journal-article", "created": {"date-parts": [[2002, 9, 26]], "date-time": "2002-09-26T12:07:27Z", "timestamp": 1033042047000}, "source": "Crossref", "is-referenced-by-count": 0, "title": ["Tissue microarrays for high-throughput profiling in molecular oncology"], "prefix": "10.1186", "volume": "2", "author": [{"given": "O-P", "family": "Kallioniemi", "sequence": "first", "affiliation": []}, {"given": "J", "family": "Kononen", "sequence": "additional", "affiliation": []}, {"given": "G", "family": "Sauter", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2000, 3, 12]]}, "reference": [{"key": "193_CR1", "doi-asserted-by": "publisher", "first-page": "844", "DOI": "10.1038/nm0798-844", "volume": "4", "author": "Kononen", "year": "1998", "unstructured": "Kononen , et al: . Nature Med. 1998, 4: 844-847. 10.1038/nm0798-844.", "journal-title": "Nature Med"}], "container-title": ["Breast Cancer Research"], "language": "en", "link": [{"URL": "http://link.springer.com/content/pdf/10.1186/bcr194.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/article/10.1186/bcr194/fulltext.html", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/content/pdf/10.1186/bcr194.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 1, 18]], "date-time": "2017-01-18T11:34:29Z", "timestamp": 1484739269000}, "score": 22.74422, "issued": {"date-parts": [[2000, 3]]}, "references-count": 1, "journal-issue": {"published-print": {"date-parts": [[2000, 3]]}, "issue": "S1"}, "alternative-id": ["193"], "URL": "http://dx.doi.org/10.1186/bcr194", "relation": {"cites": []}, "ISSN": ["1465-542X"], "issn-type": [{"value": "1465-542X", "type": "electronic"}], "article-number": "S.34"}, {"indexed": {"date-parts": [[2019, 11, 25]], "date-time": "2019-11-25T22:31:52Z", "timestamp": 1574721112932}, "publisher-location": "Cham", "reference-count": 93, "publisher": "Springer International Publishing", "isbn-type": [{"value": "9783319417592", "type": "print"}, {"value": "9783319417615", "type": "electronic"}], "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2016, 1, 1]], "date-time": "2016-01-01T00:00:00Z", "timestamp": 1451606400000}, "delay-in-days": 0, "content-version": "unspecified"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2016]]}, "DOI": "10.1007/978-3-319-41761-5_8", "type": "book-chapter", "created": {"date-parts": [[2016, 11, 26]], "date-time": "2016-11-26T01:32:24Z", "timestamp": 1480123944000}, "page": "99-119", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Novel Immunohistochemical Based Biomarkers in Breast Cancer"], "prefix": "10.1007", "author": [{"given": "Emad A.", "family": "Rakha", "sequence": "first", "affiliation": []}, {"given": "Ian O.", "family": "Ellis", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2016, 11, 27]]}, "reference": [{"issue": "3", "key": "8_CR1", "doi-asserted-by": "crossref", "first-page": "340", "DOI": "10.1002/ijc.21004", "volume": "116", "author": "DM Abd El-Rehim", "year": "2005", "unstructured": "Abd El-Rehim DM, Ball G, Pinder SE et al (2005) High-throughput protein expression analysis using tissue microarray technology of a large well-characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analyses. Int J Cancer 116(3):340\u2013350", "journal-title": "Int J Cancer"}, {"issue": "4", "key": "8_CR2", "first-page": "419", "volume": "220", "author": "TM Abdel-Fatah", "year": "2010", "unstructured": "Abdel-Fatah TM, Powe DG, Agboola J et al (2010a) The biological, clinical and prognostic implications of p53 transcriptional pathways in breast cancers. J Pathol 220(4):419\u2013434", "journal-title": "J Pathol"}, {"issue": "4", "key": "8_CR3", "doi-asserted-by": "crossref", "first-page": "388", "DOI": "10.1002/path.2775", "volume": "222", "author": "TM Abdel-Fatah", "year": "2010", "unstructured": "Abdel-Fatah TM, Powe DG, Ball G et al (2010b) Proposal for a modified grading system based on mitotic index and Bcl2 provides objective determination of clinical outcome for patients with breast cancer. J Pathol 222(4):388\u2013399", "journal-title": "J Pathol"}, {"issue": "26", "key": "8_CR4", "doi-asserted-by": "crossref", "first-page": "21964", "DOI": "10.18632/oncotarget.4157", "volume": "6", "author": "TM Abdel-Fatah", "year": "2015", "unstructured": "Abdel-Fatah TM, Arora A, Moseley PM et al (2015) DNA repair prognostic index modelling reveals an essential role for base excision repair in influencing clinical outcomes in ER negative and triple negative breast cancers. Oncotarget 6(26):21964\u201321978", "journal-title": "Oncotarget"}, {"issue": "3", "key": "8_CR5", "doi-asserted-by": "crossref", "first-page": "511", "DOI": "10.1007/s10549-015-3348-9", "volume": "150", "author": "R Abduljabbar", "year": "2015", "unstructured": "Abduljabbar R, Al-Kaabi MM, Negm OH et al (2015a) Prognostic and biological significance of peroxisome proliferator-activated receptor-gamma in luminal breast cancer. Breast Cancer Res Treat 150(3):511\u2013522", "journal-title": "Breast Cancer Res Treat"}, {"issue": "2", "key": "8_CR6", "doi-asserted-by": "crossref", "first-page": "335", "DOI": "10.1007/s10549-015-3335-1", "volume": "150", "author": "R Abduljabbar", "year": "2015", "unstructured": "Abduljabbar R, Negm OH, Lai CF et al (2015b) Clinical and biological significance of glucocorticoid receptor (GR) expression in breast cancer. Breast Cancer Res Treat 150(2):335\u2013346", "journal-title": "Breast Cancer Res Treat"}, {"issue": "3", "key": "8_CR7", "doi-asserted-by": "crossref", "first-page": "979", "DOI": "10.1007/s10549-011-1865-8", "volume": "133", "author": "MA Ahmed", "year": "2012", "unstructured": "Ahmed MA, Aleskandarany MA, Rakha EA et al (2012) A CD44(\u2212)/CD24(+) phenotype is a poor prognostic marker in early invasive breast cancer. Breast Cancer Res Treat 133(3):979\u2013995", "journal-title": "Breast Cancer Res Treat"}, {"issue": "1", "key": "8_CR8", "doi-asserted-by": "crossref", "first-page": "204", "DOI": "10.1016/j.molonc.2014.08.001", "volume": "9", "author": "N Albarakati", "year": "2015", "unstructured": "Albarakati N, Abdel-Fatah TM, Doherty R et al (2015) Targeting BRCA1-BER deficient breast cancer by ATM or DNA-PKcs blockade either alone or in combination with cisplatin for personalized therapy. Mol Oncol 9(1):204\u2013217", "journal-title": "Mol Oncol"}, {"issue": "2", "key": "8_CR9", "doi-asserted-by": "crossref", "first-page": "407", "DOI": "10.1007/s10549-010-1012-y", "volume": "127", "author": "MA Aleskandarany", "year": "2011", "unstructured": "Aleskandarany MA, Rakha EA, Ahmed MA, Powe DG, Ellis IO, Green AR (2011) Clinicopathologic and molecular significance of phospho-Akt expression in early invasive breast cancer. Breast Cancer Res Treat 127(2):407\u2013416", "journal-title": "Breast Cancer Res Treat"}, {"issue": "1", "key": "8_CR10", "doi-asserted-by": "crossref", "first-page": "R3", "DOI": "10.1186/bcr3084", "volume": "14", "author": "MA Aleskandarany", "year": "2012", "unstructured": "Aleskandarany MA, Green AR, Benhasouna AA et al (2012) Prognostic value of proliferation assay in the luminal, HER2-positive, and triple-negative biologic classes of breast cancer. Breast Cancer Res 14(1):R3", "journal-title": "Breast Cancer Res"}, {"issue": "1", "key": "8_CR11", "doi-asserted-by": "crossref", "first-page": "81", "DOI": "10.1007/s10549-015-3306-6", "volume": "150", "author": "M Aleskandarany", "year": "2015", "unstructured": "Aleskandarany M, Caracappa D, Nolan CC et al (2015) DNA damage response markers are differentially expressed in BRCA-mutated breast cancers. Breast Cancer Res Treat 150(1):81\u201390", "journal-title": "Breast Cancer Res Treat"}, {"issue": "1", "key": "8_CR12", "doi-asserted-by": "crossref", "first-page": "97", "DOI": "10.1002/path.2976", "volume": "226", "author": "HR Ali", "year": "2012", "unstructured": "Ali HR, Dawson SJ, Blows FM et al (2012) A Ki67/BCL2 index based on immunohistochemistry is highly prognostic in ER-positive breast cancer. J Pathol 226(1):97\u2013107", "journal-title": "J Pathol"}, {"issue": "2", "key": "8_CR13", "doi-asserted-by": "crossref", "first-page": "301", "DOI": "10.1007/s10549-013-2542-x", "volume": "139", "author": "AT Alshareeda", "year": "2013", "unstructured": "Alshareeda AT, Negm OH, Albarakati N et al (2013) Clinicopathological significance of KU70/KU80, a key DNA damage repair protein in breast cancer. Breast Cancer Res Treat 139(2):301\u2013310", "journal-title": "Breast Cancer Res Treat"}, {"issue": "3", "key": "8_CR14", "doi-asserted-by": "crossref", "first-page": "519", "DOI": "10.1007/s10549-014-2897-7", "volume": "144", "author": "AT Alshareeda", "year": "2014", "unstructured": "Alshareeda AT, Negm OH, Green AR et al (2014) SUMOylation proteins in breast cancer. Breast Cancer Res Treat 144(3):519\u2013530", "journal-title": "Breast Cancer Res Treat"}, {"issue": "12", "key": "8_CR15", "doi-asserted-by": "crossref", "first-page": "1929", "DOI": "10.1038/bjc.2015.165", "volume": "112", "author": "AT Alshareeda", "year": "2015", "unstructured": "Alshareeda AT, Negm OH, Green AR et al (2015) KPNA2 is a nuclear export protein that contributes to aberrant localisation of key proteins and poor prognosis of breast cancer. Br J Cancer 112(12):1929\u20131937", "journal-title": "Br J Cancer"}, {"issue": "1", "key": "8_CR16", "doi-asserted-by": "crossref", "first-page": "6", "DOI": "10.1136/jcp.2008.059899", "volume": "62", "author": "S Badve", "year": "2009", "unstructured": "Badve S, Nakshatri H (2009) Oestrogen-receptor-positive breast cancer: towards bridging histopathological and molecular classifications. J Clin Pathol 62(1):6\u201312", "journal-title": "J Clin Pathol"}, {"issue": "3", "key": "8_CR17", "doi-asserted-by": "crossref", "first-page": "281", "DOI": "10.1007/BF00666005", "volume": "32", "author": "I Balslev", "year": "1994", "unstructured": "Balslev I, Axelsson CK, Zedeler K, Rasmussen BB, Carstensen B, Mouridsen HT (1994) The Nottingham Prognostic Index applied to 9149 patients from the studies of the Danish Breast Cancer Cooperative Group (DBCG). Breast Cancer Res Treat 32(3):281\u2013290", "journal-title": "Breast Cancer Res Treat"}, {"key": "8_CR18", "unstructured": "Bartlett JM, Thomas J, Ross DT et al (2010) Mammostrat as a tool to stratify breast cancer patients at risk of recurrence during endocrine therapy. Breast Cancer Res 12(4):R47. doi: 10.1186/bcr2604 (England)", "DOI": "10.1186/bcr2604", "doi-asserted-by": "publisher"}, {"issue": "36", "key": "8_CR19", "doi-asserted-by": "crossref", "first-page": "4477", "DOI": "10.1200/JCO.2012.42.8896", "volume": "30", "author": "JM Bartlett", "year": "2012", "unstructured": "Bartlett JM, Bloom KJ, Piper T et al (2012) Mammostrat as an immunohistochemical multigene assay for prediction of early relapse risk in the tamoxifen versus exemestane adjuvant multicenter trial pathology study. J Clin Oncol 30(36):4477\u20134484", "journal-title": "J Clin Oncol"}, {"issue": "10", "key": "8_CR20", "doi-asserted-by": "crossref", "first-page": "1545", "DOI": "10.1016/j.ejca.2007.01.003", "volume": "43", "author": "RW Blamey", "year": "2007", "unstructured": "Blamey RW, Pinder SE, Ball GR et al (2007) Reading the prognosis of the individual with breast cancer. Eur J Cancer 43(10):1545\u20131547", "journal-title": "Eur J Cancer"}, {"issue": "5", "key": "8_CR21", "doi-asserted-by": "crossref", "first-page": "e1000279", "DOI": "10.1371/journal.pmed.1000279", "volume": "7", "author": "FM Blows", "year": "2010", "unstructured": "Blows FM, Driver KE, Schmidt MK et al (2010) Subtyping of breast cancer by immunohistochemistry to investigate a relationship between subtype and short and long term survival: a collaborative analysis of data for 10,159 cases from 12 studies. PLoS Med 7(5):e1000279", "journal-title": "PLoS Med"}, {"issue": "3", "key": "8_CR22", "doi-asserted-by": "crossref", "first-page": "283", "DOI": "10.1007/BF00689843", "volume": "25", "author": "J Brown", "year": "1993", "unstructured": "Brown J, Jones M, Benson EA (1993) Comment on the Nottingham Prognostic Index. Breast Cancer Res Treat 25(3):283", "journal-title": "Breast Cancer Res Treat"}, {"issue": "1", "key": "8_CR23", "doi-asserted-by": "crossref", "first-page": "27", "DOI": "10.1097/00019606-200303000-00004", "volume": "12", "author": "G Callagy", "year": "2003", "unstructured": "Callagy G, Cattaneo E, Daigo Y et al (2003) Molecular classification of breast carcinomas using tissue microarrays. Diagn Mol Pathol 12(1):27\u201334", "journal-title": "Diagn Mol Pathol"}, {"key": "8_CR24", "doi-asserted-by": "crossref", "first-page": "153", "DOI": "10.1186/1471-2407-8-153", "volume": "8", "author": "GM Callagy", "year": "2008", "unstructured": "Callagy GM, Webber MJ, Pharoah PD, Caldas C (2008) Meta-analysis confirms BCL2 is an independent prognostic marker in breast cancer. BMC Cancer 8:153", "journal-title": "BMC Cancer"}, {"issue": "5", "key": "8_CR25", "doi-asserted-by": "crossref", "first-page": "1368", "DOI": "10.1158/1078-0432.CCR-07-1658", "volume": "14", "author": "MC Cheang", "year": "2008", "unstructured": "Cheang MC, Voduc D, Bajdik C et al (2008) Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype. Clin Cancer Res 14(5):1368\u20131376", "journal-title": "Clin Cancer Res"}, {"issue": "10", "key": "8_CR26", "doi-asserted-by": "crossref", "first-page": "736", "DOI": "10.1093/jnci/djp082", "volume": "101", "author": "MC Cheang", "year": "2009", "unstructured": "Cheang MC, Chia SK, Voduc D et al (2009) Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer. J Natl Cancer Inst 101(10):736\u2013750", "journal-title": "J Natl Cancer Inst"}, {"issue": "3", "key": "8_CR27", "doi-asserted-by": "crossref", "first-page": "631", "DOI": "10.1007/s10549-015-3288-4", "volume": "149", "author": "LY Chen", "year": "2015", "unstructured": "Chen LY, Tsang JY, Ni YB et al (2015) Bcl2 and Ki67 refine prognostication in luminal breast cancers. Breast Cancer Res Treat 149(3):631\u2013643", "journal-title": "Breast Cancer Res Treat"}, {"issue": "4", "key": "8_CR28", "doi-asserted-by": "crossref", "first-page": "339", "DOI": "10.1136/jclinpath-2011-200377", "volume": "65", "author": "Y Chia", "year": "2012", "unstructured": "Chia Y, Thike AA, Cheok PY, Chong LY-Z, Man-Kit Tse G, Tan PH (2012) Stromal keratin expression in phyllodes tumours of the breast: a comparison with other spindle cell breast lesions. J Clin Pathol 65(4):339\u2013347", "journal-title": "J Clin Pathol"}, {"issue": "1", "key": "8_CR29", "doi-asserted-by": "crossref", "first-page": "20", "DOI": "10.1111/j.1365-2559.2007.02898.x", "volume": "52", "author": "LC Collins", "year": "2008", "unstructured": "Collins LC, Schnitt SJ (2008) Papillary lesions of the breast: selected diagnostic and management issues. Histopathology 52(1):20\u201329", "journal-title": "Histopathology"}, {"issue": "11", "key": "8_CR30", "doi-asserted-by": "crossref", "first-page": "1723", "DOI": "10.1093/annonc/mdi352", "volume": "16", "author": "M Colozza", "year": "2005", "unstructured": "Colozza M, Azambuja E, Cardoso F, Sotiriou C, Larsimont D, Piccart MJ (2005) Proliferative markers as prognostic and predictive tools in early breast cancer: where are we now? Ann Oncol 16(11):1723\u20131739", "journal-title": "Ann Oncol"}, {"issue": "32", "key": "8_CR31", "doi-asserted-by": "crossref", "first-page": "4273", "DOI": "10.1200/JCO.2010.31.2835", "volume": "29", "author": "J Cuzick", "year": "2011", "unstructured": "Cuzick J, Dowsett M, Pineda S et al (2011) Prognostic value of a combined estrogen receptor, progesterone receptor, Ki-67, and human epidermal growth factor receptor 2 immunohistochemical score and comparison with the Genomic Health recurrence score in early breast cancer. J Clin Oncol 29(32):4273\u20134278", "journal-title": "J Clin Oncol"}, {"issue": "5", "key": "8_CR32", "doi-asserted-by": "crossref", "first-page": "591", "DOI": "10.1016/S0959-8049(00)00435-4", "volume": "37", "author": "G D\u2019Eredita", "year": "2001", "unstructured": "D\u2019Eredita G, Giardina C, Martellotta M, Natale T, Ferrarese F (2001) Prognostic factors in breast cancer: the predictive value of the Nottingham Prognostic Index in patients with a long-term follow-up that were treated in a single institution. Eur J Cancer 37(5):591\u2013596", "journal-title": "Eur J Cancer"}, {"issue": "5", "key": "8_CR33", "doi-asserted-by": "crossref", "first-page": "668", "DOI": "10.1038/sj.bjc.6605736", "volume": "103", "author": "SJ Dawson", "year": "2010", "unstructured": "Dawson SJ, Makretsov N, Blows FM et al (2010) BCL2 in breast cancer: a favourable prognostic marker across molecular subtypes and independent of adjuvant therapy received. Br J Cancer 103(5):668\u2013675", "journal-title": "Br J Cancer"}, {"key": "8_CR34", "unstructured": "de Azambuja E, Cardoso F, de Castro G, Jr. et al (2007) Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12,155 patients. Br J Cancer 96(10):1504\u20131513", "DOI": "10.1038/sj.bjc.6603756", "doi-asserted-by": "crossref"}, {"issue": "4", "key": "8_CR35", "first-page": "422", "volume": "135", "author": "R Dewar", "year": "2011", "unstructured": "Dewar R, Fadare O, Gilmore H, Gown AM (2011) Best practices in diagnostic immunohistochemistry: myoepithelial markers in breast pathology. Arch Pathol Lab Med 135(4):422\u2013429", "journal-title": "Arch Pathol Lab Med"}, {"issue": "1", "key": "8_CR36", "first-page": "147", "volume": "2", "author": "W Domagala", "year": "1996", "unstructured": "Domagala W, Markiewski M, Harezga B, Dukowicz A, Osborn M (1996) Prognostic significance of tumor cell proliferation rate as determined by the MIB-1 antibody in breast carcinoma: its relationship with vimentin and p53 protein. Clin Cancer Res 2(1):147\u2013154", "journal-title": "Clin Cancer Res"}, {"issue": "22", "key": "8_CR37", "doi-asserted-by": "crossref", "first-page": "2783", "DOI": "10.1200/JCO.2012.46.1558", "volume": "31", "author": "M Dowsett", "year": "2013", "unstructured": "Dowsett M, Sestak I, Lopez-Knowles E et al (2013) Comparison of PAM50 risk of recurrence score with oncotype DX and IHC4 for predicting risk of distant recurrence after endocrine therapy. J Clin Oncol 31(22):2783\u20132790", "journal-title": "J Clin Oncol"}, {"key": "8_CR38", "unstructured": "Early Breast Cancer Trialists\u2019 Collaborative Group (1998) Tamoxifen for early breast cancer: an overview of the randomised trials. Lancet 351(9114):1451\u20131467", "DOI": "10.1016/S0140-6736(97)11423-4", "doi-asserted-by": "crossref"}, {"issue": "9472", "key": "8_CR39", "doi-asserted-by": "crossref", "first-page": "1687", "DOI": "10.1016/S0140-6736(05)66544-0", "volume": "365", "author": "Early Breast Cancer Trialists\u2019 Collaborative Group", "year": "2005", "unstructured": "Early Breast Cancer Trialists\u2019 Collaborative Group (2005) Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 365(9472):1687\u20131717", "journal-title": "Lancet"}, {"issue": "9", "key": "8_CR40", "doi-asserted-by": "crossref", "first-page": "3802", "DOI": "10.1158/0008-5472.CAN-08-3907", "volume": "69", "author": "SE Elsheikh", "year": "2009", "unstructured": "Elsheikh SE, Green AR, Rakha EA et al (2009) Global histone modifications in breast cancer correlate with tumor phenotypes, prognostic factors, and patient outcome. Cancer Res 69(9):3802\u20133809", "journal-title": "Cancer Res"}, {"issue": "5", "key": "8_CR41", "doi-asserted-by": "crossref", "first-page": "403", "DOI": "10.1111/j.1365-2559.1991.tb00229.x", "volume": "19", "author": "CW Elston", "year": "1991", "unstructured": "Elston CW, Ellis IO (1991) Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 19(5):403\u2013410", "journal-title": "Histopathology"}, {"issue": "3", "key": "8_CR42", "doi-asserted-by": "crossref", "first-page": "209", "DOI": "10.1016/S1040-8428(99)00034-7", "volume": "31", "author": "CW Elston", "year": "1999", "unstructured": "Elston CW, Ellis IO, Pinder SE (1999) Pathological prognostic factors in breast cancer. Crit Rev Oncol Hematol 31(3):209\u2013223", "journal-title": "Crit Rev Oncol Hematol"}, {"issue": "3", "key": "8_CR43", "doi-asserted-by": "crossref", "first-page": "207", "DOI": "10.1007/BF01840834", "volume": "22", "author": "MH Galea", "year": "1992", "unstructured": "Galea MH, Blamey RW, Elston CE, Ellis IO (1992) The Nottingham Prognostic Index in primary breast cancer. Breast Cancer Res Treat 22(3):207\u2013219", "journal-title": "Breast Cancer Res Treat"}, {"issue": "15", "key": "8_CR44", "doi-asserted-by": "crossref", "first-page": "1206", "DOI": "10.1093/jnci/85.15.1206", "volume": "85", "author": "G Gasparini", "year": "1993", "unstructured": "Gasparini G, Pozza F, Harris AL (1993) Evaluating the potential usefulness of new prognostic and predictive indicators in node-negative breast cancer patients. J Natl Cancer Inst 85(15):1206\u20131219", "journal-title": "J Natl Cancer Inst"}, {"key": "8_CR45", "unstructured": "Goldhirsch A, Wood WC, Coates AS et al (2011) Strategies for subtypes\u2014dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011. Ann Oncol 22(8): 1736\u20131747. doi: 10.1093/annonc/mdr304 (England)", "DOI": "10.1093/annonc/mdr304", "doi-asserted-by": "publisher"}, {"issue": "9", "key": "8_CR46", "doi-asserted-by": "crossref", "first-page": "2206", "DOI": "10.1093/annonc/mdt303", "volume": "24", "author": "A Goldhirsch", "year": "2013", "unstructured": "Goldhirsch A, Winer EP, Coates AS et al (2013) Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013. Ann Oncol 24(9):2206\u20132223", "journal-title": "Ann Oncol"}, {"issue": "7", "key": "8_CR47", "doi-asserted-by": "crossref", "first-page": "1886", "DOI": "10.1038/bjc.2013.528", "volume": "109", "author": "AR Green", "year": "2013", "unstructured": "Green AR, Powe DG, Rakha EA et al (2013) Identification of key clinical phenotypes of breast cancer using a reduced panel of protein biomarkers. Br J Cancer 109(7):1886\u20131894", "journal-title": "Br J Cancer"}, {"issue": "3", "key": "8_CR48", "doi-asserted-by": "crossref", "first-page": "603", "DOI": "10.1007/s10549-009-0419-9", "volume": "120", "author": "HO Habashy", "year": "2010", "unstructured": "Habashy HO, Powe DG, Rakha EA et al (2010) The prognostic significance of PELP1 expression in invasive breast cancer with emphasis on the ER-positive luminal-like subtype. Breast Cancer Res Treat 120(3):603\u2013612", "journal-title": "Breast Cancer Res Treat"}, {"issue": "2", "key": "8_CR49", "doi-asserted-by": "crossref", "first-page": "315", "DOI": "10.1007/s10549-010-1073-y", "volume": "128", "author": "HO Habashy", "year": "2011", "unstructured": "Habashy HO, Powe DG, Glaab E et al (2011a) RERG (Ras-like, oestrogen-regulated, growth-inhibitor) expression in breast cancer: a marker of ER-positive luminal-like subtype. Breast Cancer Res Treat 128(2):315\u2013326", "journal-title": "Breast Cancer Res Treat"}, {"issue": "1", "key": "8_CR50", "doi-asserted-by": "crossref", "first-page": "11", "DOI": "10.1007/s10549-010-1161-z", "volume": "129", "author": "HO Habashy", "year": "2011", "unstructured": "Habashy HO, Rakha EA, Aleskandarany M et al (2011b) FOXO3a nuclear localisation is associated with good prognosis in luminal-like breast cancer. Breast Cancer Res Treat 129(1):11\u201321", "journal-title": "Breast Cancer Res Treat"}, {"issue": "2", "key": "8_CR51", "doi-asserted-by": "crossref", "first-page": "307", "DOI": "10.1007/s10549-013-2614-y", "volume": "140", "author": "HO Habashy", "year": "2013", "unstructured": "Habashy HO, Rakha EA, Ellis IO, Powe DG (2013) The oestrogen receptor coactivator CARM1 has an oncogenic effect and is associated with poor prognosis in breast cancer. Breast Cancer Res Treat 140(2):307\u2013316", "journal-title": "Breast Cancer Res Treat"}, {"issue": "16", "key": "8_CR52", "doi-asserted-by": "crossref", "first-page": "2784", "DOI": "10.1200/JCO.2009.25.6529", "volume": "28", "author": "ME Hammond", "year": "2010", "unstructured": "Hammond ME, Hayes DF, Dowsett M et al (2010) American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. J Clin Oncol 28(16):2784\u20132795", "journal-title": "J Clin Oncol"}, {"issue": "33", "key": "8_CR53", "doi-asserted-by": "crossref", "first-page": "5287", "DOI": "10.1200/JCO.2007.14.2364", "volume": "25", "author": "L Harris", "year": "2007", "unstructured": "Harris L, Fritsche H, Mennel R et al (2007) American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer. J Clin Oncol 25(33):5287\u20135312", "journal-title": "J Clin Oncol"}, {"issue": "3", "key": "8_CR54", "doi-asserted-by": "crossref", "first-page": "361", "DOI": "10.1038/bjc.1982.62", "volume": "45", "author": "JL Haybittle", "year": "1982", "unstructured": "Haybittle JL, Blamey RW, Elston CW et al (1982) A prognostic index in primary breast cancer. Br J Cancer 45(3):361\u2013366", "journal-title": "Br J Cancer"}, {"issue": "1\u20133", "key": "8_CR55", "doi-asserted-by": "crossref", "first-page": "305", "DOI": "10.1023/A:1006197805041", "volume": "52", "author": "DF Hayes", "year": "1998", "unstructured": "Hayes DF, Trock B, Harris AL (1998) Assessing the clinical impact of prognostic factors: when is \u201cstatistically significant\u201d clinically useful? Breast Cancer Res Treat 52(1\u20133):305\u2013319", "journal-title": "Breast Cancer Res Treat"}, {"issue": "2", "key": "8_CR56", "doi-asserted-by": "crossref", "first-page": "539", "DOI": "10.1007/s10549-013-2560-8", "volume": "139", "author": "EC Inwald", "year": "2013", "unstructured": "Inwald EC, Klinkhammer-Schalke M, Hofstadter F et al (2013) Ki-67 is a prognostic parameter in breast cancer patients: results of a large population-based cohort of a cancer registry. Breast Cancer Res Treat 139(2):539\u2013552", "journal-title": "Breast Cancer Res Treat"}, {"issue": "1", "key": "8_CR57", "doi-asserted-by": "crossref", "first-page": "91", "DOI": "10.1007/s10549-015-3308-4", "volume": "150", "author": "DA Jerjees", "year": "2015", "unstructured": "Jerjees DA, Negm OH, Alabdullah ML et al (2015) The mammalian target of rapamycin complex 1 (mTORC1) in breast cancer: the impact of oestrogen receptor and HER2 pathways. Breast Cancer Res Treat 150(1):91\u2013103", "journal-title": "Breast Cancer Res Treat"}, {"key": "8_CR58", "doi-asserted-by": "crossref", "first-page": "31", "DOI": "10.4103/1477-3163.90676", "volume": "10", "author": "C Karakas", "year": "2011", "unstructured": "Karakas C (2011) Paget\u2019s disease of the breast. J Carcinog 10:31", "journal-title": "J Carcinog"}, {"issue": "11", "key": "8_CR59", "doi-asserted-by": "crossref", "first-page": "1438", "DOI": "10.1038/modpathol.2010.141", "volume": "23", "author": "M Lacroix-Triki", "year": "2010", "unstructured": "Lacroix-Triki M, Geyer FC, Lambros MB et al (2010) Beta-catenin/Wnt signalling pathway in fibromatosis, metaplastic carcinomas and phyllodes tumours of the breast. Mod Pathol 23(11):1438\u20131448", "journal-title": "Mod Pathol"}, {"issue": "12", "key": "8_CR60", "doi-asserted-by": "crossref", "first-page": "1333", "DOI": "10.1136/jcp.2006.046078", "volume": "60", "author": "AH Lee", "year": "2007", "unstructured": "Lee AH (2007) The histological diagnosis of metastases to the breast from extramammary malignancies. J Clin Pathol 60(12):1333\u20131341", "journal-title": "J Clin Pathol"}, {"issue": "18", "key": "8_CR61", "doi-asserted-by": "crossref", "first-page": "1285", "DOI": "10.1093/jnci/djj357", "volume": "98", "author": "D Mauri", "year": "2006", "unstructured": "Mauri D, Pavlidis N, Polyzos NP, Ioannidis JP (2006) Survival with aromatase inhibitors and inactivators versus standard hormonal therapy in advanced breast cancer: meta-analysis. J Natl Cancer Inst 98(18):1285\u20131291", "journal-title": "J Natl Cancer Inst"}, {"key": "8_CR62", "first-page": "37", "volume": "6", "author": "K Mislick", "year": "2014", "unstructured": "Mislick K, Schonfeld W, Bodnar C, Tong KB (2014) Cost-effectiveness analysis of Mammostrat(R) compared with Oncotype DX(R) to inform the treatment of breast cancer. ClinicoEcon Outcomes Res 6:37\u201347", "journal-title": "ClinicoEcon Outcomes Res"}, {"issue": "16", "key": "8_CR63", "doi-asserted-by": "crossref", "first-page": "5367", "DOI": "10.1158/1078-0432.CCR-04-0220", "volume": "10", "author": "TO Nielsen", "year": "2004", "unstructured": "Nielsen TO, Hsu FD, Jensen K et al (2004) Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma. Clin Cancer Res 10(16):5367\u20135374", "journal-title": "Clin Cancer Res"}, {"issue": "3", "key": "8_CR64", "doi-asserted-by": "crossref", "first-page": "232", "DOI": "10.1046/j.1365-2559.2000.00882.x", "volume": "37", "author": "F Otterbach", "year": "2000", "unstructured": "Otterbach F, Bankfalvi A, Bergner S, Decker T, Krech R, Boecker W (2000) Cytokeratin 5/6 immunohistochemistry assists the differential diagnosis of atypical proliferations of the breast. Histopathology 37(3):232\u2013240", "journal-title": "Histopathology"}, {"issue": "1", "key": "8_CR65", "doi-asserted-by": "crossref", "first-page": "11", "DOI": "10.1007/s00428-007-0435-2", "volume": "451", "author": "D Park", "year": "2007", "unstructured": "Park D, Karesen R, Noren T, Sauer T (2007) Ki-67 expression in primary breast carcinomas and their axillary lymph node metastases: clinical implications. Virchows Arch 451(1):11\u201318", "journal-title": "Virchows Arch"}, {"key": "8_CR66", "unstructured": "Pathology Reporting of Breast Disease (2005a) A Joint Document Incorporating the Third Edition of the NHS Breast Screening Programme\u2019s Guidelines for Pathology Reporting in Breast Cancer Screening and the Second Edition of The Royal College of Pathologists\u2019 Minimum Dataset for Breast Cancer Histopathology. NHSBSP Pub. No 58"}, {"key": "8_CR67", "unstructured": "Pathology Reporting of Breast Disease (2005b) A Joint Document Incorporating the Third Edition of the NHS Breast Screening Programme\u2019s Guidelines for Pathology Reporting in Breast Cancer Screening and the Second Edition of The Royal College of Pathologists\u2019 Minimum Dataset for Breast Cancer Histopathology. (January 2005)"}, {"issue": "6797", "key": "8_CR68", "doi-asserted-by": "crossref", "first-page": "747", "DOI": "10.1038/35021093", "volume": "406", "author": "CM Perou", "year": "2000", "unstructured": "Perou CM, Sorlie T, Eisen MB et al (2000) Molecular portraits of human breast tumours. Nature 406(6797):747\u2013752", "journal-title": "Nature"}, {"issue": "3", "key": "8_CR69", "doi-asserted-by": "crossref", "first-page": "477", "DOI": "10.1007/s10549-015-3559-0", "volume": "153", "author": "F Petrelli", "year": "2015", "unstructured": "Petrelli F, Viale G, Cabiddu M, Barni S (2015) Prognostic value of different cut-off levels of Ki-67 in breast cancer: a systematic review and meta-analysis of 64,196 patients. Breast Cancer Res Treat 153(3):477\u2013491", "journal-title": "Breast Cancer Res Treat"}, {"key": "8_CR70", "first-page": "5", "volume": "207", "author": "E Rakha", "year": "2005", "unstructured": "Rakha E, Putti T, Abd El-Rehim D, Paish EC, Ellis I (2005) Breast carcinomas with basal/myoepithelial differentiation: a review of morphology and immunophenotypical analysis. J Pathol 207:5", "journal-title": "J Pathol"}, {"issue": "1", "key": "8_CR71", "doi-asserted-by": "crossref", "first-page": "67", "DOI": "10.1111/j.1365-2559.2007.02894.x", "volume": "52", "author": "EA Rakha", "year": "2008", "unstructured": "Rakha EA, El-Sayed ME, Reis-Filho JS, Ellis IO (2008a) Expression profiling technology: its contribution to our understanding of breast cancer. Histopathology 52(1):67\u201381", "journal-title": "Histopathology"}, {"issue": "6", "key": "8_CR72", "doi-asserted-by": "crossref", "first-page": "857", "DOI": "10.1016/j.humpath.2007.10.011", "volume": "39", "author": "EA Rakha", "year": "2008", "unstructured": "Rakha EA, El-Sheikh SE, Kandil MA, El-Sayed ME, Green AR, Ellis IO (2008b) Expression of BRCA1 protein in breast cancer and its prognostic significance. Hum Pathol 39(6):857\u2013865", "journal-title": "Hum Pathol"}, {"issue": "7", "key": "8_CR73", "doi-asserted-by": "crossref", "first-page": "2302", "DOI": "10.1158/1078-0432.CCR-08-2132", "volume": "15", "author": "EA Rakha", "year": "2009", "unstructured": "Rakha EA, Elsheikh SE, Aleskandarany MA et al (2009) Triple-negative breast cancer: distinguishing between basal and nonbasal subtypes. Clin Cancer Res 15(7):2302\u20132310", "journal-title": "Clin Cancer Res"}, {"issue": "10", "key": "8_CR74", "doi-asserted-by": "crossref", "first-page": "1472", "DOI": "10.1097/PAS.0b013e3181f01916", "volume": "34", "author": "EA Rakha", "year": "2010", "unstructured": "Rakha EA, Patel A, Powe DG et al (2010) Clinical and biological significance of E-cadherin protein expression in invasive lobular carcinoma of the breast. Am J Surg Pathol 34(10):1472\u20131479", "journal-title": "Am J Surg Pathol"}, {"issue": "8", "key": "8_CR75", "doi-asserted-by": "crossref", "first-page": "1093", "DOI": "10.1097/PAS.0b013e31821b3f65", "volume": "35", "author": "EA Rakha", "year": "2011", "unstructured": "Rakha EA, Gandhi N, Climent F et al (2011) Encapsulated papillary carcinoma of the breast: an invasive tumor with excellent prognosis. Am J Surg Pathol 35(8):1093\u20131103", "journal-title": "Am J Surg Pathol"}, {"issue": "5", "key": "8_CR76", "doi-asserted-by": "crossref", "first-page": "695", "DOI": "10.1111/his.12066", "volume": "62", "author": "EA Rakha", "year": "2013", "unstructured": "Rakha EA, Teoh TK, Lee AH, Nolan CC, Ellis IO, Green AR (2013) Further evidence that E-cadherin is not a tumour suppressor gene in invasive ductal carcinoma of the breast: an immunohistochemical study. Histopathology 62(5):695\u2013701", "journal-title": "Histopathology"}, {"issue": "7", "key": "8_CR77", "doi-asserted-by": "crossref", "first-page": "1688", "DOI": "10.1038/bjc.2014.120", "volume": "110", "author": "EA Rakha", "year": "2014", "unstructured": "Rakha EA, Soria D, Green AR et al (2014a) Nottingham Prognostic Index Plus (NPI+): a modern clinical decision making tool in breast cancer. Br J Cancer 110(7):1688\u20131697", "journal-title": "Br J Cancer"}, {"key": "8_CR78", "unstructured": "Rakha EA, Soria D, Green AR et al (2014b) Nottingham Prognostic Index Plus (NPI+): a modern clinical decision making tool in breast cancer. Br J Cancer", "DOI": "10.1038/bjc.2014.120", "doi-asserted-by": "crossref"}, {"key": "8_CR79", "unstructured": "Rakha EA, Soria D, Green AR et al (2014c) Nottingham Prognostic Index Plus (NPI+): a modern clinical decision making tool in breast cancer. Br J Cancer 1532\u20131827 (Electronic)", "DOI": "10.1038/bjc.2014.120", "doi-asserted-by": "crossref"}, {"issue": "2", "key": "8_CR80", "doi-asserted-by": "crossref", "first-page": "93", "DOI": "10.1136/jclinpath-2014-202571", "volume": "68", "author": "EA Rakha", "year": "2015", "unstructured": "Rakha EA, Pinder SE, Bartlett JM et al (2015) Updated UK recommendations for HER2 assessment in breast cancer. J Clin Pathol 68(2):93\u201399", "journal-title": "J Clin Pathol"}, {"issue": "19", "key": "8_CR81", "doi-asserted-by": "crossref", "first-page": "3039", "DOI": "10.1200/JCO.2006.05.6564", "volume": "24", "author": "BZ Ring", "year": "2006", "unstructured": "Ring BZ, Seitz RS, Beck R et al (2006) Novel prognostic immunohistochemical biomarker panel for estrogen receptor-positive breast cancer. J Clin Oncol 24(19):3039\u20133047", "journal-title": "J Clin Oncol"}, {"issue": "6", "key": "8_CR82", "doi-asserted-by": "crossref", "first-page": "1311", "DOI": "10.1002/ijc.22430", "volume": "120", "author": "P Rolland", "year": "2007", "unstructured": "Rolland P, Spendlove I, Madjd Z et al (2007) The p53 positive Bcl-2 negative phenotype is an independent marker of prognosis in breast cancer. Int J Cancer 120(6):1311\u20131317", "journal-title": "Int J Cancer"}, {"key": "8_CR83", "unstructured": "Ross DT, Kim CY, Tang G et al (2008) Chemosensitivity and stratification by a five monoclonal antibody immunohistochemistry test in the NSABP B14 and B20 trials. Clin Cancer Res 14(20):6602\u20136609. doi: 10.1158/1078-0432.ccr-08-0647 (United States)", "DOI": "10.1158/1078-0432.ccr-08-0647", "doi-asserted-by": "publisher"}, {"issue": "Suppl 5", "key": "8_CR84", "doi-asserted-by": "crossref", "first-page": "v8", "DOI": "10.1093/annonc/mdv298", "volume": "26", "author": "E Senkus", "year": "2015", "unstructured": "Senkus E, Kyriakides S, Ohno S et al (2015) Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 26(Suppl 5):v8\u2013v30", "journal-title": "Ann Oncol"}, {"issue": "3", "key": "8_CR85", "doi-asserted-by": "crossref", "first-page": "237", "DOI": "10.1002/(SICI)1096-9896(199907)188:3<237::AID-PATH343>3.0.CO;2-8", "volume": "188", "author": "BS Shoker", "year": "1999", "unstructured": "Shoker BS, Jarvis C, Sibson DR, Walker C, Sloane JP (1999) Oestrogen receptor expression in the normal and pre-cancerous breast. J Pathol 188(3):237\u2013244", "journal-title": "J Pathol"}, {"issue": "19", "key": "8_CR86", "doi-asserted-by": "crossref", "first-page": "10869", "DOI": "10.1073/pnas.191367098", "volume": "98", "author": "T Sorlie", "year": "2001", "unstructured": "Sorlie T, Perou CM, Tibshirani R et al (2001) Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A 98(19):10869\u201310874", "journal-title": "Proc Natl Acad Sci U S A"}, {"issue": "4", "key": "8_CR87", "doi-asserted-by": "crossref", "first-page": "323", "DOI": "10.1016/j.breast.2008.02.002", "volume": "17", "author": "R Stuart-Harris", "year": "2008", "unstructured": "Stuart-Harris R, Caldas C, Pinder SE, Pharoah P (2008) Proliferation markers and survival in early breast cancer: a systematic review and meta-analysis of 85 studies in 32,825 patients. Breast 17(4):323\u2013334", "journal-title": "Breast"}, {"issue": "5", "key": "8_CR88", "doi-asserted-by": "crossref", "first-page": "1321", "DOI": "10.1002/cncr.11188", "volume": "97", "author": "H Trihia", "year": "2003", "unstructured": "Trihia H, Murray S, Price K et al (2003) Ki-67 expression in breast carcinoma: its association with grading systems, clinical parameters, and other prognostic factors\u2013a surrogate marker? Cancer 97(5):1321\u20131331", "journal-title": "Cancer"}, {"issue": "34", "key": "8_CR89", "doi-asserted-by": "crossref", "first-page": "5569", "DOI": "10.1200/JCO.2008.17.0829", "volume": "26", "author": "G Viale", "year": "2008", "unstructured": "Viale G, Giobbie-Hurder A, Regan MM et al (2008a) Prognostic and predictive value of centrally reviewed Ki-67 labeling index in postmenopausal women with endocrine-responsive breast cancer: results from Breast International Group Trial 1-98 comparing adjuvant tamoxifen with letrozole. J Clin Oncol 26(34):5569\u20135575", "journal-title": "J Clin Oncol"}, {"issue": "3", "key": "8_CR90", "doi-asserted-by": "crossref", "first-page": "207", "DOI": "10.1093/jnci/djm289", "volume": "100", "author": "G Viale", "year": "2008", "unstructured": "Viale G, Regan MM, Mastropasqua MG et al (2008b) Predictive value of tumor Ki-67 expression in two randomized trials of adjuvant chemoendocrine therapy for node-negative breast cancer. J Natl Cancer Inst 100(3):207\u2013212", "journal-title": "J Natl Cancer Inst"}, {"issue": "9", "key": "8_CR91", "doi-asserted-by": "crossref", "first-page": "3077", "DOI": "10.1158/0008-5472.CAN-07-3293", "volume": "68", "author": "IB Weinstein", "year": "2008", "unstructured": "Weinstein IB, Joe A (2008) Oncogene addiction. Cancer Res 68(9):3077\u20133080", "journal-title": "Cancer Res"}, {"issue": "31", "key": "8_CR92", "doi-asserted-by": "crossref", "first-page": "3997", "DOI": "10.1200/JCO.2013.50.9984", "volume": "31", "author": "AC Wolff", "year": "2013", "unstructured": "Wolff AC, Hammond ME, Hicks DG et al (2013) Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update. J Clin Oncol 31(31):3997\u20134013", "journal-title": "J Clin Oncol"}, {"issue": "8", "key": "8_CR93", "doi-asserted-by": "crossref", "first-page": "766", "DOI": "10.1136/jclinpath-2012-200726", "volume": "65", "author": "R Yamaguchi", "year": "2012", "unstructured": "Yamaguchi R, Maeshiro K, Ellis IO et al (2012) Infiltrative epitheliosis of the breast. J Clin Pathol 65(8):766\u2013768", "journal-title": "J Clin Pathol"}], "container-title": ["Molecular Pathology of Breast Cancer"], "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/978-3-319-41761-5_8", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 9, 16]], "date-time": "2019-09-16T00:11:08Z", "timestamp": 1568592668000}, "score": 22.74422, "issued": {"date-parts": [[2016]]}, "ISBN": ["9783319417592", "9783319417615"], "references-count": 93, "URL": "http://dx.doi.org/10.1007/978-3-319-41761-5_8", "relation": {"cites": []}}, {"indexed": {"date-parts": [[2019, 11, 21]], "date-time": "2019-11-21T02:39:06Z", "timestamp": 1574303946172}, "reference-count": 0, "publisher": "Thomas Telford Ltd.", "issue": "1847", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Minutes of the Proceedings of the Institution of Civil Engineers"], "published-print": {"date-parts": [[1847, 1]]}, "DOI": "10.1680/imotp.1847.24289", "type": "journal-article", "created": {"date-parts": [[2007, 7, 3]], "date-time": "2007-07-03T13:10:23Z", "timestamp": 1183468223000}, "page": "478-484", "source": "Crossref", "is-referenced-by-count": 0, "title": ["DISCUSSION. THE DYMCHURCH WALL, WHICH FORMS THE SEA DEFENCES OF ROMNEY MARSH."], "prefix": "10.1680", "volume": "6", "author": [{"given": "D", "family": "O BRIEN", "sequence": "first", "affiliation": []}], "member": "735", "container-title": ["Minutes of the Proceedings of the Institution of Civil Engineers"], "language": "en", "link": [{"URL": "http://www.icevirtuallibrary.com/doi/pdf/10.1680/imotp.1847.24289", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2016, 8, 25]], "date-time": "2016-08-25T02:48:00Z", "timestamp": 1472093280000}, "score": 22.544167, "issued": {"date-parts": [[1847, 1]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[1847, 1]]}, "issue": "1847"}, "alternative-id": ["10.1680/imotp.1847.24289"], "URL": "http://dx.doi.org/10.1680/imotp.1847.24289", "ISSN": ["1753-7843"], "issn-type": [{"value": "1753-7843", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 25]], "date-time": "2019-11-25T22:10:19Z", "timestamp": 1574719819442}, "publisher-location": "New York, NY", "reference-count": 136, "publisher": "Springer New York", "isbn-type": [{"value": "9781493928859", "type": "print"}, {"value": "9781493928866", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2015]]}, "DOI": "10.1007/978-1-4939-2886-6_10", "type": "book-chapter", "created": {"date-parts": [[2015, 8, 12]], "date-time": "2015-08-12T08:51:12Z", "timestamp": 1439369472000}, "page": "137-155", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Molecular Classification of Breast Cancer"], "prefix": "10.1007", "author": [{"given": "Mohammed A.", "family": "Aleskandarany", "sequence": "first", "affiliation": []}, {"given": "Ian O.", "family": "Ellis", "sequence": "additional", "affiliation": []}, {"given": "Emad A.", "family": "Rakha", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2015, 8, 13]]}, "reference": [{"issue": "3", "key": "10_CR1", "doi-asserted-by": "publisher", "first-page": "209", "DOI": "10.1016/S1040-8428(99)00034-7", "volume": "31", "author": "CW Elston", "year": "1999", "unstructured": "Elston CW, Ellis IO, Pinder SE. Pathological prognostic factors in breast cancer. Crit Rev Oncol Hematol. 1999;31(3):209\u201323.", "journal-title": "Crit Rev Oncol Hematol"}, {"key": "10_CR2", "unstructured": "Rakha EA, El-Sayed ME, Lee AH, Elston CW, Grainge MJ, Hodi Z, et al. Prognostic significance of Nottingham histologic grade in invasive breast carcinoma. J Clin Oncol. 2008;26(19):3153\u20138. PubMed PMID: 18490649. Epub 2008/05/21. eng.", "DOI": "10.1200/JCO.2007.15.5986", "doi-asserted-by": "crossref"}, {"key": "10_CR3", "unstructured": "Galea MH, Blamey RW, Elston CE, Ellis IO. The Nottingham Prognostic Index in primary breast-cancer. Breast Cancer Res Treat. 1992;22(3):207\u201319. PubMed PMID: ISI:A1992JQ41500005.", "DOI": "10.1007/BF01840834", "doi-asserted-by": "crossref"}, {"key": "10_CR4", "unstructured": "Sinn H-P, Kreipe H. A brief overview of the WHO classification of breast tumors, 4th edition, focusing on issues and updates from the 3rd edition. Breast Care. 2013;8(2):149\u201354. PubMed PMID: PMC3683948.", "DOI": "10.1159/000350774", "doi-asserted-by": "crossref"}, {"issue": "1", "key": "10_CR5", "doi-asserted-by": "publisher", "first-page": "121", "DOI": "10.1007/s10549-007-9768-4", "volume": "111", "author": "EA Rakha", "year": "2008", "unstructured": "Rakha EA, El-Sayed ME, Menon S, Green AR, Lee AH, Ellis IO. Histologic grading is an independent prognostic factor in invasive lobular carcinoma of the breast. Breast Cancer Res Treat. 2008;111(1):121\u20137.", "journal-title": "Breast Cancer Res Treat"}, {"issue": "9278", "key": "10_CR6", "doi-asserted-by": "publisher", "first-page": "277", "DOI": "10.1016/S0140-6736(01)05483-6", "volume": "358", "author": "BF Cole", "year": "2001", "unstructured": "Cole BF, Gelber RD, Gelber S, Coates AS, Goldhirsch A. Polychemotherapy for early breast cancer: an overview of the randomised clinical trials with quality-adjusted survival analysis. The Lancet. 2001;358(9278):277\u201386.", "journal-title": "The Lancet"}, {"issue": "3", "key": "10_CR7", "doi-asserted-by": "publisher", "first-page": "319", "DOI": "10.1007/s10549-006-9385-7", "volume": "103", "author": "Y Feng", "year": "2007", "unstructured": "Feng Y, Sun B, Li X, Zhang L, Niu Y, Xiao C, et al. Differentially expressed genes between primary cancer and paired lymph node metastases predict clinical outcome of node-positive breast cancer patients. Breast Cancer Res Treat. 2007;103(3):319\u201329.", "journal-title": "Breast Cancer Res Treat"}, {"issue": "9217", "key": "10_CR8", "doi-asserted-by": "publisher", "first-page": "1822", "DOI": "10.1016/S0140-6736(00)02277-7", "volume": "355", "author": "R Peto", "year": "2000", "unstructured": "Peto R, Boreham J, Clarke M, Davies C, Beral V. UK and USA breast cancer deaths down 25\u00a0% in year 2000 at ages 20\u201369 years. Lancet. 2000;355(9217):1822.", "journal-title": "Lancet"}, {"issue": "20", "key": "10_CR9", "doi-asserted-by": "publisher", "first-page": "1456", "DOI": "10.1093/jnci/88.20.1456", "volume": "88", "author": "DF Hayes", "year": "1996", "unstructured": "Hayes DF, Bast RC, Desch CE, Fritsche H Jr, Kemeny NE, Jessup JM, et al. Tumor marker utility grading system: a framework to evaluate clinical utility of tumor markers. J Natl Cancer Inst. 1996;88(20):1456\u201366.", "journal-title": "J Natl Cancer Inst"}, {"issue": "5366", "key": "10_CR10", "doi-asserted-by": "publisher", "first-page": "1077", "DOI": "10.1126/science.280.5366.1077", "volume": "280", "author": "DG Wang", "year": "1998", "unstructured": "Wang DG, Fan JB, Siao CJ, Berno A, Young P, Sapolsky R, et al. Large-scale identification, mapping, and genotyping of single-nucleotide polymorphisms in the human genome. Science. 1998;280(5366):1077\u201382.", "journal-title": "Science"}, {"issue": "2", "key": "10_CR11", "doi-asserted-by": "publisher", "first-page": "207", "DOI": "10.1038/2524", "volume": "20", "author": "D Pinkel", "year": "1998", "unstructured": "Pinkel D, Segraves R, Sudar D, Clark S, Poole I, Kowbel D, et al. High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays. Nat Genet. 1998;20(2):207\u201311.", "journal-title": "Nat Genet"}, {"issue": "5", "key": "10_CR12", "doi-asserted-by": "publisher", "first-page": "e5548", "DOI": "10.1371/journal.pone.0005548", "volume": "4", "author": "MR Schweiger", "year": "2009", "unstructured": "Schweiger MR, Kerick M, Timmermann B, Albrecht MW, Borodina T, Parkhomchuk D, et al. Genome-wide massively parallel sequencing of formaldehyde fixed-paraffin embedded (FFPE) tumor tissues for copy-number- and mutation-analysis. PLoS ONE. 2009;4(5):e5548.", "journal-title": "PLoS ONE"}, {"issue": "5072", "key": "10_CR13", "doi-asserted-by": "publisher", "first-page": "967", "DOI": "10.1126/science.1354393", "volume": "257", "author": "P Liang", "year": "1992", "unstructured": "Liang P, Pardee AB. Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science. 1992;257(5072):967\u201371.", "journal-title": "Science"}, {"issue": "5235", "key": "10_CR14", "doi-asserted-by": "publisher", "first-page": "484", "DOI": "10.1126/science.270.5235.484", "volume": "270", "author": "VE Velculescu", "year": "1995", "unstructured": "Velculescu VE, Zhang L, Vogelstein B, Kinzler KW. Serial analysis of gene expression. Science. 1995;270(5235):484\u20137.", "journal-title": "Science"}, {"issue": "1 Suppl", "key": "10_CR15", "doi-asserted-by": "publisher", "first-page": "33", "DOI": "10.1038/4462", "volume": "21", "author": "PO Brown", "year": "1999", "unstructured": "Brown PO, Botstein D. Exploring the new world of the genome with DNA microarrays. Nat Genet. 1999;21(1 Suppl):33\u20137.", "journal-title": "Nat Genet"}, {"key": "10_CR16", "unstructured": "Torres TT, Metta M, Ottenwalder B, Schlotterer C. Gene expression profiling by massively parallel sequencing. Genome Res. 2008;18(1):172\u20137. PubMed PMID: 18032722. Pubmed Central PMCID: 2134766.", "DOI": "10.1101/gr.6984908", "doi-asserted-by": "crossref"}, {"key": "10_CR17", "unstructured": "Rakha EA, Pinder SE, Bartlett JM, Ibrahim M, Starczynski J, Carder PJ, et al. Updated UK recommendations for HER2 assessment in breast cancer. J Clin Pathol. 2015;68(2):93\u20139. PubMed PMID: 25488926. Pubmed Central PMCID: 4316916.", "DOI": "10.1136/jclinpath-2014-202571", "doi-asserted-by": "crossref"}, {"key": "10_CR18", "unstructured": "Pathology reporting of breast disease. A Joint Document Incorporating the Third Edition of the NHS Breast Screening Programme\u2019s Guidelines for Pathology Reporting in Breast Cancer Screening and the Second Edition of The Royal College of Pathologists\u2019 Minimum Dataset for Breast Cancer Histopathology, Jan 2005. NHSBSP Pub. No 58\u00a0p."}, {"issue": "16", "key": "10_CR19", "doi-asserted-by": "publisher", "first-page": "2784", "DOI": "10.1200/JCO.2009.25.6529", "volume": "28", "author": "ME Hammond", "year": "2010", "unstructured": "Hammond ME, Hayes DF, Dowsett M, Allred DC, Hagerty KL, Badve S, et al. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. J Clin Oncol. 2010;28(16):2784\u201395.", "journal-title": "J Clin Oncol"}, {"issue": "10", "key": "10_CR20", "doi-asserted-by": "publisher", "first-page": "1569", "DOI": "10.1093/annonc/mdi326", "volume": "16", "author": "A Goldhirsch", "year": "2005", "unstructured": "Goldhirsch A, Glick JH, Gelber RD, Coates AS, Thurlimann B, Senn HJ. Meeting highlights: international expert consensus on the primary therapy of early breast cancer 2005. Ann Oncol. 2005;16(10):1569\u201383.", "journal-title": "Ann Oncol"}, {"key": "10_CR21", "unstructured": "Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005;365(9472):1687\u2013717. PubMed PMID: 15894097."}, {"key": "10_CR22", "unstructured": "Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer. An overview of 61 randomized trials among 28,896 women. Early Breast Cancer Trialists\u2019 Collaborative Group. N Engl J Med. 1988;319(26):1681\u201392. PubMed PMID: 3205265.", "DOI": "10.1056/NEJM198812293192601", "doi-asserted-by": "crossref"}, {"key": "10_CR23", "unstructured": "Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists\u2019 Collaborative Group. Lancet. 1998;351(9114):1451\u201367. PubMed PMID: 9605801.", "DOI": "10.1016/S0140-6736(97)11423-4", "doi-asserted-by": "crossref"}, {"issue": "21", "key": "10_CR24", "doi-asserted-by": "publisher", "first-page": "1529", "DOI": "10.1093/jnci/88.21.1529", "volume": "88", "author": "B Fisher", "year": "1996", "unstructured": "Fisher B, Dignam J, Bryant J, DeCillis A, Wickerham DL, Wolmark N, et al. Five versus more than five years of tamoxifen therapy for breast cancer patients with negative lymph nodes and estrogen receptor-positive tumors. J Natl Cancer Inst. 1996;88(21):1529\u201342.", "journal-title": "J Natl Cancer Inst"}, {"issue": "10", "key": "10_CR25", "doi-asserted-by": "publisher", "first-page": "1973", "DOI": "10.1200/JCO.2003.09.099", "volume": "21", "author": "VJ Bardou", "year": "2003", "unstructured": "Bardou VJ, Arpino G, Elledge RM, Osborne CK, Clark GM. Progesterone receptor status significantly improves outcome prediction over estrogen receptor status alone for adjuvant endocrine therapy in two large breast cancer databases. J Clin Oncol. 2003;21(10):1973\u20139.", "journal-title": "J Clin Oncol"}, {"issue": "30", "key": "10_CR26", "doi-asserted-by": "publisher", "first-page": "4772", "DOI": "10.1200/JCO.2007.12.2747", "volume": "25", "author": "EA Rakha", "year": "2007", "unstructured": "Rakha EA, El-Sayed ME, Green AR, Paish EC, Powe DG, Gee J, et al. Biologic and clinical characteristics of breast cancer with single hormone receptor positive phenotype. J Clin Oncol. 2007;25(30):4772\u20138.", "journal-title": "J Clin Oncol"}, {"issue": "8", "key": "10_CR27", "doi-asserted-by": "crossref", "first-page": "1284", "DOI": "10.1200/JCO.1992.10.8.1284", "volume": "10", "author": "PM Ravdin", "year": "1992", "unstructured": "Ravdin PM, Green S, Dorr TM, McGuire WL, Fabian C, Pugh RP, et al. Prognostic significance of progesterone receptor levels in estrogen receptor-positive patients with metastatic breast cancer treated with tamoxifen: results of a prospective Southwest Oncology Group study. J Clin Oncol. 1992;10(8):1284\u201391.", "journal-title": "J Clin Oncol"}, {"key": "10_CR28", "unstructured": "Colomer R, Beltran M, Dorcas J, Cortes-Funes H, Hornedo J, Valentin V, et al. It is not time to stop progesterone receptor testing in breast cancer. J Clin Oncol. 2005;23(16):3868\u20139; author reply 9\u201370. PubMed PMID: 15923595.", "DOI": "10.1200/JCO.2005.05.203", "doi-asserted-by": "crossref"}, {"issue": "15", "key": "10_CR29", "doi-asserted-by": "publisher", "first-page": "4614", "DOI": "10.1158/1078-0432.CCR-06-0248", "volume": "12", "author": "M Stendahl", "year": "2006", "unstructured": "Stendahl M, Ryden L, Nordenskjold B, Jonsson PE, Landberg G, Jirstrom K. High progesterone receptor expression correlates to the effect of adjuvant tamoxifen in premenopausal breast cancer patients. Clin Cancer Res. 2006;12(15):4614\u20138.", "journal-title": "Clin Cancer Res"}, {"issue": "21", "key": "10_CR30", "doi-asserted-by": "publisher", "first-page": "1571", "DOI": "10.1093/jnci/djj415", "volume": "98", "author": "MM Regan", "year": "2006", "unstructured": "Regan MM, Viale G, Mastropasqua MG, Maiorano E, Golouh R, Carbone A, et al. Re-evaluating adjuvant breast cancer trials: assessing hormone receptor status by immunohistochemical versus extraction assays. J Natl Cancer Inst. 2006;98(21):1571\u201381.", "journal-title": "J Natl Cancer Inst"}, {"issue": "4785", "key": "10_CR31", "doi-asserted-by": "publisher", "first-page": "177", "DOI": "10.1126/science.3798106", "volume": "235", "author": "DJ Slamon", "year": "1987", "unstructured": "Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science. 1987;235(4785):177\u201382.", "journal-title": "Science"}, {"issue": "8", "key": "10_CR32", "doi-asserted-by": "publisher", "first-page": "1007", "DOI": "10.1097/01.LAB.0000024360.48464.A4", "volume": "82", "author": "N Dandachi", "year": "2002", "unstructured": "Dandachi N, Dietze O, Hauser-Kronberger C. Chromogenic in situ hybridization: a novel approach to a practical and sensitive method for the detection of HER2 oncogene in archival human breast carcinoma. Lab Invest. 2002;82(8):1007\u201314.", "journal-title": "Lab Invest"}, {"issue": "1", "key": "10_CR33", "doi-asserted-by": "publisher", "first-page": "118", "DOI": "10.1200/JCO.2006.09.2775", "volume": "25", "author": "AC Wolff", "year": "2007", "unstructured": "Wolff AC, Hammond ME, Schwartz JN, Hagerty KL, Allred DC, Cote RJ, et al. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. J Clin Oncol. 2007;25(1):118\u201345.", "journal-title": "J Clin Oncol"}, {"issue": "4", "key": "10_CR34", "doi-asserted-by": "publisher", "first-page": "411", "DOI": "10.1002/path.1354", "volume": "199", "author": "J Bartlett", "year": "2003", "unstructured": "Bartlett J, Mallon E, Cooke T. The clinical evaluation of HER-2 status: which test to use? J Pathol. 2003;199(4):411\u20137.", "journal-title": "J Pathol"}, {"issue": "12", "key": "10_CR35", "doi-asserted-by": "publisher", "first-page": "1927", "DOI": "10.1093/annonc/mdm201", "volume": "18", "author": "M Kaufmann", "year": "2007", "unstructured": "Kaufmann M, von Minckwitz G, Bear HD, Buzdar A, McGale P, Bonnefoi H, et al. Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: new perspectives 2006. Ann Oncol. 2007;18(12):1927\u201334.", "journal-title": "Ann Oncol"}, {"issue": "Suppl 1", "key": "10_CR36", "doi-asserted-by": "publisher", "first-page": "1", "DOI": "10.3310/hta13suppl1/01", "volume": "13", "author": "S Ward", "year": "2009", "unstructured": "Ward S, Pilgrim H, Hind D. Trastuzumab for the treatment of primary breast cancer in HER2-positive women: a single technology appraisal. Health Technol Assess. 2009;13(Suppl 1):1\u20136.", "journal-title": "Health Technol Assess"}, {"key": "10_CR37", "unstructured": "Rakha EA, Reis-Filho JS, Ellis IO. Combinatorial biomarker expression in breast cancer. Breast Cancer Res Treat. 2010;120(2):293\u2013308. PubMed PMID: 20107892. Epub 2010/01/29. eng.", "DOI": "10.1007/s10549-010-0746-x", "doi-asserted-by": "crossref"}, {"key": "10_CR38", "unstructured": "Cuzick J, Dowsett M, Wale C, Salter J, Quinn E, Zabaglo L, et al. Prognostic value of a combined ER, PgR, Ki67, HER2 immunohistochemical (IHC4) score and comparison with the GHI recurrence score\u2014results from TransATAC. Cancer Res. 2009;Suppl 24: Abstract 74.", "DOI": "10.1158/0008-5472.SABCS-09-74", "doi-asserted-by": "crossref"}, {"key": "10_CR39", "unstructured": "Carey LA, Perou CM, Livasy CA, Dressler LG, Cowan D, Conway K, et al. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. J Am Med Assoc (JAMA). 2006;295(21):2492\u2013502. PubMed PMID: ISI:000238057300024.", "DOI": "10.1001/jama.295.21.2492", "doi-asserted-by": "crossref"}, {"issue": "5", "key": "10_CR40", "doi-asserted-by": "publisher", "first-page": "R65", "DOI": "10.1186/bcr1771", "volume": "9", "author": "B Kreike", "year": "2007", "unstructured": "Kreike B, van Kouwenhove M, Horlings H, Weigelt B, Bartelink H, Van de Vijver MJ. Gene expression profiling and histopathological characterization of triple negative/basal-like breast carcinomas. Breast Cancer Res. 2007;9(5):R65.", "journal-title": "Breast Cancer Res"}, {"key": "10_CR41", "unstructured": "Kurebayashi J, Moriya T, Ishida T, Hirakawa H, Kurosumi M, Akiyama F, et al. The prevalence of intrinsic subtypes and prognosis in breast cancer patients of different races. The Breast. 2007;16(2, Suppl 1):72\u20137."}, {"issue": "3", "key": "10_CR42", "doi-asserted-by": "crossref", "first-page": "591", "DOI": "10.1007/s10549-010-1028-3", "volume": "127", "author": "MA Aleskandarany", "year": "2010", "unstructured": "Aleskandarany MA, Rakha EA, Macmillan RD, Powe DG, Ellis IO, Green AR. MIB1/Ki-67 labelling index can classify grade 2 breast cancer into two clinically distinct subgroups. Breast Cancer Res Treat. 2010;127(3):591\u20139.", "journal-title": "Breast Cancer Res Treat"}, {"key": "10_CR43", "unstructured": "Colozza M, Azambuja E, Cardoso F, Sotiriou C, Larsimont D, Piccart MJ. Proliferative markers as prognostic and predictive tools in early breast cancer: where are we now? 2005. p. 1723\u201339.", "DOI": "10.1093/annonc/mdi352", "doi-asserted-by": "crossref"}, {"issue": "3", "key": "10_CR44", "doi-asserted-by": "publisher", "first-page": "207", "DOI": "10.1093/jnci/djm289", "volume": "100", "author": "G Viale", "year": "2008", "unstructured": "Viale G, Regan MM, Mastropasqua MG, Maffini F, Maiorano E, Colleoni M, et al. Predictive value of tumor Ki-67 expression in two randomized trials of adjuvant chemoendocrine therapy for node-negative breast cancer. J Natl Cancer Inst. 2008;100(3):207\u201312.", "journal-title": "J Natl Cancer Inst"}, {"issue": "2", "key": "10_CR45", "doi-asserted-by": "publisher", "first-page": "241", "DOI": "10.1007/s10549-008-0126-y", "volume": "115", "author": "JP Baak", "year": "2009", "unstructured": "Baak JP, Gudlaugsson E, Skaland I, Guo LH, Klos J, Lende TH, et al. Proliferation is the strongest prognosticator in node-negative breast cancer: significance, error sources, alternatives and comparison with molecular prognostic markers. Breast Cancer Res Treat. 2009;115(2):241\u201354.", "journal-title": "Breast Cancer Res Treat"}, {"issue": "2", "key": "10_CR46", "doi-asserted-by": "publisher", "first-page": "174", "DOI": "10.1016/S1470-2045(09)70262-1", "volume": "11", "author": "R Yerushalmi", "year": "2010", "unstructured": "Yerushalmi R, Woods R, Ravdin PM, Hayes MM, Gelmon KA. Ki67 in breast cancer: prognostic and predictive potential. Lancet Oncol. 2010;11(2):174\u201383.", "journal-title": "Lancet Oncol"}, {"issue": "10", "key": "10_CR47", "doi-asserted-by": "publisher", "first-page": "736", "DOI": "10.1093/jnci/djp082", "volume": "101", "author": "MC Cheang", "year": "2009", "unstructured": "Cheang MC, Chia SK, Voduc D, Gao D, Leung S, Snider J, et al. Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer. J Natl Cancer Inst. 2009;101(10):736\u201350.", "journal-title": "J Natl Cancer Inst"}, {"key": "10_CR48", "unstructured": "Aleskandarany MA, Rakha EA, Macmillan RD, Powe DG, Ellis IO, Green AR. MIB1/Ki-67 labelling index can classify grade 2 breast cancer into two clinically distinct subgroups. Breast Cancer Res Treat. 2010. PubMed PMID: 20623333. Epub 2010/07/14. Eng.", "DOI": "10.1007/s10549-010-1028-3", "doi-asserted-by": "crossref"}, {"key": "10_CR49", "unstructured": "Aleskandarany MA, Green AR, Rakha EA, Mohammed RA, Elsheikh SE, Powe DG, et al. Growth fraction as a predictor of response to chemotherapy in node-negative breast cancer. Int J Cancer. 2010. PubMed PMID: 19711345.", "DOI": "10.1002/ijc.24860", "doi-asserted-by": "crossref"}, {"issue": "4", "key": "10_CR50", "doi-asserted-by": "publisher", "first-page": "574", "DOI": "10.1016/S0959-8049(99)00005-2", "volume": "35", "author": "M Colleoni", "year": "1999", "unstructured": "Colleoni M, Orvieto E, Nole F, Orlando L, Minchella I, Viale G, et al. Prediction of response to primary chemotherapy for operable breast cancer. Eur J Cancer. 1999;35(4):574\u20139.", "journal-title": "Eur J Cancer"}, {"key": "10_CR51", "unstructured": "Augenlicht LH, Wahrman MZ, Halsey H, Anderson L, Taylor J, Lipkin M. Expression of cloned sequences in biopsies of human colonic tissue and in colonic carcinoma cells induced to differentiate in vitro. Cancer Res. 1987;47(22):6017\u201321. PubMed PMID: 3664505. Epub 1987/11/15. eng."}, {"key": "10_CR52", "unstructured": "Bertucci F, Finetti P, Cervera N, Maraninchi D, Viens P, Birnbaum D. Gene expression profiling and clinical outcome in breast cancer. OMICS. 2006;10(4):429\u201343. PubMed PMID: 17233555. Epub 2007/01/20. eng.", "DOI": "10.1089/omi.2006.10.429", "doi-asserted-by": "crossref"}, {"key": "10_CR53", "unstructured": "Cowin PA, Anglesio M, Etemadmoghadam D, Bowtell DD. Profiling the cancer genome. Annu Rev Genomics Hum Genet. 2010;11:133\u201359. PubMed PMID: 20590430. Epub 2010/07/02. eng.", "DOI": "10.1146/annurev-genom-082509-141536", "doi-asserted-by": "crossref"}, {"key": "10_CR54", "unstructured": "Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, et al. Molecular portraits of human breast tumours. Nature. 2000;406(6797):747\u201352. PubMed PMID: ISI:000088767700049."}, {"issue": "19", "key": "10_CR55", "doi-asserted-by": "publisher", "first-page": "10869", "DOI": "10.1073/pnas.191367098", "volume": "98", "author": "T Sorlie", "year": "2001", "unstructured": "Sorlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA. 2001;98(19):10869\u201374.", "journal-title": "Proc Natl Acad Sci USA"}, {"issue": "3", "key": "10_CR56", "doi-asserted-by": "crossref", "first-page": "340", "DOI": "10.1002/ijc.21004", "volume": "116", "author": "DM Abd El-Rehim", "year": "2005", "unstructured": "Abd El-Rehim DM, Ball G, Pinder SE, Rakha E, Paish C, Robertson JF, et al. High-throughput protein expression analysis using tissue microarray technology of a large well-characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analyses. Int J Cancer. 2005;116(3):340\u201350.", "journal-title": "Int J Cancer"}, {"issue": "11", "key": "10_CR57", "doi-asserted-by": "publisher", "first-page": "1665", "DOI": "10.1200/JCO.2005.03.9115", "volume": "24", "author": "JA Foekens", "year": "2006", "unstructured": "Foekens JA, Atkins D, Zhang Y, Sweep FC, Harbeck N, Paradiso A, et al. Multicenter validation of a gene expression-based prognostic signature in lymph node-negative primary breast cancer. J Clin Oncol. 2006;24(11):1665\u201371.", "journal-title": "J Clin Oncol"}, {"issue": "6871", "key": "10_CR58", "doi-asserted-by": "publisher", "first-page": "530", "DOI": "10.1038/415530a", "volume": "415", "author": "LJ Veer van \u2019t", "year": "2002", "unstructured": "van \u2019t Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AA, Mao M, et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature. 2002;415(6871):530\u20136.", "journal-title": "Nature"}, {"key": "10_CR59", "unstructured": "Wang Y, Klijn JG, Zhang Y, Sieuwerts AM, Look MP, Yang F, et al. Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet. 2005;365(9460):671\u20139. PubMed PMID: 15721472."}, {"issue": "6", "key": "10_CR60", "doi-asserted-by": "publisher", "first-page": "607", "DOI": "10.1016/j.ccr.2004.05.015", "volume": "5", "author": "XJ Ma", "year": "2004", "unstructured": "Ma XJ, Wang Z, Ryan PD, Isakoff SJ, Barmettler A, Fuller A, et al. A two-gene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifen. Cancer Cell. 2004;5(6):607\u201316.", "journal-title": "Cancer Cell"}, {"issue": "2", "key": "10_CR61", "doi-asserted-by": "publisher", "first-page": "303", "DOI": "10.1007/s10549-008-0183-2", "volume": "116", "author": "Y Zhang", "year": "2009", "unstructured": "Zhang Y, Sieuwerts AM, McGreevy M, Casey G, Cufer T, Paradiso A, et al. The 76-gene signature defines high-risk patients that benefit from adjuvant tamoxifen therapy. Breast Cancer Res Treat. 2009;116(2):303\u20139.", "journal-title": "Breast Cancer Res Treat"}, {"issue": "26", "key": "10_CR62", "doi-asserted-by": "publisher", "first-page": "4236", "DOI": "10.1200/JCO.2006.05.6861", "volume": "24", "author": "KR Hess", "year": "2006", "unstructured": "Hess KR, Anderson K, Symmans WF, Valero V, Ibrahim N, Mejia JA, et al. Pharmacogenomic predictor of sensitivity to preoperative chemotherapy with paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide in breast cancer. J Clin Oncol. 2006;24(26):4236\u201344.", "journal-title": "J Clin Oncol"}, {"issue": "11", "key": "10_CR63", "doi-asserted-by": "publisher", "first-page": "1294", "DOI": "10.1038/nm1491", "volume": "12", "author": "A Potti", "year": "2006", "unstructured": "Potti A, Dressman HK, Bild A, Riedel RF, Chan G, Sayer R, et al. Genomic signatures to guide the use of chemotherapeutics. Nat Med. 2006;12(11):1294\u2013300.", "journal-title": "Nat Med"}, {"issue": "10", "key": "10_CR64", "doi-asserted-by": "publisher", "first-page": "5974", "DOI": "10.1073/pnas.0931261100", "volume": "100", "author": "XJ Ma", "year": "2003", "unstructured": "Ma XJ, Salunga R, Tuggle JT, Gaudet J, Enright E, McQuary P, et al. Gene expression profiles of human breast cancer progression. Proc Natl Acad Sci USA. 2003;100(10):5974\u20139.", "journal-title": "Proc Natl Acad Sci USA"}, {"issue": "10", "key": "10_CR65", "doi-asserted-by": "publisher", "first-page": "5278", "DOI": "10.1158/0008-5472.CAN-05-4610", "volume": "66", "author": "CS Schuetz", "year": "2006", "unstructured": "Schuetz CS, Bonin M, Clare SE, Nieselt K, Sotlar K, Walter M, et al. Progression-specific genes identified by expression profiling of matched ductal carcinomas in situ and invasive breast tumors, combining laser capture microdissection and oligonucleotide microarray analysis. Cancer Res. 2006;66(10):5278\u201386.", "journal-title": "Cancer Res"}, {"issue": "21", "key": "10_CR66", "first-page": "7167", "volume": "63", "author": "JE Korkola", "year": "2003", "unstructured": "Korkola JE, DeVries S, Fridlyand J, Hwang ES, Estep AL, Chen YY, et al. Differentiation of lobular versus ductal breast carcinomas by expression microarray analysis. Cancer Res. 2003;63(21):7167\u201375.", "journal-title": "Cancer Res"}, {"issue": "6", "key": "10_CR67", "doi-asserted-by": "publisher", "first-page": "2523", "DOI": "10.1091/mbc.E03-11-0786", "volume": "15", "author": "H Zhao", "year": "2004", "unstructured": "Zhao H, Langerod A, Ji Y, Nowels KW, Nesland JM, Tibshirani R, et al. Different gene expression patterns in invasive lobular and ductal carcinomas of the breast. Mol Biol Cell. 2004;15(6):2523\u201336.", "journal-title": "Mol Biol Cell"}, {"issue": "20", "key": "10_CR68", "doi-asserted-by": "publisher", "first-page": "11462", "DOI": "10.1073/pnas.201162998", "volume": "98", "author": "M West", "year": "2001", "unstructured": "West M, Blanchette C, Dressman H, Huang E, Ishida S, Spang R, et al. Predicting the clinical status of human breast cancer by using gene expression profiles. Proc Natl Acad Sci USA. 2001;98(20):11462\u20137.", "journal-title": "Proc Natl Acad Sci USA"}, {"issue": "9369", "key": "10_CR69", "doi-asserted-by": "publisher", "first-page": "1590", "DOI": "10.1016/S0140-6736(03)13308-9", "volume": "361", "author": "E Huang", "year": "2003", "unstructured": "Huang E, Cheng SH, Dressman H, Pittman J, Tsou MH, Horng CF, et al. Gene expression predictors of breast cancer outcomes. Lancet. 2003;361(9369):1590\u20136.", "journal-title": "Lancet"}, {"issue": "6797", "key": "10_CR70", "doi-asserted-by": "publisher", "first-page": "747", "DOI": "10.1038/35021093", "volume": "406", "author": "CM Perou", "year": "2000", "unstructured": "Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, et al. Molecular portraits of human breast tumours. Nature. 2000;406(6797):747\u201352.", "journal-title": "Nature"}, {"key": "10_CR71", "unstructured": "Habashy HO, Powe DG, Abdel-Fatah TM, Gee JM, Nicholson RI, Green AR, et al. A review of the biological and clinical characteristics of luminal-like oestrogen receptor-positive breast cancer. Histopathology. 2012;60(6):854\u201363. PubMed PMID: 21906125. Epub 2011/09/13. eng.", "DOI": "10.1111/j.1365-2559.2011.03912.x", "doi-asserted-by": "crossref"}, {"issue": "18", "key": "10_CR72", "doi-asserted-by": "crossref", "first-page": "10393", "DOI": "10.1073/pnas.1732912100", "volume": "100", "author": "C Sotiriou", "year": "2003", "unstructured": "Sotiriou C, Neo SY, McShane LM, Korn EL, Long PM, Jazaeri A, et al. Breast cancer classification and prognosis based on gene expression profiles from a population-based study. Proc Natl Acad Sci USA. 2003;100(18):10393\u20138.", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "10_CR73", "unstructured": "Rakha EA, Soria D, Green AR, Lemetre C, Powe DG, Nolan CC, et al. Nottingham Prognostic Index Plus (NPI+): a modern clinical decision making tool in breast cancer. Br J Cancer. 2014;110(7):1688\u201397. PubMed PMID: 24619074. Pubmed Central PMCID: 3974073.", "DOI": "10.1038/bjc.2014.120", "doi-asserted-by": "crossref"}, {"key": "10_CR74", "unstructured": "Herschkowitz JI, Simin K, Weigman VJ, Mikaelian I, Usary J, Hu Z, et al. Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors. Genome Biol. 2007;8(5):R76. PubMed PMID: 17493263. Pubmed Central PMCID: 1929138.", "DOI": "10.1186/gb-2007-8-5-r76", "doi-asserted-by": "crossref"}, {"issue": "29", "key": "10_CR75", "doi-asserted-by": "publisher", "first-page": "4660", "DOI": "10.1038/sj.onc.1208561", "volume": "24", "author": "P Farmer", "year": "2005", "unstructured": "Farmer P, Bonnefoi H, Becette V, Tubiana-Hulin M, Fumoleau P, Larsimont D, et al. Identification of molecular apocrine breast tumours by microarray analysis. Oncogene. 2005;24(29):4660\u201371.", "journal-title": "Oncogene"}, {"key": "10_CR76", "unstructured": "Sorlie T, Tibshirani R, Parker J, Hastie T, Marron JS, Nobel A, et al. Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci USA. 2003;100(14):8418\u201323. PubMed PMID: ISI:000184222500069.", "DOI": "10.1073/pnas.0932692100", "doi-asserted-by": "publisher"}, {"key": "10_CR77", "unstructured": "Sotiriou C, Neo SY, McShane LM, Korn EL, Long PM, Jazaeri A, et al. Breast cancer classification and prognosis based on gene expression profiles from a population-based study. Proc Natl Acad Sci USA. 2003;100(18):10393\u20138. PubMed PMID: ISI:000185119300048.", "DOI": "10.1073/pnas.1732912100", "doi-asserted-by": "crossref"}, {"issue": "11", "key": "10_CR78", "doi-asserted-by": "publisher", "first-page": "1033", "DOI": "10.1002/gcc.20366", "volume": "45", "author": "Anna Bergamaschi YHKPWTSTH-BPELRTA-LB-DJRP", "year": "2006", "unstructured": "Anna Bergamaschi YHKPWTSTH-BPELRTA-LB-DJRP. Distinct patterns of DNA copy number alteration are associated with different clinicopathological features and gene-expression subtypes of breast cancer. Genes Chromosom Cancer. 2006;45(11):1033\u201340.", "journal-title": "Genes Chromosom Cancer"}, {"issue": "1", "key": "10_CR79", "doi-asserted-by": "publisher", "first-page": "11", "DOI": "10.1007/BF01806130", "volume": "10", "author": "SH Dairkee", "year": "1987", "unstructured": "Dairkee SH, Ljung BM, Smith H, Hackett A. Immunolocalization of a human basal epithelium specific keratin in benign and malignant breast disease. Breast Cancer Res Treat. 1987;10(1):11\u201320.", "journal-title": "Breast Cancer Res Treat"}, {"issue": "4", "key": "10_CR80", "doi-asserted-by": "publisher", "first-page": "386", "DOI": "10.1002/(SICI)1096-9896(199608)179:4<386::AID-PATH631>3.0.CO;2-V", "volume": "179", "author": "D Santini", "year": "1996", "unstructured": "Santini D, Ceccarelli C, Taffurelli M, Pileri S, Marrano D. Differentiation pathways in primary invasive breast carcinoma as suggested by intermediate filament and biopathological marker expression. J Pathol. 1996;179(4):386\u201391.", "journal-title": "J Pathol."}, {"issue": "25", "key": "10_CR81", "doi-asserted-by": "publisher", "first-page": "1999", "DOI": "10.1056/NEJMoa021967", "volume": "347", "author": "MJ Vijver van de", "year": "2002", "unstructured": "van de Vijver MJ, He YD, van\u2019t Veer LJ, Dai H, Hart AA, Voskuil DW, et al. A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med. 2002;347(25):1999\u20132009.", "journal-title": "N Engl J Med"}, {"issue": "1", "key": "10_CR82", "doi-asserted-by": "publisher", "first-page": "90", "DOI": "10.1158/1078-0432.CCR-06-1371", "volume": "13", "author": "K Savage", "year": "2007", "unstructured": "Savage K, Lambros MB, Robertson D, Jones RL, Jones C, Mackay A, et al. Caveolin 1 is overexpressed and amplified in a subset of basal-like and metaplastic breast carcinomas: a morphologic, ultrastructural, immunohistochemical, and in situ hybridization analysis. Clin Cancer Res. 2007;13(1):90\u2013101.", "journal-title": "Clin Cancer Res"}, {"issue": "11", "key": "10_CR83", "doi-asserted-by": "publisher", "first-page": "537", "DOI": "10.1016/j.molmed.2006.09.004", "volume": "12", "author": "F Yehiely", "year": "2006", "unstructured": "Yehiely F, Moyano JV, Evans JR, Nielsen TO, Cryns VL. Deconstructing the molecular portrait of basal-like breast cancer. Trends Mol Med. 2006;12(11):537\u201344.", "journal-title": "Trends Mol Med."}, {"key": "10_CR84", "doi-asserted-by": "publisher", "first-page": "96", "DOI": "10.1186/1471-2164-7-96", "volume": "7", "author": "Z Hu", "year": "2006", "unstructured": "Hu Z, Fan C, Oh DS, Marron JS, He X, Qaqish BF, et al. The molecular portraits of breast tumors are conserved across microarray platforms. BMC Genom. 2006;7:96.", "journal-title": "BMC Genom"}, {"issue": "8", "key": "10_CR85", "doi-asserted-by": "publisher", "first-page": "2877", "DOI": "10.1128/MCB.26.8.2877-2886.2006", "volume": "26", "author": "K Wilhelmsen", "year": "2006", "unstructured": "Wilhelmsen K, Litjens SH, Sonnenberg A. Multiple functions of the integrin alpha6beta4 in epidermal homeostasis and tumorigenesis. Mol Cell Biol. 2006;26(8):2877\u201386.", "journal-title": "Mol Cell Biol"}, {"issue": "8", "key": "10_CR86", "doi-asserted-by": "publisher", "first-page": "789", "DOI": "10.1038/nm1087", "volume": "10", "author": "B Vogelstein", "year": "2004", "unstructured": "Vogelstein B, Kinzler KW. Cancer genes and the pathways they control. Nat Med. 2004;10(8):789\u201399.", "journal-title": "Nat Med"}, {"issue": "3", "key": "10_CR87", "doi-asserted-by": "publisher", "first-page": "615", "DOI": "10.1083/jcb.148.3.615", "volume": "148", "author": "N Koshikawa", "year": "2000", "unstructured": "Koshikawa N, Giannelli G, Cirulli V, Miyazaki K, Quaranta V. Role of cell surface metalloprotease MT1-MMP in epithelial cell migration over laminin-5. J Cell Biol. 2000;148(3):615\u201324.", "journal-title": "J Cell Biol"}, {"issue": "1", "key": "10_CR88", "doi-asserted-by": "publisher", "first-page": "57", "DOI": "10.1016/S0092-8674(00)81683-9", "volume": "100", "author": "D Hanahan", "year": "2000", "unstructured": "Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000;100(1):57\u201370.", "journal-title": "Cell"}, {"issue": "6", "key": "10_CR89", "doi-asserted-by": "publisher", "first-page": "531", "DOI": "10.1016/S1535-6108(03)00135-1", "volume": "3", "author": "N Dumont", "year": "2003", "unstructured": "Dumont N, Arteaga CL. Targeting the TGF beta signaling network in human neoplasia. Cancer Cell. 2003;3(6):531\u20136.", "journal-title": "Cancer Cell"}, {"issue": "6", "key": "10_CR90", "doi-asserted-by": "publisher", "first-page": "560", "DOI": "10.1056/NEJMoa052933", "volume": "355", "author": "C Fan", "year": "2006", "unstructured": "Fan C, Oh DS, Wessels L, Weigelt B, Nuyten DS, Nobel AB, et al. Concordance among gene-expression-based predictors for breast cancer. N Engl J Med. 2006;355(6):560\u20139.", "journal-title": "N Engl J Med"}, {"issue": "11", "key": "10_CR91", "doi-asserted-by": "publisher", "first-page": "1033", "DOI": "10.1002/gcc.20366", "volume": "45", "author": "A Bergamaschi", "year": "2006", "unstructured": "Bergamaschi A, Kim YH, Wang P, Sorlie T, Hernandez-Boussard T, Lonning PE, et al. Distinct patterns of DNA copy number alteration are associated with different clinicopathological features and gene-expression subtypes of breast cancer. Genes Chromosomes Cancer. 2006;45(11):1033\u201340.", "journal-title": "Genes Chromosomes Cancer"}, {"issue": "6", "key": "10_CR92", "doi-asserted-by": "publisher", "first-page": "529", "DOI": "10.1016/j.ccr.2006.10.009", "volume": "10", "author": "K Chin", "year": "2006", "unstructured": "Chin K, DeVries S, Fridlyand J, Spellman PT, Roydasgupta R, Kuo WL, et al. Genomic and transcriptional aberrations linked to breast cancer pathophysiologies. Cancer Cell. 2006;10(6):529\u201341.", "journal-title": "Cancer Cell"}, {"issue": "2", "key": "10_CR93", "doi-asserted-by": "crossref", "first-page": "R24", "DOI": "10.1186/bcr1666", "volume": "9", "author": "A Vincent-Salomon", "year": "2007", "unstructured": "Vincent-Salomon A, Gruel N, Lucchesi C, Mac Grogan G, Dendale R, Sigal-Zafrani B, et al. Identification of typical medullary breast carcinoma as a genomic sub-group of basal-like carcinomas, a heterogeneous new molecular entity. Breast Cancer Res. 2007;9(2):R24.", "journal-title": "Breast Cancer Res"}, {"key": "10_CR94", "unstructured": "Rakha E, Reis-Filho JS. Basal-like breast carcinoma: from expression profiling to routine practice. Arch Pathol Lab Med. 2009;133(6):860\u20138. PubMed PMID: 19492878. Epub 2009/06/06. eng."}, {"issue": "43", "key": "10_CR95", "doi-asserted-by": "publisher", "first-page": "5846", "DOI": "10.1038/sj.onc.1209876", "volume": "25", "author": "NC Turner", "year": "2006", "unstructured": "Turner NC, Reis-Filho JS. Basal-like breast cancer and the BRCA1 phenotype. Oncogene. 2006;25(43):5846\u201353.", "journal-title": "Oncogene"}, {"key": "10_CR96", "unstructured": "Leidy J, Khan A, Kandil D. Basal-like breast cancer: update on clinicopathologic, immunohistochemical, and molecular features. Arch Pathol Lab Med. 2014;138(1):37\u201343. PubMed PMID: 24377810. Epub 2014/01/01. eng.", "DOI": "10.5858/arpa.2012-0439-RA", "doi-asserted-by": "crossref"}, {"issue": "2", "key": "10_CR97", "first-page": "263", "volume": "220", "author": "B Weigelt", "year": "2010", "unstructured": "Weigelt B, Baehner FL, Reis-Filho JS. The contribution of gene expression profiling to breast cancer classification, prognostication and prediction: a retrospective of the last decade. J Pathol. 2010;220(2):263\u201380.", "journal-title": "J Pathol"}, {"issue": "4", "key": "10_CR98", "doi-asserted-by": "publisher", "first-page": "339", "DOI": "10.1016/S1470-2045(10)70008-5", "volume": "11", "author": "B Weigelt", "year": "2010", "unstructured": "Weigelt B, Mackay A, A\u2019Hern R, Natrajan R, Tan DS, Dowsett M, et al. Breast cancer molecular profiling with single sample predictors: a retrospective analysis. Lancet Oncol. 2010;11(4):339\u201349.", "journal-title": "Lancet Oncol."}, {"issue": "14", "key": "10_CR99", "doi-asserted-by": "publisher", "first-page": "8418", "DOI": "10.1073/pnas.0932692100", "volume": "100", "author": "T Sorlie", "year": "2003", "unstructured": "Sorlie T, Tibshirani R, Parker J, Hastie T, Marron JS, Nobel A, et al. Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci U S A. 2003;100(14):8418\u201323.", "journal-title": "Proc Natl Acad Sci U S A."}, {"issue": "4", "key": "10_CR100", "doi-asserted-by": "publisher", "first-page": "R34", "DOI": "10.1186/bcr1517", "volume": "8", "author": "S Calza", "year": "2006", "unstructured": "Calza S, Hall P, Auer G, Bjohle J, Klaar S, Kronenwett U, et al. Intrinsic molecular signature of breast cancer in a population-based cohort of 412 patients. Breast Cancer Res. 2006;8(4):R34.", "journal-title": "Breast Cancer Res"}, {"key": "10_CR101", "unstructured": "Curtis C, Shah SP, Chin SF, Turashvili G, Rueda OM, Dunning MJ, et al. The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups. Nature. 2012;486(7403):346\u201352. PubMed PMID: 22522925. Pubmed Central PMCID: 3440846."}, {"issue": "9", "key": "10_CR102", "doi-asserted-by": "publisher", "first-page": "4636", "DOI": "10.1158/0008-5472.CAN-06-0031", "volume": "66", "author": "F Bertucci", "year": "2006", "unstructured": "Bertucci F, Finetti P, Cervera N, Charafe-Jauffret E, Mamessier E, Adelaide J, et al. Gene expression profiling shows medullary breast cancer is a subgroup of basal breast cancers. Cancer Res. 2006;66(9):4636\u201344.", "journal-title": "Cancer Res"}, {"key": "10_CR103", "unstructured": "Vincent-Salomon A, Gruel N, Lucchesi C, MacGrogan G, Dendale R, Sigal-Zafrani B, et al. Identification of typical medullary breast carcinoma as a genomic sub-group of basal-like carcinomas, a heterogeneous new molecular entity. Breast Cancer Res. 2007;9(2):R24. PubMed PMID: 17417968. Pubmed Central PMCID: PMC1868916. Epub 2007/04/10. eng.", "DOI": "10.1186/bcr1666", "doi-asserted-by": "crossref"}, {"issue": "2", "key": "10_CR104", "doi-asserted-by": "publisher", "first-page": "273", "DOI": "10.1007/s10549-008-0197-9", "volume": "117", "author": "B Weigelt", "year": "2009", "unstructured": "Weigelt B, Kreike B, Reis-Filho JS. Metaplastic breast carcinomas are basal-like breast cancers: a genomic profiling analysis. Breast Cancer Res Treat. 2009;117(2):273\u201380.", "journal-title": "Breast Cancer Res Treat"}, {"issue": "2", "key": "10_CR105", "doi-asserted-by": "publisher", "first-page": "141", "DOI": "10.1002/path.2407", "volume": "216", "author": "B Weigelt", "year": "2008", "unstructured": "Weigelt B, Horlings HM, Kreike B, Hayes MM, Hauptmann M, Wessels LF, et al. Refinement of breast cancer classification by molecular characterization of histological special types. J Pathol. 2008;216(2):141\u201350.", "journal-title": "J Pathol"}, {"key": "10_CR106", "unstructured": "Weigelt B, Geyer FC, Reis-Filho JS. Histological types of breast cancer: how special are they? Mol Oncol. 2010;4(3):192\u2013208.", "DOI": "10.1016/j.molonc.2010.04.004", "doi-asserted-by": "crossref"}, {"issue": "4", "key": "10_CR107", "doi-asserted-by": "publisher", "first-page": "262", "DOI": "10.1093/jnci/djj052", "volume": "98", "author": "C Sotiriou", "year": "2006", "unstructured": "Sotiriou C, Wirapati P, Loi S, Harris A, Fox S, Smeds J, et al. Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis. J Natl Cancer Inst. 2006;98(4):262\u201372.", "journal-title": "J Natl Cancer Inst"}, {"issue": "27", "key": "10_CR108", "doi-asserted-by": "publisher", "first-page": "2817", "DOI": "10.1056/NEJMoa041588", "volume": "351", "author": "S Paik", "year": "2004", "unstructured": "Paik S, Shak S, Tang G, Kim C, Baker J, Cronin M, et al. A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med. 2004;351(27):2817\u201326.", "journal-title": "N Engl J Med"}, {"issue": "4", "key": "10_CR109", "doi-asserted-by": "publisher", "first-page": "R65", "DOI": "10.1186/bcr2124", "volume": "10", "author": "P Wirapati", "year": "2008", "unstructured": "Wirapati P, Sotiriou C, Kunkel S, Farmer P, Pradervand S, Haibe-Kains B, et al. Meta-analysis of gene expression profiles in breast cancer: toward a unified understanding of breast cancer subtyping and prognosis signatures. Breast Cancer Res. 2008;10(4):R65.", "journal-title": "Breast Cancer Res"}, {"issue": "1", "key": "10_CR110", "doi-asserted-by": "publisher", "first-page": "67", "DOI": "10.1146/annurev.pathmechdis.3.121806.151505", "volume": "3", "author": "MCU Cheang", "year": "2008", "unstructured": "Cheang MCU, van de Rijn M, Nielsen TO. Gene expression profiling of breast cancer. Annu Rev Pathol. 2008;3(1):67\u201397.", "journal-title": "Annu Rev Pathol"}, {"key": "10_CR111", "unstructured": "Prat A, Parker JS, Fan C, Cheang MC, Miller LD, Bergh J, et al. Concordance among gene expression-based predictors for ER-positive breast cancer treated with adjuvant tamoxifen. Ann Oncol. 2012;23(11):2866\u201373. PubMed PMID: 22532584. Pubmed Central PMCID: 3477878.", "DOI": "10.1093/annonc/mds080", "doi-asserted-by": "crossref"}, {"key": "10_CR112", "unstructured": "Gyorffy B, Hatzis C, Sanft T, Hofstatter E, Aktas B, Pusztai L. Multigene prognostic tests in breast cancer: past, present, future. Breast Cancer Res. 2015;17(1):11. PubMed PMID: doi:\n                  10.1186/s13058-015-0514-2\n                  \n                .", "DOI": "10.1186/s13058-015-0514-2", "doi-asserted-by": "publisher"}, {"key": "10_CR113", "unstructured": "Kim C, Paik S. Gene-expression-based prognostic assays for breast cancer. Nat Rev Clin Oncol. 2010;7(6):340\u20137. PubMed PMID: 20440284. Epub 2010/05/05. eng.", "DOI": "10.1038/nrclinonc.2010.61", "doi-asserted-by": "crossref"}, {"key": "10_CR114", "unstructured": "Azim HA, Jr., Michiels S, Zagouri F, Delaloge S, Filipits M, Namer M, et al. Utility of prognostic genomic tests in breast cancer practice: The IMPAKT 2012 Working Group Consensus Statement. Ann Oncol (official journal of the European Society for Medical Oncology/ESMO). 2013;24(3):647\u201354. PubMed PMID: 23337633. Epub 2013/01/23. eng.", "DOI": "10.1093/annonc/mds645", "doi-asserted-by": "crossref"}, {"issue": "7", "key": "10_CR115", "doi-asserted-by": "publisher", "first-page": "2302", "DOI": "10.1158/1078-0432.CCR-08-2132", "volume": "15", "author": "EA Rakha", "year": "2009", "unstructured": "Rakha EA, Elsheikh SE, Aleskandarany MA, Habashi HO, Green AR, Powe DG, et al. Triple-negative breast cancer: distinguishing between basal and nonbasal subtypes. Clin Cancer Res. 2009;15(7):2302\u201310.", "journal-title": "Clin Cancer Res"}, {"issue": "16", "key": "10_CR116", "doi-asserted-by": "publisher", "first-page": "5367", "DOI": "10.1158/1078-0432.CCR-04-0220", "volume": "10", "author": "TO Nielsen", "year": "2004", "unstructured": "Nielsen TO, Hsu FD, Jensen K, Cheang M, Karaca G, Hu Z, et al. Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma. Clin Cancer Res. 2004;10(16):5367\u201374.", "journal-title": "Clin Cancer Res"}, {"key": "10_CR117", "unstructured": "Abd El-Rehim DM, Ball G, Pinder SE, Rakha E, Paish C, Robertson JFR, et al. High-throughput protein expression analysis using tissue microarray technology of a large well-characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analyses. Int J Cancer. 2005;116(3):340\u201350. PubMed PMID: ISI:000230466100002.", "DOI": "10.1002/ijc.21004", "doi-asserted-by": "crossref"}, {"key": "10_CR118", "unstructured": "Blows FM, Driver KE, Schmidt MK, Broeks A, van Leeuwen FE, Wesseling J, et al. Subtyping of breast cancer by immunohistochemistry to investigate a relationship between subtype and short and long term survival: a collaborative analysis of data for 10,159 cases from 12 studies. PLoS Med. 2010;7(5):e1000279. PubMed PMID: 20520800. Pubmed Central PMCID: 2876119.", "DOI": "10.1371/journal.pmed.1000279", "doi-asserted-by": "crossref"}, {"issue": "1", "key": "10_CR119", "doi-asserted-by": "publisher", "first-page": "67", "DOI": "10.1111/j.1365-2559.2007.02894.x", "volume": "52", "author": "EA Rakha", "year": "2008", "unstructured": "Rakha EA, El-Sayed ME, Reis-Filho JS, Ellis IO. Expression profiling technology: its contribution to our understanding of breast cancer. Histopathology. 2008;52(1):67\u201381.", "journal-title": "Histopathology"}, {"key": "10_CR120", "unstructured": "Goldhirsch A, Winer EP, Coates AS, Gelber RD, Piccart-Gebhart M, Thurlimann B, et al. Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013. Ann Oncol (official journal of the European Society for Medical Oncology/ESMO). 2013;24(9):2206\u201323. PubMed PMID: 23917950. Pubmed Central PMCID: PMC3755334. Epub 2013/08/07. eng."}, {"key": "10_CR121", "unstructured": "Weinstein IB, Joe A. Oncogene addiction. Cancer Res. 2008;68(9):3077\u201380.", "DOI": "10.1158/0008-5472.CAN-07-3293", "doi-asserted-by": "crossref"}, {"key": "10_CR122", "unstructured": "Aleskandarany MA, Green AR, Benhasouna AA, Barros FF, Neal K, Reis-Filho JS, et al. Prognostic value of proliferation assay in the luminal, HER2-positive, and triple-negative biologic classes of breast cancer. Breast Cancer Res. 2012;14(1):R3. PubMed PMID: 22225836. Pubmed Central PMCID: PMC3496118. Epub 2012/01/10. eng.", "DOI": "10.1186/bcr3084", "doi-asserted-by": "crossref"}, {"issue": "5", "key": "10_CR123", "doi-asserted-by": "publisher", "first-page": "1368", "DOI": "10.1158/1078-0432.CCR-07-1658", "volume": "14", "author": "MC Cheang", "year": "2008", "unstructured": "Cheang MC, Voduc D, Bajdik C, Leung S, McKinney S, Chia SK, et al. Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype. Clin Cancer Res. 2008;14(5):1368\u201376.", "journal-title": "Clin Cancer Res"}, {"issue": "2", "key": "10_CR124", "doi-asserted-by": "publisher", "first-page": "264", "DOI": "10.1038/modpathol.3800528", "volume": "19", "author": "CA Livasy", "year": "2006", "unstructured": "Livasy CA, Karaca G, Nanda R, Tretiakova MS, Olopade OI, Moore DT, et al. Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma. Mod Pathol. 2006;19(2):264\u201371.", "journal-title": "Mod Pathol"}, {"key": "10_CR125", "unstructured": "Badve S, Dabbs DJ, Schnitt SJ, Baehner FL, Decker T, Eusebi V, et al. Basal-like and triple-negative breast cancers: a critical review with an emphasis on the implications for pathologists and oncologists. Mod Pathol. 2011;24(2):157\u201367.", "DOI": "10.1038/modpathol.2010.200", "doi-asserted-by": "crossref"}, {"key": "10_CR126", "unstructured": "Green AR, Powe DG, Rakha EA, Soria D, Lemetre C, Nolan CC, et al. Identification of key clinical phenotypes of breast cancer using a reduced panel of protein biomarkers. Br J Cancer. 2013;109(7):1886\u201394.", "DOI": "10.1038/bjc.2013.528", "doi-asserted-by": "crossref"}, {"key": "10_CR127", "unstructured": "Soria D, Garibaldi Jm, Ambrogi F, Green AR, Powe D, Rakha E, Macmillan RD, et al. A methodology to identify consensus classes from clustering algorithms applied to immunohistochemical data from breast cancer patients. 2010 20100308 DCOM- 20100701(1879-0534 (Electronic)). eng."}, {"key": "10_CR128", "unstructured": "Green AR, Powe DG, Rakha EA, Soria D, Lemetre C, Nolan CC, et al. Identification of key clinical phenotypes of breast cancer using a reduced panel of protein biomarkers. Br J Cancer. 2013;109(7):1886\u201394. PubMed PMID: 24008658. Pubmed Central PMCID: 3790179.", "DOI": "10.1038/bjc.2013.528", "doi-asserted-by": "crossref"}, {"issue": "11", "key": "10_CR129", "doi-asserted-by": "publisher", "first-page": "1134", "DOI": "10.1634/theoncologist.2008-0184", "volume": "13", "author": "DC Allred", "year": "2008", "unstructured": "Allred DC. Commentary: hormone receptor testing in breast cancer: a distress signal from Canada. Oncologist. 2008;13(11):1134\u20136.", "journal-title": "Oncologist"}, {"issue": "1", "key": "10_CR130", "doi-asserted-by": "publisher", "first-page": "14", "DOI": "10.1093/jnci/95.1.14", "volume": "95", "author": "R Simon", "year": "2003", "unstructured": "Simon R, Radmacher MD, Dobbin K, McShane LM. Pitfalls in the use of DNA microarray data for diagnostic and prognostic classification. J Natl Cancer Inst. 2003;95(1):14\u20138.", "journal-title": "J Natl Cancer Inst"}, {"issue": "2", "key": "10_CR131", "doi-asserted-by": "publisher", "first-page": "195", "DOI": "10.1677/joe.0.1780195", "volume": "178", "author": "T Forster", "year": "2003", "unstructured": "Forster T, Roy D, Ghazal P. Experiments using microarray technology: limitations and standard operating procedures. J Endocrinol. 2003;178(2):195\u2013204.", "journal-title": "J Endocrinol"}, {"issue": "4", "key": "10_CR132", "doi-asserted-by": "publisher", "first-page": "732", "DOI": "10.1200/JCO.2005.05.145", "volume": "23", "author": "MP Jansen", "year": "2005", "unstructured": "Jansen MP, Foekens JA, van Staveren IL, Dirkzwager-Kiel MM, Ritstier K, Look MP, et al. Molecular classification of tamoxifen-resistant breast carcinomas by gene expression profiling. J Clin Oncol. 2005;23(4):732\u201340.", "journal-title": "J Clin Oncol"}, {"key": "10_CR133", "doi-asserted-by": "publisher", "first-page": "239", "DOI": "10.1186/1471-2164-9-239", "volume": "9", "author": "S Loi", "year": "2008", "unstructured": "Loi S, Haibe-Kains B, Desmedt C, Wirapati P, Lallemand F, Tutt AM, et al. Predicting prognosis using molecular profiling in estrogen receptor-positive breast cancer treated with tamoxifen. BMC Genom. 2008;9:239.", "journal-title": "BMC Genom"}, {"issue": "8", "key": "10_CR134", "doi-asserted-by": "publisher", "first-page": "1160", "DOI": "10.1200/JCO.2008.18.1370", "volume": "27", "author": "JS Parker", "year": "2009", "unstructured": "Parker JS, Mullins M, Cheang MC, Leung S, Voduc D, Vickery T, et al. Supervised risk predictor of breast cancer based on intrinsic subtypes. J Clin Oncol. 2009;27(8):1160\u20137.", "journal-title": "J Clin Oncol"}, {"issue": "20", "key": "10_CR135", "doi-asserted-by": "publisher", "first-page": "12963", "DOI": "10.1073/pnas.162471999", "volume": "99", "author": "JR Pollack", "year": "2002", "unstructured": "Pollack JR, Sorlie T, Perou CM, Rees CA, Jeffrey SS, Lonning PE, et al. Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors. Proc Natl Acad Sci USA. 2002;99(20):12963\u20138.", "journal-title": "Proc Natl Acad Sci USA"}, {"issue": "11", "key": "10_CR136", "first-page": "2993", "volume": "62", "author": "B Fritz", "year": "2002", "unstructured": "Fritz B, Schubert F, Wrobel G, Schwaenen C, Wessendorf S, Nessling M, et al. Microarray-based copy number and expression profiling in dedifferentiated and pleomorphic liposarcoma. Cancer Res. 2002;62(11):2993\u20138.", "journal-title": "Cancer Res"}], "container-title": ["Molecular Pathology Library", "Precision Molecular Pathology of Breast Cancer"], "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/978-1-4939-2886-6_10", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 30]], "date-time": "2019-05-30T16:27:36Z", "timestamp": 1559233656000}, "score": 22.531933, "issued": {"date-parts": [[2015]]}, "ISBN": ["9781493928859", "9781493928866"], "references-count": 136, "URL": "http://dx.doi.org/10.1007/978-1-4939-2886-6_10", "relation": {"cites": []}, "ISSN": ["1935-987X", "1935-9888"], "issn-type": [{"value": "1935-987X", "type": "print"}, {"value": "1935-9888", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 25]], "date-time": "2019-11-25T22:10:19Z", "timestamp": 1574719819643}, "publisher-location": "New York, NY", "reference-count": 142, "publisher": "Springer New York", "isbn-type": [{"value": "9781493928859", "type": "print"}, {"value": "9781493928866", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2015]]}, "DOI": "10.1007/978-1-4939-2886-6_16", "type": "book-chapter", "created": {"date-parts": [[2015, 8, 12]], "date-time": "2015-08-12T08:51:12Z", "timestamp": 1439369472000}, "page": "271-289", "source": "Crossref", "is-referenced-by-count": 1, "title": ["Molecular Pathology of Breast Cancer Metastasis"], "prefix": "10.1007", "author": [{"given": "Mohammed A.", "family": "Aleskandarany", "sequence": "first", "affiliation": []}, {"given": "Ian O.", "family": "Ellis", "sequence": "additional", "affiliation": []}, {"given": "Emad A.", "family": "Rakha", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2015, 8, 13]]}, "reference": [{"issue": "1", "key": "16_CR1", "doi-asserted-by": "publisher", "first-page": "57", "DOI": "10.1016/S0092-8674(00)81683-9", "volume": "100", "author": "D Hanahan", "year": "2000", "unstructured": "Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000;100(1):57\u201370.", "journal-title": "Cell"}, {"issue": "12", "key": "16_CR2", "doi-asserted-by": "publisher", "first-page": "1668", "DOI": "10.1016/S0959-8049(03)00273-9", "volume": "39", "author": "GW Sledge", "year": "2003", "unstructured": "Sledge GW, Miller KD. Exploiting the hallmarks of cancer: the future conquest of breast cancer. Eur J Cancer. 2003;39(12):1668\u201375.", "journal-title": "Eur J Cancer"}, {"issue": "6", "key": "16_CR3", "doi-asserted-by": "publisher", "first-page": "429", "DOI": "10.1007/s001090050128", "volume": "75", "author": "MW Beckmann", "year": "1997", "unstructured": "Beckmann MW, Niederacher D, Schn\u00fcrch HG, Gusterson BA, Bender HG. Multistep carcinogenesis of breast cancer and tumour heterogeneity. J Mol Med. 1997;75(6):429\u201339.", "journal-title": "J Mol Med"}, {"issue": "6", "key": "16_CR4", "doi-asserted-by": "publisher", "first-page": "453", "DOI": "10.1038/nrc1098", "volume": "3", "author": "IJ Fidler", "year": "2003", "unstructured": "Fidler IJ. The pathogenesis of cancer metastasis: the \u2018seed and soil\u2019 hypothesis revisited. Nat Rev Cancer. 2003;3(6):453\u20138.", "journal-title": "Nat Rev Cancer"}, {"key": "16_CR5", "unstructured": "Weinberg RA. Mechanisms of malignant progression. Carcinogenesis. 2008;29(6):1092\u20131095. PubMed PMID: 18453542. Epub 2008/05/06. eng.", "DOI": "10.1093/carcin/bgn104", "doi-asserted-by": "crossref"}, {"key": "16_CR6", "unstructured": "Rabbani SA, Mazar AP. Evaluating distant metastases in breast cancer: from biology to outcomes. Cancer Metastasis Rev. 2007;26(3\u20134):663\u2013674. PubMed PMID: 17823779. Epub 2007/09/08. eng.", "DOI": "10.1007/s10555-007-9085-8", "doi-asserted-by": "crossref"}, {"key": "16_CR7", "unstructured": "Nicolini A, Giardino R, Carpi A, Ferrari P, Anselmi L, Colosimo S, et al. Metastatic breast cancer: an updating. Biomed Pharmacother. 2006;60(9):548\u2013556. PubMed PMID: 16950593. Epub 2006/09/05. eng.", "DOI": "10.1016/j.biopha.2006.07.086", "doi-asserted-by": "crossref"}, {"key": "16_CR8", "unstructured": "Weigelt B, Peterse JL, van \u2018t Veer LJ. Breast cancer metastasis: markers and models. Nat Rev Cancer. 2005;5(8):591\u2013602. PubMed PMID: 16056258. Epub 2005/08/02. eng.", "DOI": "10.1038/nrc1670", "doi-asserted-by": "crossref"}, {"key": "16_CR9", "unstructured": "Duffy MJ, McGowan PM, Gallagher WM. Cancer invasion and metastasis: changing views. J Pathol. 2008;214(3):283\u2013293. PubMed PMID: 18095256. Epub 2007/12/21. eng.", "DOI": "10.1002/path.2282", "doi-asserted-by": "crossref"}, {"issue": "3", "key": "16_CR10", "doi-asserted-by": "publisher", "first-page": "170", "DOI": "10.1093/jnci/djp482", "volume": "102", "author": "BA Virnig", "year": "2010", "unstructured": "Virnig BA, Tuttle TM, Shamliyan T, Kane RL. Ductal carcinoma in situ of the breast: a systematic review of incidence, treatment, and outcomes. J Natl Cancer Inst. 2010;102(3):170\u20138.", "journal-title": "J Natl Cancer Inst"}, {"key": "16_CR11", "unstructured": "Christofori G. New signals from the invasive front. Nature. 2006;441(7092):444\u2013450. PubMed PMID: 16724056. Epub 2006/05/26. eng.", "DOI": "10.1038/nature04872", "doi-asserted-by": "crossref"}, {"key": "16_CR12", "unstructured": "Gupta GP, Massague J. Cancer metastasis: building a framework. Cell. 2006;127(4):679\u2013695. PubMed PMID: 17110329. Epub 2006/11/18. eng.", "DOI": "10.1016/j.cell.2006.11.001", "doi-asserted-by": "crossref"}, {"key": "16_CR13", "unstructured": "Shchors K, Evan G. Tumor angiogenesis: cause or consequence of cancer? Cancer Res. 2007;67(15):7059\u20137061. PubMed PMID: 17671171. Epub 2007/08/03. eng.", "DOI": "10.1158/0008-5472.CAN-07-2053", "doi-asserted-by": "crossref"}, {"key": "16_CR14", "unstructured": "Thiery JP. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer. 2002;2(6):442\u2013454. PubMed PMID: 12189386. Epub 2002/08/22. eng.", "DOI": "10.1038/nrc822", "doi-asserted-by": "crossref"}, {"issue": "5", "key": "16_CR15", "doi-asserted-by": "publisher", "first-page": "341", "DOI": "10.1038/nrg2101", "volume": "8", "author": "DX Nguyen", "year": "2007", "unstructured": "Nguyen DX, Massague J. Genetic determinants of cancer metastasis. Nat Rev Genet. 2007;8(5):341\u201352.", "journal-title": "Nat Rev Genet"}, {"key": "16_CR16", "unstructured": "Schmidt S, Friedl P. Interstitial cell migration: integrin-dependent and alternative adhesion mechanisms. Cell Tissue Res. 2010;339(1):83\u201392. PubMed PMID: 19921267. Epub 2009/11/19. eng.", "DOI": "10.1007/s00441-009-0892-9", "doi-asserted-by": "crossref"}, {"key": "16_CR17", "unstructured": "Knust E. Regulation of epithelial cell shape and polarity by cell-cell adhesion (Review). Mol Membr Biol. 2002;19(2):113\u2013120. PubMed PMID: 12126229. Epub 2002/07/20. eng.", "DOI": "10.1080/09687680210137219", "doi-asserted-by": "crossref"}, {"key": "16_CR18", "unstructured": "Friedl P. Prespecification and plasticity: shifting mechanisms of cell migration. Curr Opin Cell Biol. 2004;16(1):14\u201323. PubMed PMID: 15037300. Epub 2004/03/24. eng.", "DOI": "10.1016/j.ceb.2003.11.001", "doi-asserted-by": "crossref"}, {"key": "16_CR19", "unstructured": "Thiery JP, Sleeman JP. Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol. 2006;7(2):131\u2013142. PubMed PMID: 16493418. Epub 2006/02/24. eng.", "DOI": "10.1038/nrm1835", "doi-asserted-by": "crossref"}, {"key": "16_CR20", "unstructured": "Moustakas A, Heldin CH. Signaling networks guiding epithelial-mesenchymal transitions during embryogenesis and cancer progression. Cancer Sci. 2007;98(10):1512\u20131520. PubMed PMID: 17645776. Epub 2007/07/25. eng.", "DOI": "10.1111/j.1349-7006.2007.00550.x", "doi-asserted-by": "crossref"}, {"key": "16_CR21", "unstructured": "Thiery JP, Sleeman JP. Complex networks orchestrate epithelial-mesenchymal transitions. 2006 20060222 DCOM- 20060317(1471-0072 (Print)). eng."}, {"key": "16_CR22", "unstructured": "Iwatsuki M, Mimori K, Yokobori T, Ishi H, Beppu T, Nakamori S, et al. Epithelial-mesenchymal transition in cancer development and its clinical significance. Cancer Sci. 2010;101(2):293\u2013239. PubMed PMID: 19961486. Epub 2009/12/08. eng.", "DOI": "10.1111/j.1349-7006.2009.01419.x", "doi-asserted-by": "crossref"}, {"issue": "2", "key": "16_CR23", "doi-asserted-by": "publisher", "first-page": "225", "DOI": "10.1007/s10911-010-9184-y", "volume": "15", "author": "R Cardiff", "year": "2010", "unstructured": "Cardiff R. The Pathology of EMT in Mouse Mammary Tumorigenesis. J Mammary Gland Biol Neoplasia. 2010;15(2):225\u201333.", "journal-title": "J Mammary Gland Biol Neoplasia"}, {"key": "16_CR24", "unstructured": "Tomaskovic-Crook E, Thompson EW, Thiery JP. Epithelial to mesenchymal transition and breast cancer. Breast Cancer Res. 2009;11(6):213. PubMed PMID: 19909494. Epub 2009/11/17. eng.", "DOI": "10.1186/bcr2416", "doi-asserted-by": "crossref"}, {"key": "16_CR25", "unstructured": "Polyak K, Weinberg RA. Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat Rev Cancer. 2009;9(4):265\u2013273. PubMed PMID: 19262571. Epub 2009/03/06. eng.", "DOI": "10.1038/nrc2620", "doi-asserted-by": "crossref"}, {"key": "16_CR26", "unstructured": "Barak V, Goike H, Panaretakis KW, Einarsson R. Clinical utility of cytokeratins as tumor markers. Clin Biochem. 2004;37(7):529\u2013540. PubMed PMID: 15234234. Epub 2004/07/06. eng.", "DOI": "10.1016/j.clinbiochem.2004.05.009", "doi-asserted-by": "crossref"}, {"key": "16_CR27", "unstructured": "Moll R, Divo M, Langbein L. The human keratins: biology and pathology. Histochem Cell Biol. 2008;129(6):705\u2013733. PubMed PMID: 18461349. Epub 2008/05/08. eng.", "DOI": "10.1007/s00418-008-0435-6", "doi-asserted-by": "crossref"}, {"issue": "1", "key": "16_CR28", "doi-asserted-by": "publisher", "first-page": "11", "DOI": "10.1016/0092-8674(82)90400-7", "volume": "31", "author": "R Moll", "year": "1982", "unstructured": "Moll R, Franke WW, Schiller DL, Geiger B, Krepler R. The catalog of human cytokeratins: Patterns of expression in normal epithelia, tumors and cultured cells. Cell. 1982;31(1):11\u201324.", "journal-title": "Cell"}, {"key": "16_CR29", "unstructured": "Wu Y, Zhou BP. New insights of epithelial-mesenchymal transition in cancer metastasis. Acta Biochim Biophys Sin (Shanghai). 2008;40(7):643\u2013650. PubMed PMID: 18604456. Epub 2008/07/08. eng.", "DOI": "10.1111/j.1745-7270.2008.00443.x", "doi-asserted-by": "crossref"}, {"key": "16_CR30", "unstructured": "Xue C, Plieth D, Venkov C, Xu C, Neilson EG. The gatekeeper effect of epithelial-mesenchymal transition regulates the frequency of breast cancer metastasis. Cancer Res. 2003;63(12):3386\u20133394. PubMed PMID: 12810675. Epub 2003/06/18. eng."}, {"issue": "14", "key": "16_CR31", "doi-asserted-by": "publisher", "first-page": "5996", "DOI": "10.1158/0008-5472.CAN-05-0699", "volume": "65", "author": "D Tarin", "year": "2005", "unstructured": "Tarin D. The fallacy of epithelial mesenchymal transition in neoplasia. Cancer Res. 2005;65(14):5996\u20136001.", "journal-title": "Cancer Res"}, {"key": "16_CR32", "unstructured": "Wicki A, Lehembre F, Wick N, Hantusch B, Kerjaschki D, Christofori G. Tumor invasion in the absence of epithelial-mesenchymal transition: podoplanin-mediated remodeling of the actin cytoskeleton. Cancer Cell. 2006;9(4):261\u2013272. PubMed PMID: 16616332. Epub 2006/04/18. eng.", "DOI": "10.1016/j.ccr.2006.03.010", "doi-asserted-by": "crossref"}, {"issue": "11", "key": "16_CR33", "doi-asserted-by": "publisher", "first-page": "1287", "DOI": "10.1038/ncb1973", "volume": "11", "author": "S Giampieri", "year": "2009", "unstructured": "Giampieri S, Manning C, Hooper S, Jones L, Hill CS, Sahai E. Localized and reversible TGF[beta] signalling switches breast cancer cells from cohesive to single cell motility. Nat Cell Biol. 2009;11(11):1287\u201396.", "journal-title": "Nat Cell Biol"}, {"key": "16_CR34", "unstructured": "Tse JC, Kalluri R. Mechanisms of metastasis: epithelial-to-mesenchymal transition and contribution of tumor microenvironment. J Cell Biochem. 2007;101(4):816-29. PubMed PMID: 17243120. Epub 2007/01/24. eng.", "DOI": "10.1002/jcb.21215", "doi-asserted-by": "crossref"}, {"key": "16_CR35", "unstructured": "Wendt MK, Smith JA, Schiemann WP. Transforming growth factor-beta-induced epithelial-mesenchymal transition facilitates epidermal growth factor-dependent breast cancer progression. Oncogene. 2010;29(49):6485\u20136498. PubMed PMID: 20802523. Epub 2010/08/31. eng.", "DOI": "10.1038/onc.2010.377", "doi-asserted-by": "crossref"}, {"key": "16_CR36", "unstructured": "Yang J, Mani SA, Donaher JL, Ramaswamy S, Itzykson RA, Come C, et al. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell. 2004;117(7):927\u2013939. PubMed PMID: 15210113. Epub 2004/06/24. eng.", "DOI": "10.1016/j.cell.2004.06.006", "doi-asserted-by": "crossref"}, {"key": "16_CR37", "unstructured": "Lamouille S, Derynck R. Emergence of the phosphoinositide 3-kinase-Akt-mammalian target of rapamycin axis in transforming growth factor-beta-induced epithelial-mesenchymal transition. Cells Tissues Organs. 2011;193(1\u20132):8\u201322. PubMed PMID: 21041997. Epub 2010/11/03. eng.", "DOI": "10.1159/000320172", "doi-asserted-by": "crossref"}, {"issue": "1", "key": "16_CR38", "doi-asserted-by": "publisher", "first-page": "57", "DOI": "10.1002/path.2508", "volume": "218", "author": "A Albasri", "year": "2009", "unstructured": "Albasri A, Seth R, Jackson D, Benhasouna A, Crook S, Nateri AS, et al. C-terminal Tensin-like (CTEN) is an oncogene which alters cell motility possibly through repression of E-cadherin in colorectal cancer. J Pathol. 2009;218(1):57\u201365.", "journal-title": "J Pathol"}, {"key": "16_CR39", "unstructured": "Moyret-Lalle C, Ruiz E, Puisieux A. Epithelial-mesenchymal transition transcription factors and miRNAs: \u201cPlastic surgeons\u201d of breast cancer. World J Clin Oncol. 2014;5(3):311\u2013322. PubMed PMID: 25114847. Pubmed Central PMCID: PMC4127603. Epub 2014/08/13. eng.", "DOI": "10.5306/wjco.v5.i3.311", "doi-asserted-by": "crossref"}, {"key": "16_CR40", "unstructured": "Peinado H, Portillo F, Cano A. Transcriptional regulation of cadherins during development and carcinogenesis. Int J Dev Biol. 2004;48(5\u20136):365\u2013375. PubMed PMID: 15349812. Epub 2004/09/07. eng.", "DOI": "10.1387/ijdb.041794hp", "doi-asserted-by": "crossref"}, {"key": "16_CR41", "unstructured": "Hazan RB, Qiao R, Keren R, Badano I, Suyama K. Cadherin switch in tumor progression. Ann N Y Acad Sci. 2004;1014:155\u2013163. PubMed PMID: 15153430. Epub 2004/05/22. eng.", "DOI": "10.1196/annals.1294.016", "doi-asserted-by": "crossref"}, {"issue": "S1", "key": "16_CR42", "doi-asserted-by": "publisher", "first-page": "S1", "DOI": "10.1002/path.2770", "volume": "222", "author": "M Aleskandarany", "year": "2010", "unstructured": "Aleskandarany M, Green A, Rakha E, Powe D, Ellis I. Epithelial mesenchymal transition in invasive breast carcinoma: molecular pathways and relation to molecular subtypes. J Pathol. 2010;222(S1):S1\u201351.", "journal-title": "J Pathol"}, {"key": "16_CR43", "unstructured": "Yoder BJ, Wilkinson EJ, Massoll NA. Molecular and morphologic distinctions between infiltrating ductal and lobular carcinoma of the breast. Breast J. 2007;13(2):172\u2013179. PubMed PMID: 17319859.", "DOI": "10.1111/j.1524-4741.2007.00393.x", "doi-asserted-by": "crossref"}, {"issue": "5", "key": "16_CR44", "doi-asserted-by": "publisher", "first-page": "615", "DOI": "10.1136/jcp.2007.053991", "volume": "61", "author": "B Mahler-Araujo", "year": "2008", "unstructured": "Mahler-Araujo B, Savage K, Parry S, Reis-Filho JS. Reduction of E-cadherin expression is associated with non-lobular breast carcinomas of basal-like and triple negative phenotype. J Clin Pathol. 2008;61(5):615\u201320.", "journal-title": "J Clin Pathol"}, {"key": "16_CR45", "unstructured": "Sarrio D, Rodriguez-Pinilla SM, Hardisson D, Cano A, Moreno-Bueno G, Palacios J. Epithelial-mesenchymal transition in breast cancer relates to the basal-like phenotype. Cancer Res. 2008;68(4):989\u2013997. PubMed PMID: 18281472. Epub 2008/02/19. eng.", "DOI": "10.1158/0008-5472.CAN-07-2017", "doi-asserted-by": "crossref"}, {"key": "16_CR46", "unstructured": "Aleskandarany MA, Negm OH, Green AR, Ahmed MA, Nolan CC, Tighe PJ, et al. Epithelial mesenchymal transition in early invasive breast cancer: an immunohistochemical and reverse phase protein array study. Breast Cancer Res Treat. 2014;145(2):339\u2013348. PubMed PMID: 24771047. Epub 2014/04/29. eng.", "DOI": "10.1007/s10549-014-2927-5", "doi-asserted-by": "crossref"}, {"key": "16_CR47", "unstructured": "Balkwill FR, Capasso M, Hagemann T. The tumor microenvironment at a glance. J Cell Sci. 2012;125(Pt 23):5591\u20135596. PubMed PMID: 23420197. Epub 2013/02/20. eng.", "DOI": "10.1242/jcs.116392", "doi-asserted-by": "crossref"}, {"key": "16_CR48", "unstructured": "Kalluri R, Zeisberg M. Fibroblasts in cancer. Nat Rev Cancer. 2006 05//print;6(5):392\u2013401.", "DOI": "10.1038/nrc1877", "doi-asserted-by": "crossref"}, {"issue": "3", "key": "16_CR49", "doi-asserted-by": "publisher", "first-page": "283", "DOI": "10.1002/path.4298", "volume": "232", "author": "LE Drake", "year": "2014", "unstructured": "Drake LE, Macleod KF. Tumour suppressor gene function in carcinoma-associated fibroblasts: from tumour cells via EMT and back again? J Pathol. 2014;232(3):283\u20138.", "journal-title": "J Pathol"}, {"key": "16_CR50", "unstructured": "Kurose K, Gilley K, Matsumoto S, Watson PH, Zhou XP, Eng C. Frequent somatic mutations in PTEN and TP53 are mutually exclusive in the stroma of breast carcinomas. Nature Genet. 2002;32(3):355\u2013357. PubMed PMID: 12379854. Epub 2002/10/16. eng.", "DOI": "10.1038/ng1013", "doi-asserted-by": "crossref"}, {"key": "16_CR51", "unstructured": "Phan-Lai V, Florczyk SJ, Kievit FM, Wang K, Gad E, Disis ML, et al. Three-dimensional scaffolds to evaluate tumor associated fibroblast-mediated suppression of breast tumor specific T cells. Biomacromolecules. 2013;14(5):1330\u20131337. PubMed PMID: 23517456. Pubmed Central PMCID: PMC3664178. Epub 2013/03/23. eng.", "DOI": "10.1021/bm301928u", "doi-asserted-by": "crossref"}, {"key": "16_CR52", "unstructured": "Wicki A, Lehembre F, Wick N, Hantusch B, Kerjaschki D, Christofori G. Tumor invasion in the absence of epithelial-mesenchymal transition: Podoplanin-mediated remodeling of the actin cytoskeleton. Cancer cell. 2006;9(4):261\u2013272.", "DOI": "10.1016/j.ccr.2006.03.010", "doi-asserted-by": "crossref"}, {"key": "16_CR53", "unstructured": "Fridman WH, Pag\u00e8s F, Saut\u00e8s-Fridman C, Galon J. The immune contexture in human tumours: impact on clinical outcome. Nat Rev Cancer. 2012;12(4):298\u2013306.", "DOI": "10.1038/nrc3245", "doi-asserted-by": "crossref"}, {"key": "16_CR54", "unstructured": "Schoenborn JR, Wilson CB. Regulation of interferon\u2010\u03b3 during innate and adaptive immune responses. In: Frederick WA, editor. Advances in immunology 96: Academic Press; 2007. p. 41\u2013101.", "DOI": "10.1016/S0065-2776(07)96002-2", "doi-asserted-by": "crossref"}, {"key": "16_CR55", "unstructured": "Hsieh CS, Lee HM, Lio CW. Selection of regulatory T cells in the thymus. Nat Rev Immunol. 2012;12(3):157\u2013167. PubMed PMID: 22322317. Epub 2012/02/11. eng.", "DOI": "10.1038/nri3155", "doi-asserted-by": "crossref"}, {"key": "16_CR56", "unstructured": "Jaberipour M, Habibagahi M, Hosseini A, Habibabad SR, Talei A, Ghaderi A. Increased CTLA-4 and FOXP3 transcripts in peripheral blood mononuclear cells of patients with breast cancer. Pathol Oncol Res. 2010;16(4):547\u2013551. PubMed PMID: 20306312. Epub 2010/03/23. eng.", "DOI": "10.1007/s12253-010-9256-8", "doi-asserted-by": "crossref"}, {"key": "16_CR57", "unstructured": "Campbell DJ, Koch MA. Treg cells: patrolling a dangerous neighborhood. 2011.", "DOI": "10.1038/nm.2433", "doi-asserted-by": "crossref"}, {"key": "16_CR58", "unstructured": "Mahmoud SM, Lee AH, Paish EC, Macmillan RD, Ellis IO, Green AR. The prognostic significance of B lymphocytes in invasive carcinoma of the breast. Breast Cancer Res Treat. 2012;132(2):545\u2013553. PubMed PMID: 21671016. Epub 2011/06/15. eng.", "DOI": "10.1007/s10549-011-1620-1", "doi-asserted-by": "crossref"}, {"key": "16_CR59", "unstructured": "Andre F, Dieci MV, Dubsky P, Sotiriou C, Curigliano G, Denkert C, et al. Molecular pathways: involvement of immune pathways in the therapeutic response and outcome in breast cancer. Clin Cancer Res. 2013;19(1):28\u201333. PubMed PMID: 23258741. Epub 2012/12/22. eng.", "DOI": "10.1158/1078-0432.CCR-11-2701", "doi-asserted-by": "crossref"}, {"issue": "10", "key": "16_CR60", "doi-asserted-by": "publisher", "first-page": "3505", "DOI": "10.1158/0008-5472.CAN-10-4316", "volume": "71", "author": "PB Olkhanud", "year": "2011", "unstructured": "Olkhanud PB, Damdinsuren B, Bodogai M, Gress RE, Sen R, Wejksza K, et al. Tumor-evoked regulatory B cells promote breast cancer metastasis by converting resting CD4+\u00a0T cells to T-regulatory cells. Cancer Res. 2011;71(10):3505\u201315.", "journal-title": "Cancer Res"}, {"key": "16_CR61", "unstructured": "Joimel U, Gest C, Soria J, Pritchard LL, Alexandre J, Laurent M, et al. Stimulation of angiogenesis resulting from cooperation between macrophages and MDA-MB-231 breast cancer cells: proposed molecular mechanism and effect of tetrathiomolybdate. BMC Cancer. 2010;10:375. PubMed PMID: 20637124. Pubmed Central PMCID: PMC2918575. Epub 2010/07/20. eng.", "DOI": "10.1186/1471-2407-10-375", "doi-asserted-by": "crossref"}, {"key": "16_CR62", "unstructured": "Pollard JW. Macrophages define the invasive microenvironment in breast cancer. J Leukoc Biol. 2008;84(3):623\u2013630. PubMed PMID: 18467655. Pubmed Central PMCID: PMC2516896. Epub 2008/05/10. eng.", "DOI": "10.1189/jlb.1107762", "doi-asserted-by": "crossref"}, {"key": "16_CR63", "unstructured": "Cursiefen C, Chen L, Borges LP, Jackson D, Cao J, Radziejewski C, et al. VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment. J Clin Invest. 2004;113(7):1040\u20131050. PubMed PMID: 15057311. Pubmed Central PMCID: PMC379325. Epub 2004/04/02. eng.", "DOI": "10.1172/JCI200420465", "doi-asserted-by": "crossref"}, {"key": "16_CR64", "unstructured": "Cheung KJ, Ewald AJ. Illuminating breast cancer invasion: diverse roles for cell\u2013cell interactions. Curr Opin Cell Biol. 2014;30(0):99\u2013111."}, {"key": "16_CR65", "unstructured": "Cekic C, Day YJ, Sag D, Linden J. Myeloid expression of Adenosine A2A receptor suppresses T and NK cell responses in the solid tumor microenvironment. Cancer Res. 2014. PubMed PMID: 25377469. Epub 2014/11/08. Eng.", "DOI": "10.1158/0008-5472.CAN-13-3583", "doi-asserted-by": "crossref"}, {"key": "16_CR66", "unstructured": "Kozlowska A, Mackiewicz J, Mackiewicz A. Therapeutic gene modified cell based cancer vaccines. Gene. 2013;525(2):200\u2013207. PubMed PMID: 23566846. Epub 2013/04/10. eng.", "DOI": "10.1016/j.gene.2013.03.056", "doi-asserted-by": "crossref"}, {"key": "16_CR67", "unstructured": "Lochter A, Bissell MJ. Involvement of extracellular matrix constituents in breast cancer. Semin Cancer Biol. 1995;6(3):165\u2013173.", "DOI": "10.1006/scbi.1995.0017", "doi-asserted-by": "crossref"}, {"key": "16_CR68", "unstructured": "Fu H, Moss J, Shore I, Slade MJ, Coombes RC, Coombes RC. Ultrastructural localization of laminin and type IV collagen in normal human breast. 2002 20020530 DCOM- 20021107(0191-3123 (Print)). eng."}, {"key": "16_CR69", "unstructured": "Lu P, Weaver VM, Werb Z. The extracellular matrix: a dynamic niche in cancer progression. J Cell Biol. 2012;196(4):395\u2013406. PubMed PMID: 22351925. Pubmed Central PMCID: PMC3283993. Epub 2012/02/22. eng.", "DOI": "10.1083/jcb.201102147", "doi-asserted-by": "crossref"}, {"key": "16_CR70", "unstructured": "Gehler S, Ponik SM, Riching KM, Keely PJ. Bi-directional signaling: extracellular matrix and integrin regulation of breast tumor progression. Critical reviews in eukaryotic gene expression.\u00a02013;23(2):139\u201357. PubMed PMID: 23582036. Epub 2013/04/16. eng.", "DOI": "10.1615/CritRevEukarGeneExpr.2013006647", "doi-asserted-by": "crossref"}, {"key": "16_CR71", "unstructured": "Pouliot N, Kusuma N. Laminin-511: a multi-functional adhesion protein regulating cell migration, tumor invasion and metastasis. Cell Adhes Migr. 2013;7(1):142\u2013149. PubMed PMID: 23076212. Pubmed Central PMCID: PMC3544778. Epub 2012/10/19. eng.", "DOI": "10.4161/cam.22125", "doi-asserted-by": "crossref"}, {"key": "16_CR72", "unstructured": "Gritsenko PG, Ilina O, Friedl P. Interstitial guidance of cancer invasion. J Pathol. 2012;226(2):185\u2013199. PubMed PMID: 22006671. Epub 2011/10/19. eng.", "DOI": "10.1002/path.3031", "doi-asserted-by": "crossref"}, {"key": "16_CR73", "unstructured": "Oskarsson T. Extracellular matrix components in breast cancer progression and metastasis. Breast (Edinburgh, Scotland). 2013;22 Suppl 2:S66\u201372. PubMed PMID: 24074795. Epub 2013/10/01. eng.", "DOI": "10.1016/j.breast.2013.07.012", "doi-asserted-by": "crossref"}, {"key": "16_CR74", "unstructured": "Rothberg JM, Sameni M, Moin K, Sloane BF. Live-cell imaging of tumor proteolysis: impact of cellular and non-cellular microenvironment. Biochim et Biophys Acta. 2012;1824(1):123\u2013132. PubMed PMID: 21854877. Pubmed Central PMCID: PMC3232330. Epub 2011/08/23. eng.", "DOI": "10.1016/j.bbapap.2011.07.025", "doi-asserted-by": "crossref"}, {"key": "16_CR75", "unstructured": "Tang L, Han X. The urokinase plasminogen activator system in breast cancer invasion and metastasis. Biomed Pharmacother. 2013;67(2):179\u2013182. PubMed PMID: 23201006. Epub 2012/12/04. eng.", "DOI": "10.1016/j.biopha.2012.10.003", "doi-asserted-by": "crossref"}, {"key": "16_CR76", "unstructured": "Agrawal AK, Ekonjo GB, Teterycz E, Zyoeko D, Grzebieniak Z, Milan M, et al. Cysteine peptidases and their inhibitors in breast and genital cancer. Folia Histochem et Cytobiologica/Pol Acad Sci Pol Histochem Cytochemical Soc. 2010;48(3):323\u2013327. PubMed PMID: 21071333. Epub 2010/11/13. eng.", "DOI": "10.2478/v10042-10-0067-2", "doi-asserted-by": "crossref"}, {"key": "16_CR77", "unstructured": "Dian D, Heublein S, Wiest I, Barthell L, Friese K, Jeschke U. Significance of the tumor protease cathepsin D for the biology of breast cancer. Histol Histopathology. 2014;29(4):433\u2013438. PubMed PMID: 24265119. Epub 2013/11/23. eng."}, {"key": "16_CR78", "unstructured": "Lebeau A, Nerlich AG, Sauer U, Lichtinghagen R, Lohrs U. Tissue distribution of major matrix metalloproteinases and their transcripts in human breast carcinomas. Anticancer Res. 1999;19(5B):4257\u20134264. PubMed PMID: 10628384. Epub 2000/01/11. eng."}, {"key": "16_CR79", "unstructured": "Roy DM, Walsh LA. Candidate prognostic markers in breast cancer: focus on extracellular proteases and their inhibitors. Breast Cancer (Dove Med Press). 2014;6:81\u201391. PubMed PMID: 25114586. Pubmed Central PMCID: PMC4090043. Epub 2014/08/13. eng.", "DOI": "10.2147/BCTT.S46020", "doi-asserted-by": "crossref"}, {"key": "16_CR80", "unstructured": "Davies KJ. The complex interaction of matrix metalloproteinases in the migration of cancer cells through breast tissue stroma. Int J Breast Cancer. 2014;2014:839094. PubMed PMID: 24800085. Pubmed Central PMCID: PMC3985306. Epub 2014/05/07. eng."}, {"key": "16_CR81", "unstructured": "Velinov N, Poptodorov G, Gabrovski N, Gabrovski S. The role of matrixmetalloproteinases in the tumor growth and metastasis. Khirurgiia. 2010 (1):44\u201349. PubMed PMID: 21972705. Epub 2010/01/01. bul.", "DOI": "10.4236/jsip.2010.11005", "doi-asserted-by": "crossref"}, {"key": "16_CR82", "unstructured": "Friedl P, Wolf K. Proteolytic interstitial cell migration: a five-step process. Cancer Metastasis Rev. 2009;28(1\u20132):129\u2013135. PubMed PMID: 19153672. Epub 2009/01/21. eng.", "DOI": "10.1007/s10555-008-9174-3", "doi-asserted-by": "crossref"}, {"key": "16_CR83", "unstructured": "Stylli SS, Kaye AH, Lock P. Invadopodia: at the cutting edge of tumour invasion. J Clin Neurosci Official J Neurosurg Soc Australas. 2008;15(7):725\u2013737. PubMed PMID: 18468901. Epub 2008/05/13. eng.", "DOI": "10.1016/j.jocn.2008.03.003", "doi-asserted-by": "crossref"}, {"key": "16_CR84", "first-page": "6", "volume": "2014", "author": "KJ Davies", "year": "2014", "unstructured": "Davies KJ. Methods of cell propulsion through the local stroma in breast cancer. Int J Breast Cancer. 2014;2014:6.", "journal-title": "Int J Breast Cancer"}, {"key": "16_CR85", "unstructured": "Rakha EA, Martin S, Lee AH, Morgan D, Pharoah PD, Hodi Z, et al. The prognostic significance of lymphovascular invasion in invasive breast carcinoma. Cancer. 2012;118(15):3670\u20133680. PubMed PMID: 22180017. Epub 2011/12/20. eng.", "DOI": "10.1002/cncr.26711", "doi-asserted-by": "crossref"}, {"key": "16_CR86", "unstructured": "Mohammed RA, Martin SG, Mahmmod AM, Macmillan RD, Green AR, Paish EC, et al. Objective assessment of lymphatic and blood vascular invasion in lymph node-negative breast carcinoma: findings from a large case series with long-term follow-up. J Pathol. 2010 Oct 14. PubMed PMID: 21132836.", "DOI": "10.1002/path.2810", "doi-asserted-by": "crossref"}, {"key": "16_CR87", "unstructured": "Gujam FJ, Going JJ, Edwards J, Mohammed ZM, McMillan DC. The role of lymphatic and blood vessel invasion in predicting survival and methods of detection in patients with primary operable breast cancer. Crit Rev Oncol/Hematol. 2014;89(2):231\u2013241. PubMed PMID: 24075309. Epub 2013/10/01. eng.", "DOI": "10.1016/j.critrevonc.2013.08.014", "doi-asserted-by": "crossref"}, {"issue": "1", "key": "16_CR88", "doi-asserted-by": "publisher", "first-page": "1", "DOI": "10.1111/j.1365-2559.2008.03169.x", "volume": "55", "author": "RA Mohammed", "year": "2009", "unstructured": "Mohammed RA, Ellis IO, Lee AH, Martin SG. Vascular invasion in breast cancer; an overview of recent prognostic developments and molecular pathophysiological mechanisms. Histopathology. 2009;55(1):1\u20139.", "journal-title": "Histopathology"}, {"key": "16_CR89", "unstructured": "Gujam FJ, Going JJ, Mohammed ZM, Orange C, Edwards J, McMillan DC. Immunohistochemical detection improves the prognostic value of lymphatic and blood vessel invasion in primary ductal breast cancer. BMC Cancer. 2014;14:676. PubMed PMID: 25234410. Pubmed Central PMCID: PMC4177173. Epub 2014/09/23. eng.", "DOI": "10.1186/1471-2407-14-676", "doi-asserted-by": "crossref"}, {"key": "16_CR90", "unstructured": "Stacker SA, Williams SP, Karnezis T, Shayan R, Fox SB, Achen MG. Lymphangiogenesis and lymphatic vessel remodelling in cancer. Nat Rev Cancer. 2014;14(3):159\u2013172.", "DOI": "10.1038/nrc3677", "doi-asserted-by": "crossref"}, {"key": "16_CR91", "unstructured": "Tammela T, Alitalo K. Lymphangiogenesis: Molecular mechanisms and future promise. Cell. 2010;140(4):460\u2013476. PubMed PMID: 20178740. Epub 2010/02/25. eng.", "DOI": "10.1016/j.cell.2010.01.045", "doi-asserted-by": "crossref"}, {"key": "16_CR92", "unstructured": "Chung AS, Ferrara N. Developmental and pathological angiogenesis. Annu Rev Cell Dev Biol. 2011;27:563\u2013584. PubMed PMID: 21756109. Epub 2011/07/16. eng.", "DOI": "10.1146/annurev-cellbio-092910-154002", "doi-asserted-by": "crossref"}, {"key": "16_CR93", "unstructured": "Shayan R, Inder R, Karnezis T, Caesar C, Paavonen K, Ashton MW, et al. Tumor location and nature of lymphatic vessels are key determinants of cancer metastasis. Clin Exp Metastasis. 2013;30(3):345\u2013356. PubMed PMID: 23124573. Epub 2012/11/06. eng.", "DOI": "10.1007/s10585-012-9541-x", "doi-asserted-by": "crossref"}, {"key": "16_CR94", "unstructured": "Ji RC. Lymphatic endothelial cells, tumor lymphangiogenesis and metastasis: new insights into intratumoral and peritumoral lymphatics. Cancer Metastasis Rev. 2006;25(4):677\u2013694. PubMed PMID: 17160713. Epub 2006/12/13. eng.", "DOI": "10.1007/s10555-006-9026-y", "doi-asserted-by": "crossref"}, {"issue": "6", "key": "16_CR95", "doi-asserted-by": "publisher", "first-page": "526", "DOI": "10.1016/j.ccr.2007.04.020", "volume": "11", "author": "JD Shields", "year": "2007", "unstructured": "Shields JD, Fleury ME, Yong C, Tomei AA, Randolph GJ, Swartz MA. Autologous chemotaxis as a mechanism of tumor cell homing to lymphatics via interstitial flow and autocrine CCR7 signaling. Cancer Cell. 2007;11(6):526\u201338.", "journal-title": "Cancer Cell"}, {"key": "16_CR96", "unstructured": "Ugras S, Stempel M, Patil S, Morrow M. Estrogen receptor, progesterone receptor, and HER2 status predict lymphovascular invasion and lymph node involvement. Ann Surg Oncol. 2014 2014/11/01;21(12):3780\u20133786. English.", "DOI": "10.1245/s10434-014-3851-y", "doi-asserted-by": "crossref"}, {"key": "16_CR97", "unstructured": "Curtis C, Shah SP, Chin S-F, Turashvili G, Rueda OM, Dunning MJ, et al. The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups. Nature. 2012;486(7403):346\u2013352.", "DOI": "10.1038/nature10983", "doi-asserted-by": "crossref"}, {"key": "16_CR98", "unstructured": "Prat A, Parker JS, Karginova O, Fan C, Livasy C, Herschkowitz JI, et al. Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer. Breast Cancer Res: BCR. 2010;12(5):R68. PubMed PMID: 20813035. Pubmed Central PMCID: PMC3096954. Epub 2010/09/04. eng.", "DOI": "10.1186/bcr2635", "doi-asserted-by": "crossref"}, {"key": "16_CR99", "unstructured": "Holm-Rasmussen EV, Jensen MB, Balslev E, Kroman N, Tvedskov TF. Reduced risk of axillary lymphatic spread in triple-negative breast cancer. Breast Cancer Res Treat. 2015;149(1):229\u2013236. PubMed PMID: 25488719. Epub 2014/12/10. eng.", "DOI": "10.1007/s10549-014-3225-y", "doi-asserted-by": "crossref"}, {"key": "16_CR100", "unstructured": "Wan L, Pantel K, Kang Y. Tumor metastasis: moving new biological insights into the clinic. Nat Med. 2013;19(11):1450\u20131464. PubMed PMID: 24202397. Epub 2013/11/10. eng.", "DOI": "10.1038/nm.3391", "doi-asserted-by": "crossref"}, {"key": "16_CR101", "unstructured": "Douma S, van Laar T, Zevenhoven J, Meuwissen R, van Garderen E, Peeper DS. Suppression of anoikis and induction of metastasis by the neurotrophic receptor TrkB. Nature. 2004;430(7003):1034\u20131039.", "DOI": "10.1038/nature02765", "doi-asserted-by": "crossref"}, {"key": "16_CR102", "unstructured": "Nierodzik ML, Karpatkin S. Thrombin induces tumor growth, metastasis, and angiogenesis: Evidence for a thrombin-regulated dormant tumor phenotype. Cancer Cell. 2006;10(5):355\u2013362. PubMed PMID: 17097558. Epub 2006/11/14. eng.", "DOI": "10.1016/j.ccr.2006.10.002", "doi-asserted-by": "crossref"}, {"key": "16_CR103", "unstructured": "Chao MP, Weissman IL, Majeti R. The CD47-SIRPalpha pathway in cancer immune evasion and potential therapeutic implications. Curr Opin Immunol. 2012;24(2):225\u2013232. PubMed PMID: 22310103. Pubmed Central PMCID: PMC3319521. Epub 2012/02/09. eng.", "DOI": "10.1016/j.coi.2012.01.010", "doi-asserted-by": "crossref"}, {"key": "16_CR104", "unstructured": "Hiratsuka S, Goel S, Kamoun WS, Maru Y, Fukumura D, Duda DG, et al. Endothelial focal adhesion kinase mediates cancer cell homing to discrete regions of the lungs via E-selectin up-regulation. Proc Natl Acad Sci USA. 2011;108(9):3725\u20133730. PubMed PMID: 21321210. Pubmed Central PMCID: PMC3048115. Epub 2011/02/16. eng.", "DOI": "10.1073/pnas.1100446108", "doi-asserted-by": "crossref"}, {"key": "16_CR105", "unstructured": "Bendas G, Borsig L. Cancer cell adhesion and metastasis: selectins, integrins, and the inhibitory potential of heparins. Int J Cell Biol. 2012;2012:676731. PubMed PMID: 22505933. Pubmed Central PMCID: PMC3296185. Epub 2012/04/17. eng.", "DOI": "10.1155/2012/676731", "doi-asserted-by": "crossref"}, {"key": "16_CR106", "unstructured": "Desgrosellier JS, Cheresh DA. Integrins in cancer: biological implications and therapeutic opportunities. Nat Rev Cancer. 2010;10(1):9\u201322. PubMed PMID: 20029421. Epub 2009/12/24. eng.", "DOI": "10.1038/nrc2748", "doi-asserted-by": "crossref"}, {"key": "16_CR107", "unstructured": "Takayama S, Ishii S, Ikeda T, Masamura S, Doi M, Kitajima M. The relationship between bone metastasis from human breast cancer and integrin alpha(v)beta3 expression. Anticancer Res. 2005;25(1A):79\u201383. PubMed PMID: 15816522. Epub 2005/04/09. eng."}, {"key": "16_CR108", "unstructured": "Sloan EK, Pouliot N, Stanley KL, Chia J, Moseley JM, Hards DK, et al. Tumor-specific expression of alphavbeta3 integrin promotes spontaneous metastasis of breast cancer to bone. Breast Cancer Res. 2006;8(2):R20. PubMed PMID: 16608535. Pubmed Central PMCID: PMC1557720. Epub 2006/04/13. eng.", "DOI": "10.1186/bcr1398", "doi-asserted-by": "crossref"}, {"key": "16_CR109", "unstructured": "Guo W, Pylayeva Y, Pepe A, Yoshioka T, Muller WJ, Inghirami G, et al. Beta 4 integrin amplifies ErbB2 signaling to promote mammary tumorigenesis. Cell. 2006;126(3):489\u2013502. PubMed PMID: 16901783. Epub 2006/08/12. eng.", "DOI": "10.1016/j.cell.2006.05.047", "doi-asserted-by": "crossref"}, {"key": "16_CR110", "unstructured": "Yoon SO, Shin S, Lipscomb EA. A novel mechanism for integrin-mediated ras activation in breast carcinoma cells: the alpha6beta4 integrin regulates ErbB2 translation and transactivates epidermal growth factor receptor/ErbB2 signaling. Cancer Res. 2006;66(5):2732\u20132739. PubMed PMID: 16510594. Epub 2006/03/03. eng.", "DOI": "10.1158/0008-5472.CAN-05-2941", "doi-asserted-by": "crossref"}, {"key": "16_CR111", "unstructured": "Lee YT. Breast carcinoma: pattern of metastasis at autopsy. J Surg Oncol. 1983;23(3):175\u2013180. PubMed PMID: 6345937. Epub 1983/07/01. eng.", "DOI": "10.1002/jso.2930230311", "doi-asserted-by": "crossref"}, {"key": "16_CR112", "unstructured": "Lu X, Kang Y. Organotropism of breast cancer metastasis. J Mammary Gland Biol Neoplasia. 2007;12(2\u20133):153\u2013162. PubMed PMID: 17566854. Epub 2007/06/15. eng.", "DOI": "10.1007/s10911-007-9047-3", "doi-asserted-by": "crossref"}, {"key": "16_CR113", "unstructured": "Muller A, Homey B, Soto H, Ge N, Catron D, Buchanan ME, et al. Involvement of chemokine receptors in breast cancer metastasis. Nature. 2001;410(6824):50\u201356. PubMed PMID: 11242036. Epub 2001/03/10. eng.", "DOI": "10.1038/35065016", "doi-asserted-by": "crossref"}, {"key": "16_CR114", "unstructured": "Mukherjee D, Zhao J. The Role of chemokine receptor CXCR4 in breast cancer metastasis. Am J Cancer Res. 2013;3(1):46\u201357. PubMed PMID: 23359227. Pubmed Central PMCID: PMC3555200. Epub 2013/01/30. eng."}, {"issue": "8", "key": "16_CR115", "doi-asserted-by": "publisher", "first-page": "895", "DOI": "10.1038/nm1469", "volume": "12", "author": "PS Steeg", "year": "2006", "unstructured": "Steeg PS. Tumor metastasis: mechanistic insights and clinical challenges. Nat Med. 2006;12(8):895\u2013904.", "journal-title": "Nat Med"}, {"key": "16_CR116", "unstructured": "Kang Y, Siegel PM, Shu W, Drobnjak M, Kakonen SM, Cordon-Cardo C, et al. A multigenic program mediating breast cancer metastasis to bone. Cancer Cell. 2003;3(6):537\u2013549. PubMed PMID: 12842083. Epub 2003/07/05. eng.", "DOI": "10.1016/S1535-6108(03)00132-6", "doi-asserted-by": "crossref"}, {"issue": "20", "key": "16_CR117", "doi-asserted-by": "publisher", "first-page": "6213s", "DOI": "10.1158/1078-0432.CCR-06-1007", "volume": "12", "author": "TA Guise", "year": "2006", "unstructured": "Guise TA, Mohammad KS, Clines G, Stebbins EG, Wong DH, Higgins LS, et al. Basic Mechanisms Responsible for Osteolytic and Osteoblastic Bone Metastases. Clin Cancer Res. 2006;12(20):6213s\u20136s.", "journal-title": "Clin Cancer Res"}, {"issue": "1", "key": "16_CR118", "doi-asserted-by": "publisher", "first-page": "57", "DOI": "10.1038/sj.cr.7290266", "volume": "15", "author": "JJ Yin", "year": "2005", "unstructured": "Yin JJ, Pollock CB, Kelly K. Mechanisms of cancer metastasis to the bone. Cell Res. 2005;15(1):57\u201362.", "journal-title": "Cell Res"}, {"issue": "24", "key": "16_CR119", "doi-asserted-by": "publisher", "first-page": "21352", "DOI": "10.1074/jbc.M111663200", "volume": "277", "author": "SL Dallas", "year": "2002", "unstructured": "Dallas SL, Rosser JL, Mundy GR, Bonewald LF. Proteolysis of latent transforming growth factor-\u03b2 (TGF-\u03b2)-binding Protein-1 by osteoclasts: a cellular mechanism for release of TGF-\u03b2 from bone matrix. J Biol Chem. 2002;277(24):21352\u201360.", "journal-title": "J Biol Chem"}, {"key": "16_CR120", "unstructured": "Brackstone M, Townson J, Chambers A. Tumour dormancy in breast cancer: an update. Breast Cancer Res. 2007;9(3):208. PubMed PMID. doi:\n                  10.1186/bcr1677\n                  \n                .", "DOI": "10.1186/bcr1677", "doi-asserted-by": "publisher"}, {"key": "16_CR121", "unstructured": "Wikman H, Vessella R, Pantel K. Cancer micrometastasis and tumour dormancy. APMIS. 2008;116(7\u20138):754\u2013770. PubMed PMID: 18834417. Epub 2008/10/07. eng.", "DOI": "10.1111/j.1600-0463.2008.01033.x", "doi-asserted-by": "crossref"}, {"key": "16_CR122", "unstructured": "Holmgren L, O\u2019Reilly MS, Folkman J. Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nat Med. 1995;1(2):149\u2013153. PubMed PMID: 7585012. Epub 1995/02/01. eng.", "DOI": "10.1038/nm0295-149", "doi-asserted-by": "crossref"}, {"key": "16_CR123", "unstructured": "Townson JL, Chambers AF. Dormancy of solitary metastatic cells. Cell Cycle. 2006;5(16):1744\u20131750. PubMed PMID: 16861927. Epub 2006/07/25. eng.", "DOI": "10.4161/cc.5.16.2864", "doi-asserted-by": "crossref"}, {"issue": "6900", "key": "16_CR124", "doi-asserted-by": "publisher", "first-page": "823", "DOI": "10.1038/418823a", "volume": "418", "author": "R Bernards", "year": "2002", "unstructured": "Bernards R, Weinberg RA. Metastasis genes: a progression puzzle. Nature. 2002;418(6900):823.", "journal-title": "Nature"}, {"key": "16_CR125", "unstructured": "Weigelt B, Glas AM, Wessels LF, Witteveen AT, Peterse JL, van\u2019t Veer LJ. Gene expression profiles of primary breast tumors maintained in distant metastases. Proc Natl Acad Sci USA. 2003;100(26):15901\u201315905. PubMed PMID: 14665696.", "DOI": "10.1073/pnas.2634067100", "doi-asserted-by": "crossref"}, {"issue": "10", "key": "16_CR126", "doi-asserted-by": "publisher", "first-page": "5974", "DOI": "10.1073/pnas.0931261100", "volume": "100", "author": "XJ Ma", "year": "2003", "unstructured": "Ma XJ, Salunga R, Tuggle JT, Gaudet J, Enright E, McQuary P, et al. Gene expression profiles of human breast cancer progression. Proc Natl Acad Sci USA. 2003;100(10):5974\u20139.", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "16_CR127", "unstructured": "Weigelt B, van\u2019t Veer LJ. Hard-wired genotype in metastatic breast cancer. Cell Cycle. 2004;3(6):756\u2013757. PubMed PMID: 15153810. Epub 2004/05/22. eng.", "DOI": "10.4161/cc.3.6.923", "doi-asserted-by": "crossref"}, {"key": "16_CR128", "unstructured": "Kennecke H, Yerushalmi R, Woods R, Cheang MC, Voduc D, Speers CH, et al. Metastatic behavior of breast cancer subtypes. J Clin Oncol. 2010;28(20):3271\u20133277. PubMed PMID: 20498394. Epub 2010/05/26. eng.", "DOI": "10.1200/JCO.2009.25.9820", "doi-asserted-by": "crossref"}, {"issue": "7", "key": "16_CR129", "doi-asserted-by": "publisher", "first-page": "2302", "DOI": "10.1158/1078-0432.CCR-08-2132", "volume": "15", "author": "EA Rakha", "year": "2009", "unstructured": "Rakha EA, Elsheikh SE, Aleskandarany MA, Habashi HO, Green AR, Powe DG, et al. Triple-negative breast cancer: distinguishing between basal and nonbasal subtypes. Clin Cancer Res. 2009;15(7):2302\u201310.", "journal-title": "Clin Cancer Res"}, {"key": "16_CR130", "unstructured": "Yaman S, Gumuskaya B, Ozkan C, Aksoy S, Guler G, Altundag K. Lymphatic and capillary invasion patterns in triple negative breast cancer. Am Surg. 2012;78(11):1238\u20131242. PubMed PMID: 23089442. Epub 2012/10/24. eng."}, {"key": "16_CR131", "unstructured": "Badve S, Dabbs DJ, Schnitt SJ, Baehner FL, Decker T, Eusebi V, et al. Basal-like and triple-negative breast cancers: a critical review with an emphasis on the implications for pathologists and oncologists. Mod Pathol. 2011;24(2):157\u2013167.", "DOI": "10.1038/modpathol.2010.200", "doi-asserted-by": "crossref"}, {"key": "16_CR132", "unstructured": "Rodenhiser DI, Andrews Jd, Vandenberg TA, Chambers AF. Gene signatures of breast cancer progression and metastasis. Breast Cancer Res. 2011 20111115 DCOM- 20140325(1465-542X (Electronic)). eng.", "DOI": "10.1186/bcr2791", "doi-asserted-by": "crossref"}, {"key": "16_CR133", "unstructured": "van de Vijver MJ, He YD, van\u2019t Veer LJ, Dai H, Hart AAM, Voskuil DW, et al. A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med. 2002;347(25):1999\u20132009. PubMed PMID: ISI:000179874500003.", "DOI": "10.1056/NEJMoa021967", "doi-asserted-by": "crossref"}, {"key": "16_CR134", "unstructured": "Buyse M, Loi S, van\u2019t Veer L, Viale G, Delorenzi M, Glas AM, et al. Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer. J Natl Cancer Inst. 2006;98(17):1183\u20131192.", "DOI": "10.1093/jnci/djj329", "doi-asserted-by": "crossref"}, {"key": "16_CR135", "unstructured": "Wang Y, Klijn JG, Zhang Y, Sieuwerts AM, Look MP, Yang F, et al. Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet. 2005;365(9460):671\u2013679. PubMed PMID: 15721472."}, {"issue": "4", "key": "16_CR136", "doi-asserted-by": "publisher", "first-page": "262", "DOI": "10.1093/jnci/djj052", "volume": "98", "author": "C Sotiriou", "year": "2006", "unstructured": "Sotiriou C, Wirapati P, Loi S, Harris A, Fox S, Smeds J, et al. Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis. J Natl Cancer Inst. 2006;98(4):262\u201372.", "journal-title": "J Natl Cancer Inst"}, {"issue": "27", "key": "16_CR137", "doi-asserted-by": "publisher", "first-page": "2817", "DOI": "10.1056/NEJMoa041588", "volume": "351", "author": "S Paik", "year": "2004", "unstructured": "Paik S, Shak S, Tang G, Kim C, Baker J, Cronin M, et al. A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med. 2004;351(27):2817\u201326.", "journal-title": "N Engl J Med"}, {"issue": "5", "key": "16_CR138", "doi-asserted-by": "publisher", "first-page": "721", "DOI": "10.1200/JCO.2007.15.1068", "volume": "26", "author": "JA Sparano", "year": "2008", "unstructured": "Sparano JA, Paik S. Development of the 21-gene assay and its application in clinical practice and clinical trials. J Clin Oncol. 2008;26(5):721\u20138.", "journal-title": "J Clin Oncol"}, {"key": "16_CR139", "unstructured": "Ross JS, Hatzis C, Symmans WF, Pusztai L, Hortobagyi GN. Commercialized multigene predictors of clinical outcome for breast cancer. Oncologist. 2008;13(5):477\u2013493. PubMed PMID: 18515733. Epub 2008/06/03. eng.", "DOI": "10.1634/theoncologist.2007-0248", "doi-asserted-by": "crossref"}, {"issue": "4", "key": "16_CR140", "doi-asserted-by": "publisher", "first-page": "R65", "DOI": "10.1186/bcr2124", "volume": "10", "author": "P Wirapati", "year": "2008", "unstructured": "Wirapati P, Sotiriou C, Kunkel S, Farmer P, Pradervand S, Haibe-Kains B, et al. Meta-analysis of gene expression profiles in breast cancer: toward a unified understanding of breast cancer subtyping and prognosis signatures. Breast Cancer Res. 2008;10(4):R65.", "journal-title": "Breast Cancer Res"}, {"key": "16_CR141", "doi-asserted-by": "publisher", "first-page": "394", "DOI": "10.1186/1471-2164-9-394", "volume": "9", "author": "B Haibe-Kains", "year": "2008", "unstructured": "Haibe-Kains B, Desmedt C, Piette F, Buyse M, Cardoso F, Van\u2019t Veer L, et al. Comparison of prognostic gene expression signatures for breast cancer. BMC Genom. 2008;9:394.", "journal-title": "BMC Genom"}, {"key": "16_CR142", "unstructured": "Mefford D, Mefford J. Stromal genes add prognostic information to proliferation and histoclinical markers: a basis for the next generation of breast cancer gene signatures. PloS One. 2012;7(6):e37646. PubMed PMID: 22719844. Pubmed Central PMCID: PMC3377707. Epub 2012/06/22. eng.", "DOI": "10.1371/journal.pone.0037646", "doi-asserted-by": "crossref"}], "container-title": ["Molecular Pathology Library", "Precision Molecular Pathology of Breast Cancer"], "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/978-1-4939-2886-6_16", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 30]], "date-time": "2019-05-30T16:34:20Z", "timestamp": 1559234060000}, "score": 22.531933, "issued": {"date-parts": [[2015]]}, "ISBN": ["9781493928859", "9781493928866"], "references-count": 142, "URL": "http://dx.doi.org/10.1007/978-1-4939-2886-6_16", "relation": {"cites": []}, "ISSN": ["1935-987X", "1935-9888"], "issn-type": [{"value": "1935-987X", "type": "print"}, {"value": "1935-9888", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 30]], "date-time": "2019-11-30T10:27:11Z", "timestamp": 1575109631069}, "reference-count": 97, "publisher": "Ovid Technologies (Wolters Kluwer Health)", "issue": "4", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Anti-Cancer Drugs"], "published-print": {"date-parts": [[2005, 4]]}, "DOI": "10.1097/00001813-200504000-00002", "type": "journal-article", "created": {"date-parts": [[2005, 3, 3]], "date-time": "2005-03-03T09:00:36Z", "timestamp": 1109840436000}, "page": "361-372", "source": "Crossref", "is-referenced-by-count": 11, "title": ["Chemotherapy strategies in the treatment of small cell lung cancer"], "prefix": "10.1097", "volume": "16", "author": [{"given": "Sanjay", "family": "Popat", "sequence": "first", "affiliation": []}, {"given": "Mary", "family": "O??Brien", "sequence": "additional", "affiliation": []}], "member": "276", "container-title": ["Anti-Cancer Drugs"], "language": "en", "deposited": {"date-parts": [[2019, 1, 31]], "date-time": "2019-01-31T15:47:29Z", "timestamp": 1548949649000}, "score": 22.520761, "subtitle": [""], "issued": {"date-parts": [[2005, 4]]}, "references-count": 97, "journal-issue": {"issue": "4"}, "URL": "http://dx.doi.org/10.1097/00001813-200504000-00002", "ISSN": ["0959-4973"], "issn-type": [{"value": "0959-4973", "type": "print"}], "subject": ["Pharmacology (medical)", "Cancer Research", "Oncology", "Pharmacology"]}, {"indexed": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T11:20:56Z", "timestamp": 1574248856196}, "reference-count": 0, "publisher": "Ovid Technologies (Wolters Kluwer Health)", "issue": "3", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Advances in Anatomic Pathology"], "published-print": {"date-parts": [[1998, 5]]}, "DOI": "10.1097/00125480-199805000-00044", "type": "journal-article", "created": {"date-parts": [[2006, 12, 6]], "date-time": "2006-12-06T09:14:34Z", "timestamp": 1165396474000}, "page": "192", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Male breast cancer is not worse than female breast cancer"], "prefix": "10.1097", "volume": "5", "author": [{"family": "&NA;", "sequence": "first", "affiliation": []}], "member": "276", "container-title": ["Advances in Anatomic Pathology"], "language": "en", "link": [{"URL": "http://journals.lww.com/anatomicpathology/Fulltext/10.1097/00125480-199805000-00044", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2018, 11, 29]], "date-time": "2018-11-29T13:26:05Z", "timestamp": 1543497965000}, "score": 22.368593, "subtitle": [""], "issued": {"date-parts": [[1998, 5]]}, "references-count": 0, "journal-issue": {"issue": "3"}, "URL": "http://dx.doi.org/10.1097/00125480-199805000-00044", "ISSN": ["1072-4109"], "issn-type": [{"value": "1072-4109", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T17:56:45Z", "timestamp": 1574445405235}, "reference-count": 0, "publisher": "Informa UK Limited", "issue": "3", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Cancer Biology & Therapy"], "published-print": {"date-parts": [[2005, 3]]}, "DOI": "10.4161/cbt.4.3.1627", "type": "journal-article", "created": {"date-parts": [[2010, 7, 15]], "date-time": "2010-07-15T16:05:18Z", "timestamp": 1279209918000}, "page": "260-260", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Stat5, a Favorable Marker in Breast Cancer, Suppresses Invasion and Aggressive Growth of Breast Cancer Cells"], "prefix": "10.1080", "volume": "4", "author": [{"family": "na", "sequence": "first", "affiliation": []}], "member": "301", "published-online": {"date-parts": [[2014, 10, 27]]}, "container-title": ["Cancer Biology & Therapy"], "language": "en", "link": [{"URL": "http://www.tandfonline.com/doi/pdf/10.4161/cbt.4.3.1627", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2016, 12, 12]], "date-time": "2016-12-12T09:20:19Z", "timestamp": 1481534419000}, "score": 22.358768, "issued": {"date-parts": [[2005, 3]]}, "references-count": 0, "journal-issue": {"published-online": {"date-parts": [[2014, 10, 27]]}, "published-print": {"date-parts": [[2005, 3]]}, "issue": "3"}, "alternative-id": ["10.4161/cbt.4.3.1627"], "URL": "http://dx.doi.org/10.4161/cbt.4.3.1627", "ISSN": ["1538-4047", "1555-8576"], "issn-type": [{"value": "1538-4047", "type": "print"}, {"value": "1555-8576", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T07:05:13Z", "timestamp": 1574233513035}, "reference-count": 0, "publisher": "American Association for the Advancement of Science (AAAS)", "issue": "3996", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Science"], "published-print": {"date-parts": [[1971, 8, 6]]}, "DOI": "10.1126/science.173.3996.540", "type": "journal-article", "created": {"date-parts": [[2006, 10, 5]], "date-time": "2006-10-05T13:17:43Z", "timestamp": 1160054263000}, "page": "540-542", "source": "Crossref", "is-referenced-by-count": 93, "title": ["Adenosine 3',5'-Monophosphate Phosphodiesterase: Multiple Molecular Forms"], "prefix": "10.1126", "volume": "173", "author": [{"given": "E.", "family": "Monn", "sequence": "first", "affiliation": []}, {"given": "R. O.", "family": "Christiansen", "sequence": "additional", "affiliation": []}], "member": "221", "container-title": ["Science"], "language": "en", "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1126/science.173.3996.540", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2016, 12, 23]], "date-time": "2016-12-23T15:50:50Z", "timestamp": 1482508250000}, "score": 22.137377, "issued": {"date-parts": [[1971, 8, 6]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[1971, 8, 6]]}, "issue": "3996"}, "URL": "http://dx.doi.org/10.1126/science.173.3996.540", "ISSN": ["0036-8075", "1095-9203"], "issn-type": [{"value": "0036-8075", "type": "print"}, {"value": "1095-9203", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 12, 3]], "date-time": "2019-12-03T23:04:09Z", "timestamp": 1575414249099}, "publisher-location": "Unitec House, 2 Albert Place, London N3 1QB, UK", "reference-count": 23, "publisher": "Future Medicine Ltd", "isbn-type": [{"value": "9781780842769", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2014, 2]]}, "DOI": "10.2217/ebo.13.374", "type": "other", "created": {"date-parts": [[2013, 12, 18]], "date-time": "2013-12-18T10:57:26Z", "timestamp": 1387364246000}, "page": "20-33", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Molecular subtypes of breast cancer"], "prefix": "10.2217", "author": [{"given": "Henry O", "family": "Ebili", "sequence": "first", "affiliation": []}, {"given": "A Olayiwola", "family": "Oluwasola", "sequence": "additional", "affiliation": []}, {"given": "Olufunmilayo I", "family": "Olopade", "sequence": "additional", "affiliation": []}], "member": "1057", "published-online": {"date-parts": [[2013, 12, 18]]}, "reference": [{"key": "ch2-bid.1", "DOI": "10.4161/cbt.10.10.13879", "doi-asserted-by": "publisher"}, {"key": "ch2-bid.2", "DOI": "10.1016/j.mpdhp.2008.03.002", "doi-asserted-by": "publisher"}, {"issue": "1", "key": "ch2-bid.3", "first-page": "5", "volume": "50", "author": "Raica M", "year": "2009", "journal-title": "Rom. J. Morphol. Embryol."}, {"key": "ch2-bid.4", "DOI": "10.1200/JCO.2008.19.6873", "doi-asserted-by": "publisher"}, {"key": "ch2-bid.5", "DOI": "10.1007/s10549-012-2173-7", "doi-asserted-by": "publisher"}, {"key": "ch2-bid.6", "DOI": "10.1186/1471-2407-11-292", "doi-asserted-by": "publisher"}, {"key": "ch2-bid.7", "DOI": "10.3322/caac.20029", "doi-asserted-by": "publisher"}, {"key": "ch2-bid.8", "author": "Zepeda-Castilla EJ", "volume": "76", "first-page": "87", "year": "2008", "journal-title": "Cir. Ciruj."}, {"key": "ch2-bid.9", "DOI": "10.1158/1078-0432.CCR-07-4756", "doi-asserted-by": "publisher"}, {"key": "ch2-bid.10", "DOI": "10.1001/jama.295.21.2492", "doi-asserted-by": "publisher"}, {"key": "ch2-bid.11", "DOI": "10.1038/modpathol.3800538", "doi-asserted-by": "publisher"}, {"key": "ch2-bid.12", "DOI": "10.1158/1055-9965.EPI-06-0806", "doi-asserted-by": "publisher"}, {"key": "ch2-bid.13", "DOI": "10.1038/sj.onc.1208561", "doi-asserted-by": "publisher"}, {"key": "ch2-bid.14", "DOI": "10.1186/gb-2007-8-8-r157", "doi-asserted-by": "publisher"}, {"key": "ch2-bid.15", "DOI": "10.1158/1078-0432.CCR-06-0353", "doi-asserted-by": "publisher"}, {"key": "ch2-bid.16", "DOI": "10.1002/path.2407", "doi-asserted-by": "publisher"}, {"key": "ch2-bid.17", "DOI": "10.1073/pnas.0932692100", "doi-asserted-by": "publisher"}, {"key": "ch2-bid.18", "DOI": "10.1186/1471-2407-8-149", "doi-asserted-by": "publisher"}, {"key": "ch2-bid.19", "DOI": "10.1038/bjc.2013.528", "doi-asserted-by": "publisher"}, {"issue": "7", "key": "ch2-bid.20", "first-page": "vii41", "volume": "19", "author": "Cufer T", "year": "2008", "journal-title": "Ann. Oncol."}, {"key": "ch2-bid.21", "DOI": "10.1056/NEJMoa052933", "doi-asserted-by": "publisher"}, {"key": "ch2-bid.22", "DOI": "10.1002/ijc.21004", "doi-asserted-by": "publisher"}, {"key": "ch2-bid.23", "author": "Hicks DG", "volume": "13", "first-page": "31", "year": "2009", "journal-title": "Connection"}], "container-title": ["Personalized Management of Breast Cancer"], "link": [{"URL": "https://www.futuremedicine.com/doi/pdf/10.2217/ebo.13.374", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T09:50:16Z", "timestamp": 1574243416000}, "score": 22.109945, "issued": {"date-parts": [[2013, 12, 18]]}, "ISBN": ["9781780842769"], "references-count": 23, "alternative-id": ["10.2217/ebo.13.374", "10.2217/9781780842769"], "URL": "http://dx.doi.org/10.2217/ebo.13.374", "relation": {"cites": []}}, {"indexed": {"date-parts": [[2019, 11, 27]], "date-time": "2019-11-27T18:52:26Z", "timestamp": 1574880746510}, "reference-count": 50, "publisher": "Springer Science and Business Media LLC", "issue": "4", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2018, 9, 24]], "date-time": "2018-09-24T00:00:00Z", "timestamp": 1537747200000}, "delay-in-days": 0, "content-version": "tdm"}], "funder": [{"DOI": "10.13039/501100003769", "name": "Eisai", "doi-asserted-by": "publisher", "award": []}], "content-domain": {"domain": ["link.springer.com"], "crossmark-restriction": false}, "short-container-title": ["Curr Breast Cancer Rep"], "published-print": {"date-parts": [[2018, 12]]}, "DOI": "10.1007/s12609-018-0292-9", "type": "journal-article", "created": {"date-parts": [[2018, 9, 24]], "date-time": "2018-09-24T06:57:31Z", "timestamp": 1537772251000}, "page": "289-295", "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Updates on Molecular Classification of Triple Negative Breast Cancer"], "prefix": "10.1007", "volume": "10", "author": [{"given": "Nkiruka", "family": "Ezenwajiaku", "sequence": "first", "affiliation": []}, {"given": "Cynthia X.", "family": "Ma", "sequence": "additional", "affiliation": []}, {"given": "Foluso O.", "family": "Ademuyiwa", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2018, 9, 24]]}, "reference": [{"issue": "8", "key": "292_CR1", "doi-asserted-by": "publisher", "first-page": "718", "DOI": "10.1016/S1470-2045(10)70176-5", "volume": "11", "author": "Charles M Perou", "year": "2010", "unstructured": "Perou CM, Parker JS, Prat A, Ellis MJ, Bernard PS. Clinical implementation of the intrinsic subtypes of breast cancer. Lancet Oncol. 2010;11(8):718\u20139 author reply 20-1.", "journal-title": "The Lancet Oncology"}, {"issue": "6797", "key": "292_CR2", "doi-asserted-by": "publisher", "first-page": "747", "DOI": "10.1038/35021093", "volume": "406", "author": "CM Perou", "year": "2000", "unstructured": "Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, et al. Molecular portraits of human breast tumours. Nature. 2000;406(6797):747\u201352.", "journal-title": "Nature"}, {"issue": "5", "key": "292_CR3", "doi-asserted-by": "publisher", "first-page": "R68", "DOI": "10.1186/bcr2635", "volume": "12", "author": "A Prat", "year": "2010", "unstructured": "Prat A, Parker JS, Karginova O, Fan C, Livasy C, Herschkowitz JI, et al. Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer. Breast Cancer Res. 2010;12(5):R68.", "journal-title": "Breast Cancer Res"}, {"issue": "29", "key": "292_CR4", "doi-asserted-by": "publisher", "first-page": "4660", "DOI": "10.1038/sj.onc.1208561", "volume": "24", "author": "P Farmer", "year": "2005", "unstructured": "Farmer P, Bonnefoi H, Becette V, Tubiana-Hulin M, Fumoleau P, Larsimont D, et al. Identification of molecular apocrine breast tumours by microarray analysis. Oncogene. 2005;24(29):4660\u201371.", "journal-title": "Oncogene"}, {"issue": "6", "key": "292_CR5", "doi-asserted-by": "publisher", "first-page": "419", "DOI": "10.1097/PAP.0b013e3181594733", "volume": "14", "author": "LK Diaz", "year": "2007", "unstructured": "Diaz LK, Cryns VL, Symmans WF, Sneige N. Triple negative breast carcinoma and the basal phenotype: from expression profiling to clinical practice. Adv Anat Pathol. 2007;14(6):419\u201330.", "journal-title": "Adv Anat Pathol"}, {"key": "292_CR6", "doi-asserted-by": "publisher", "first-page": "S132", "DOI": "10.1016/j.breast.2015.07.032", "volume": "24", "author": "DG Stover", "year": "2015", "unstructured": "Stover DG, Winer EP. Tailoring adjuvant chemotherapy regimens for patients with triple negative breast cancer. Breast. 2015;24:S132\u2013S5.", "journal-title": "Breast"}, {"issue": "7", "key": "292_CR7", "doi-asserted-by": "publisher", "first-page": "1071", "DOI": "10.1007/s10552-009-9331-1", "volume": "20", "author": "KF Trivers", "year": "2009", "unstructured": "Trivers KF, Lund MJ, Porter PL, Liff JM, Flagg EW, Coates RJ, et al. The epidemiology of triple-negative breast cancer, including race. Cancer Causes Control. 2009;20(7):1071\u201382.", "journal-title": "Cancer Causes Control"}, {"issue": "15", "key": "292_CR8", "doi-asserted-by": "publisher", "first-page": "2568", "DOI": "10.1200/JCO.2007.13.1748", "volume": "26", "author": "EA Rakha", "year": "2008", "unstructured": "Rakha EA, Reis-Filho JS, Ellis IO. Basal-like breast cancer: a critical review. J Clin Oncol. 2008;26(15):2568\u201381.", "journal-title": "J Clin Oncol"}, {"issue": "1", "key": "292_CR9", "doi-asserted-by": "publisher", "first-page": "108", "DOI": "10.1111/j.1365-2559.2007.02889.x", "volume": "52", "author": "JS Reis-Filho", "year": "2008", "unstructured": "Reis-Filho JS, Tutt AN. Triple negative tumours: a critical review. Histopathology. 2008;52(1):108\u201318.", "journal-title": "Histopathology"}, {"key": "292_CR10", "unstructured": "National Comprehensive Cancer Network. Breast Cancer (Version 1.2018). \n                    https://www.nccn.org/professionals/physician_gls/pdf/breast_blocks.pdf\n                    \n                  ."}, {"issue": "15 Pt 1", "key": "292_CR11", "doi-asserted-by": "publisher", "first-page": "4429", "DOI": "10.1158/1078-0432.CCR-06-3045", "volume": "13", "author": "R Dent", "year": "2007", "unstructured": "Dent R, Trudeau M, Pritchard KI, Hanna WM, Kahn HK, Sawka CA, et al. Triple-negative breast cancer: clinical features and patterns of recurrence. Clin Cancer Res. 2007;13(15 Pt 1):4429\u201334.", "journal-title": "Clin Cancer Res"}, {"key": "292_CR12", "author": "F Pareja", "volume": "2", "year": "2016", "unstructured": "Pareja F, Geyer FC, Marchio C, Burke KA, Weigelt B, Reis-Filho JS. Triple-negative breast cancer: the importance of molecular and histologic subtyping, and recognition of low-grade variants. NPJ Breast Cancer. 2016;2:16036.", "journal-title": "NPJ Breast Cancer", "DOI": "10.1038/npjbcancer.2016.36", "doi-asserted-by": "publisher"}, {"issue": "7403", "key": "292_CR13", "doi-asserted-by": "publisher", "first-page": "395", "DOI": "10.1038/nature10933", "volume": "486", "author": "SP Shah", "year": "2012", "unstructured": "Shah SP, Roth A, Goya R, Oloumi A, Ha G, Zhao Y, et al. The clonal and mutational evolution spectrum of primary triple-negative breast cancers. Nature. 2012;486(7403):395\u20139.", "journal-title": "Nature"}, {"issue": "7418", "key": "292_CR14", "doi-asserted-by": "publisher", "first-page": "61", "DOI": "10.1038/nature11412", "volume": "490", "author": "Cancer Genome Atlas Network", "year": "2012", "unstructured": "Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490(7418):61\u201370.", "journal-title": "Nature"}, {"issue": "1\u20132", "key": "292_CR15", "first-page": "73", "volume": "32", "author": "CX Ma", "year": "2010", "unstructured": "Ma CX, Luo J, Ellis MJ. Molecular profiling of triple negative breast cancer. Breast Dis. 2010;32(1\u20132):73\u201384.", "journal-title": "Breast Dis"}, {"issue": "7471", "key": "292_CR16", "doi-asserted-by": "publisher", "first-page": "333", "DOI": "10.1038/nature12634", "volume": "502", "author": "C Kandoth", "year": "2013", "unstructured": "Kandoth C, McLellan MD, Vandin F, Ye K, Niu B, Lu C, et al. Mutational landscape and significance across 12 major cancer types. Nature. 2013;502(7471):333\u20139.", "journal-title": "Nature"}, {"issue": "7418", "key": "292_CR17", "doi-asserted-by": "publisher", "first-page": "61", "DOI": "10.1038/nature11412", "volume": "490", "author": "N Cancer Genome Atlas", "year": "2012", "unstructured": "Cancer Genome Atlas N. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490(7418):61\u201370.", "journal-title": "Nature"}, {"issue": "7", "key": "292_CR18", "doi-asserted-by": "publisher", "first-page": "2750", "DOI": "10.1172/JCI45014", "volume": "121", "author": "BD Lehmann", "year": "2011", "unstructured": "Lehmann BD, Bauer JA, Chen X, Sanders ME, Chakravarthy AB, Shyr Y, et al. Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies. J Clin Invest. 2011;121(7):2750\u201367.", "journal-title": "J Clin Invest"}, {"issue": "2", "key": "292_CR19", "doi-asserted-by": "publisher", "first-page": "142", "DOI": "10.1002/path.4280", "volume": "232", "author": "BD Lehmann", "year": "2014", "unstructured": "Lehmann BD, Pietenpol JA. Identification and use of biomarkers in treatment strategies for triple-negative breast cancer subtypes. J Pathol. 2014;232(2):142\u201350.", "journal-title": "J Pathol"}, {"issue": "6", "key": "292_CR20", "doi-asserted-by": "publisher", "first-page": "e0157368", "DOI": "10.1371/journal.pone.0157368", "volume": "11", "author": "BD Lehmann", "year": "2016", "unstructured": "Lehmann BD, Jovanovic B, Chen X, Estrada MV, Johnson KN, Shyr Y, et al. Refinement of triple-negative breast cancer molecular subtypes: implications for neoadjuvant chemotherapy selection. PLoS One. 2016;11(6):e0157368.", "journal-title": "PLoS One"}, {"issue": "7", "key": "292_CR21", "doi-asserted-by": "publisher", "first-page": "1688", "DOI": "10.1158/1078-0432.CCR-14-0432", "volume": "21", "author": "MD Burstein", "year": "2015", "unstructured": "Burstein MD, Tsimelzon A, Poage GM, Covington KR, Contreras A, Fuqua SA, et al. Comprehensive genomic analysis identifies novel subtypes and targets of triple-negative breast cancer. Clin Cancer Res. 2015;21(7):1688\u201398.", "journal-title": "Clin Cancer Res"}, {"key": "292_CR22", "doi-asserted-by": "publisher", "first-page": "43", "DOI": "10.1186/s13058-015-0550-y", "volume": "17", "author": "P Jezequel", "year": "2015", "unstructured": "Jezequel P, Loussouarn D, Guerin-Charbonnel C, Campion L, Vanier A, Gouraud W, et al. Gene-expression molecular subtyping of triple-negative breast cancer tumours: importance of immune response. Breast Cancer Res. 2015;17:43.", "journal-title": "Breast Cancer Res"}, {"issue": "1", "key": "292_CR23", "doi-asserted-by": "publisher", "first-page": "33", "DOI": "10.1186/s13058-016-0690-8", "volume": "18", "author": "YR Liu", "year": "2016", "unstructured": "Liu YR, Jiang YZ, Xu XE, Yu KD, Jin X, Hu X, et al. Comprehensive transcriptome analysis identifies novel molecular subtypes and subtype-specific RNAs of triple-negative breast cancer. Breast Cancer Res. 2016;18(1):33.", "journal-title": "Breast Cancer Res"}, {"issue": "1", "key": "292_CR24", "doi-asserted-by": "publisher", "first-page": "236", "DOI": "10.1002/ijc.23518", "volume": "123", "author": "F Bertucci", "year": "2008", "unstructured": "Bertucci F, Finetti P, Cervera N, Esterni B, Hermitte F, Viens P, et al. How basal are triple-negative breast cancers? Int J Cancer. 2008;123(1):236\u201340.", "journal-title": "Int J Cancer"}, {"issue": "19", "key": "292_CR25", "doi-asserted-by": "publisher", "first-page": "1482", "DOI": "10.1093/jnci/djg050", "volume": "95", "author": "WD Foulkes", "year": "2003", "unstructured": "Foulkes WD, Stefansson IM, Chappuis PO, Begin LR, Goffin JR, Wong N, et al. Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer. J Natl Cancer Inst. 2003;95(19):1482\u20135.", "journal-title": "J Natl Cancer Inst"}, {"issue": "7", "key": "292_CR26", "doi-asserted-by": "publisher", "first-page": "564", "DOI": "10.1093/jnci/92.7.564", "volume": "92", "author": "M Esteller", "year": "2000", "unstructured": "Esteller M, Silva JM, Dominguez G, Bonilla F, Matias-Guiu X, Lerma E, et al. Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors. J Natl Cancer Inst. 2000;92(7):564\u20139.", "journal-title": "J Natl Cancer Inst"}, {"key": "292_CR27", "doi-asserted-by": "publisher", "first-page": "2126", "DOI": "10.1038/sj.onc.1210014", "volume": "26", "author": "NC Turner", "year": "2006", "unstructured": "Turner NC, Reis-Filho JS, Russell AM, Springall RJ, Ryder K, Steele D, et al. BRCA1 dysfunction in sporadic basal-like breast cancer. Oncogene. 2006;26:2126.", "journal-title": "Oncogene"}, {"key": "292_CR28", "author": "I Echavarria", "first-page": "1845", "year": "2018", "unstructured": "Echavarria I, L\u00f3pez-Tarruella S, Picornell A, Garc\u00eda-Saenz J\u00c1, Jerez Y, Hoadley K, et al. Pathological response in a triple-negative breast cancer cohort treated with neoadjuvant carboplatin and docetaxel according to Lehmann\u2019s refined classification. In: Clin Cancer Res, vol. 24; 2018. p. 1845\u201352.", "volume-title": "Clin Cancer Res"}, {"issue": "19", "key": "292_CR29", "doi-asserted-by": "publisher", "first-page": "5533", "DOI": "10.1158/1078-0432.CCR-13-0799", "volume": "19", "author": "H Masuda", "year": "2013", "unstructured": "Masuda H, Baggerly KA, Wang Y, Zhang Y, Gonzalez-Angulo AM, Meric-Bernstam F, et al. Differential response to neoadjuvant chemotherapy among 7 triple-negative breast cancer molecular subtypes. Clin Cancer Res. 2013;19(19):5533\u201340.", "journal-title": "Clin Cancer Res"}, {"issue": "9", "key": "292_CR30", "doi-asserted-by": "publisher", "first-page": "3352", "DOI": "10.1021/cr020456u", "volume": "105", "author": "W Gao", "year": "2005", "unstructured": "Gao W, Bohl CE, Dalton JT. Chemistry and structural biology of androgen receptor. Chem Rev. 2005;105(9):3352\u201370.", "journal-title": "Chem Rev"}, {"issue": "2", "key": "292_CR31", "doi-asserted-by": "publisher", "first-page": "77", "DOI": "10.1016/j.jnci.2012.04.001", "volume": "24", "author": "HA Alshenawy", "year": "2012", "unstructured": "Alshenawy HA. Prevalence of androgen receptors in invasive breast carcinoma and its relation with estrogen receptor, progesterone receptor and Her2/neu expression. J Egypt Natl Canc Inst. 2012;24(2):77\u201383.", "journal-title": "J Egypt Natl Canc Inst"}, {"issue": "2", "key": "292_CR32", "doi-asserted-by": "publisher", "first-page": "477", "DOI": "10.1007/s10549-011-1715-8", "volume": "130", "author": "S Loibl", "year": "2011", "unstructured": "Loibl S, Muller BM, von Minckwitz G, Schwabe M, Roller M, Darb-Esfahani S, et al. Androgen receptor expression in primary breast cancer and its predictive and prognostic value in patients treated with neoadjuvant chemotherapy. Breast Cancer Res Treat. 2011;130(2):477\u201387.", "journal-title": "Breast Cancer Res Treat"}, {"key": "292_CR33", "doi-asserted-by": "publisher", "first-page": "4675", "DOI": "10.2147/OTT.S126051", "volume": "10", "author": "A Mina", "year": "2017", "unstructured": "Mina A, Yoder R, Sharma P. Targeting the androgen receptor in triple-negative breast cancer: current perspectives. Onco Targets Ther. 2017;10:4675\u201385.", "journal-title": "Onco Targets Ther"}, {"issue": "3", "key": "292_CR34", "doi-asserted-by": "publisher", "first-page": "488", "DOI": "10.1093/annonc/mdp510", "volume": "21", "author": "S Park", "year": "2010", "unstructured": "Park S, Koo J, Park HS, Kim JH, Choi SY, Lee JH, et al. Expression of androgen receptors in primary breast cancer. Ann Oncol. 2010;21(3):488\u201392.", "journal-title": "Ann Oncol"}, {"issue": "8", "key": "292_CR35", "doi-asserted-by": "publisher", "first-page": "3589", "DOI": "10.1158/0008-5472.CAN-08-4016", "volume": "69", "author": "E Alli", "year": "2009", "unstructured": "Alli E, Sharma VB, Sunderesakumar P, Ford JM. Defective repair of oxidative dna damage in triple-negative breast cancer confers sensitivity to inhibition of poly(ADP-ribose) polymerase. Cancer Res. 2009;69(8):3589\u201396.", "journal-title": "Cancer Res"}, {"issue": "20", "key": "292_CR36", "doi-asserted-by": "publisher", "first-page": "7970", "DOI": "10.1158/0008-5472.CAN-09-4521", "volume": "70", "author": "K Hastak", "year": "2010", "unstructured": "Hastak K, Alli E, Ford JM. Synergistic chemosensitivity of triple-negative breast cancer cell lines to poly(ADP-Ribose) polymerase inhibition, gemcitabine, and cisplatin. Cancer Res. 2010;70(20):7970\u201380.", "journal-title": "Cancer Res"}, {"issue": "6", "key": "292_CR37", "doi-asserted-by": "publisher", "first-page": "523", "DOI": "10.1056/NEJMoa1706450", "volume": "377", "author": "M Robson", "year": "2017", "unstructured": "Robson M, Im SA, Senkus E, Xu B, Domchek SM, Masuda N, et al. Olaparib for metastatic breast cancer in patients with a germline BRCA mutation. N Engl J Med. 2017;377(6):523\u201333.", "journal-title": "N Engl J Med"}, {"key": "292_CR38", "unstructured": "A study evaluating talazoparib (BMN 673), a PARP inhibitor, in advanced and/or metastatic breast cancer patients with BRCA mutation (EMBRACA Study) 2018. Available from: \n                    https://clinicaltrials.gov/ct2/show/NCT01945775\n                    \n                  ."}, {"issue": "5", "key": "292_CR39", "doi-asserted-by": "publisher", "first-page": "1368", "DOI": "10.1158/1078-0432.CCR-07-1658", "volume": "14", "author": "MC Cheang", "year": "2008", "unstructured": "Cheang MC, Voduc D, Bajdik C, Leung S, McKinney S, Chia SK, et al. Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype. Clin Cancer Res. 2008;14(5):1368\u201376.", "journal-title": "Clin Cancer Res"}, {"issue": "5", "key": "292_CR40", "doi-asserted-by": "publisher", "first-page": "R61", "DOI": "10.1186/bcr1767", "volume": "9", "author": "AL Stratford", "year": "2007", "unstructured": "Stratford AL, Habibi G, Astanehe A, Jiang H, Hu K, Park E, et al. Epidermal growth factor receptor (EGFR) is transcriptionally induced by the Y-box binding protein-1 (YB-1) and can be inhibited with Iressa in basal-like breast cancer, providing a potential target for therapy. Breast Cancer Res. 2007;9(5):R61.", "journal-title": "Breast Cancer Res"}, {"issue": "20", "key": "292_CR41", "doi-asserted-by": "publisher", "first-page": "2586", "DOI": "10.1200/JCO.2012.46.2408", "volume": "31", "author": "J Baselga", "year": "2013", "unstructured": "Baselga J, Gomez P, Greil R, Braga S, Climent MA, Wardley AM, et al. Randomized phase II study of the anti-epidermal growth factor receptor monoclonal antibody cetuximab with cisplatin versus cisplatin alone in patients with metastatic triple-negative breast cancer. J Clin Oncol. 2013;31(20):2586\u201392.", "journal-title": "J Clin Oncol"}, {"key": "292_CR42", "doi-asserted-by": "publisher", "first-page": "3994", "DOI": "10.1038/sj.onc.1209415", "volume": "25", "author": "AS Doane", "year": "2006", "unstructured": "Doane AS, Danso M, Lal P, Donaton M, Zhang L, Hudis C, et al. An estrogen receptor-negative breast cancer subset characterized by a hormonally regulated transcriptional program and response to androgen. Oncogene. 2006;25:3994\u20134008.", "journal-title": "Oncogene"}, {"issue": "19", "key": "292_CR43", "doi-asserted-by": "publisher", "first-page": "5505", "DOI": "10.1158/1078-0432.CCR-12-3327", "volume": "19", "author": "A Gucalp", "year": "2013", "unstructured": "Gucalp A, Tolaney S, Isakoff SJ, Ingle JN, Liu MC, Carey LA, et al. Phase II trial of bicalutamide in patients with androgen receptor\u2013positive, estrogen receptor\u2013negative metastatic breast cancer. Clin Cancer Res. 2013;19(19):5505\u201312.", "journal-title": "Clin Cancer Res"}, {"issue": "9", "key": "292_CR44", "doi-asserted-by": "publisher", "first-page": "884", "DOI": "10.1200/JCO.2016.71.3495", "volume": "36", "author": "TA Traina", "year": "2018", "unstructured": "Traina TA, Miller K, Yardley DA, Eakle J, Schwartzberg LS, O\u2019Shaughnessy J, et al. Enzalutamide for the treatment of androgen receptor-expressing triple-negative breast cancer. J Clin Oncol. 2018;36(9):884\u201390.", "journal-title": "J Clin Oncol"}, {"issue": "suppl_1", "key": "292_CR45", "doi-asserted-by": "publisher", "first-page": "mdx145-mdx", "DOI": "10.1093/annonc/mdx145", "volume": "28", "author": "U Asghar", "year": "2017", "unstructured": "Asghar U, Barr A, Cutts R, Beaney M, Sampath D, Giltnane J, et al. 44PUnravelling mechanisms of resistance to CDK4/6 inhibitors using triple negative breast cancer (TNBC). Ann Oncol. 2017;28(suppl_1):mdx145-mdx.", "journal-title": "Ann Oncol"}, {"issue": "27", "key": "292_CR46", "doi-asserted-by": "publisher", "first-page": "2959", "DOI": "10.1200/JCO.2013.55.0491", "volume": "32", "author": "S Adams", "year": "2014", "unstructured": "Adams S, Gray RJ, Demaria S, Goldstein L, Perez EA, Shulman LN, et al. Prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancers from two phase III randomized adjuvant breast cancer trials: ECOG 2197 and ECOG 1199. J Clin Oncol. 2014;32(27):2959\u201366.", "journal-title": "J Clin Oncol"}, {"issue": "1", "key": "292_CR47", "doi-asserted-by": "publisher", "first-page": "105", "DOI": "10.1200/JCO.2009.23.7370", "volume": "28", "author": "C Denkert", "year": "2010", "unstructured": "Denkert C, Loibl S, Noske A, Roller M, Muller BM, Komor M, et al. Tumor-associated lymphocytes as an independent predictor of response to neoadjuvant chemotherapy in breast cancer. J Clin Oncol. 2010;28(1):105\u201313.", "journal-title": "J Clin Oncol"}, {"issue": "1", "key": "292_CR48", "doi-asserted-by": "publisher", "first-page": "40", "DOI": "10.1016/S1470-2045(17)30904-X", "volume": "19", "author": "C Denkert", "year": "2018", "unstructured": "Denkert C, von Minckwitz G, Darb-Esfahani S, Lederer B, Heppner BI, Weber KE, et al. Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy. Lancet Oncol. 2018;19(1):40\u201350.", "journal-title": "Lancet Oncol"}, {"issue": "4", "key": "292_CR49", "doi-asserted-by": "publisher", "first-page": "361", "DOI": "10.1158/2326-6066.CIR-13-0127", "volume": "2", "author": "EA Mittendorf", "year": "2014", "unstructured": "Mittendorf EA, Philips AV, Meric-Bernstam F, Qiao N, Wu Y, Harrington S, et al. PD-L1 expression in triple-negative breast cancer. Cancer Immunol Res. 2014;2(4):361\u201370.", "journal-title": "Cancer Immunol Res"}, {"key": "292_CR50", "author": "N Tung", "volume": "2", "year": "2016", "unstructured": "Tung N, Garber JE, Hacker MR, Torous V, Freeman GJ, Poles E, et al. Prevalence and predictors of androgen receptor and programmed death-ligand 1 in BRCA1-associated and sporadic triple-negative breast cancer. NPJ Breast Cancer. 2016;2:16002.", "journal-title": "NPJ Breast Cancer", "DOI": "10.1038/npjbcancer.2016.2", "doi-asserted-by": "publisher"}], "container-title": ["Current Breast Cancer Reports"], "language": "en", "link": [{"URL": "http://link.springer.com/article/10.1007/s12609-018-0292-9/fulltext.html", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/content/pdf/10.1007/s12609-018-0292-9.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/content/pdf/10.1007/s12609-018-0292-9.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 9, 23]], "date-time": "2019-09-23T23:23:45Z", "timestamp": 1569281025000}, "score": 22.09236, "issued": {"date-parts": [[2018, 9, 24]]}, "references-count": 50, "journal-issue": {"published-print": {"date-parts": [[2018, 12]]}, "issue": "4"}, "alternative-id": ["292"], "URL": "http://dx.doi.org/10.1007/s12609-018-0292-9", "relation": {"cites": []}, "ISSN": ["1943-4588", "1943-4596"], "issn-type": [{"value": "1943-4588", "type": "print"}, {"value": "1943-4596", "type": "electronic"}], "assertion": [{"value": "24 September 2018", "order": 1, "name": "first_online", "label": "First Online", "group": {"name": "ArticleHistory", "label": "Article History"}}, {"order": 1, "name": "Ethics", "group": {"name": "EthicsHeading", "label": "Compliance with Ethical Standards"}}, {"value": "Cynthia X. Ma has served on the advisory board for Merck, Pfizer, Novartis, Eli Lily, and AstraZeneca and has received a grant from Eisai.Nkiruka Ezenwajiaku and Foluso O. Ademuyiwa declare that they have no competing interests.", "order": 2, "name": "Ethics", "group": {"name": "EthicsHeading", "label": "Conflict of Interest"}}, {"value": "This article does not contain any studies with human or animal subjects performed by any of the authors.", "order": 3, "name": "Ethics", "group": {"name": "EthicsHeading", "label": "Human and Animal Rights and Informed Consent"}}]}, {"indexed": {"date-parts": [[2019, 12, 1]], "date-time": "2019-12-01T09:06:04Z", "timestamp": 1575191164267}, "reference-count": 0, "publisher": "Ovid Technologies (Wolters Kluwer Health)", "issue": "6", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Cancer Nursing"], "published-print": {"date-parts": [[2005, 11]]}, "DOI": "10.1097/00002820-200511000-00008", "type": "journal-article", "created": {"date-parts": [[2005, 12, 5]], "date-time": "2005-12-05T10:11:36Z", "timestamp": 1133777496000}, "page": "458-459", "source": "Crossref", "is-referenced-by-count": 1, "title": ["Breast Cancer Survivors' Intentions of Managing Lymphedema"], "prefix": "10.1097", "volume": "28", "author": [{"family": "&NA;", "sequence": "first", "affiliation": []}], "member": "276", "container-title": ["Cancer Nursing"], "language": "en", "deposited": {"date-parts": [[2018, 2, 8]], "date-time": "2018-02-08T20:14:18Z", "timestamp": 1518120858000}, "score": 22.087795, "subtitle": [""], "issued": {"date-parts": [[2005, 11]]}, "references-count": 0, "journal-issue": {"issue": "6"}, "URL": "http://dx.doi.org/10.1097/00002820-200511000-00008", "ISSN": ["0162-220X"], "issn-type": [{"value": "0162-220X", "type": "print"}], "subject": ["Oncology(nursing)", "Oncology"]}], "items-per-page": 20, "query": {"start-index": 0, "search-terms": null}}}